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ABSTRACT

Chen, Xi. Ph.D., Purdue University, May 2016. Impact of Dietary Modification on
Aflatoxicosis in Poultry. Major Professor: Todd Applegate.

Aflatoxin contamination in feed and feed ingredients is of high worldwide
prevalence, posing serious risks to the livestock industry. A series of studies were
conducted to better understand the comprehensive impact of aflatoxicosis and its
interrelationships with dietary modifications in broiler chicks and ducks. Results of these
studies emphasize the many factors that the severity of aflatoxicosis depends on, including
animal species, age, presence of mycotoxin adsorbent, and concentration of major dietary
nutrients. Exposure to 2 mg/kg cultured AFB1 led to reduced feed intake, BW gain,
depressed feed efficiency, increased relative liver weight, negatively affected serum
measures and complement activity, as well as affected hepatic gene expression in 21 d
broiler chicks. Additionally, impaired gut barrier, increased endogenous N loss, and
reduced energy, N, and amino acid digestibility, and altered mRNA expression of intestinal
tight junction proteins and transporters are also consequences of AFB1 exposure at 1.5
mg/kg in broilers. Disparately, as low as 0.1 mg/kg AFB1 led to significantly impaired
growth, liver functions, and innate immune dynamics in 14 d Pekin ducklings, while effects
of AFB1 on the gastrointestinal tract are less noticeable in ducks, with partial changes in
jejunum morphology, digestive enzyme activity, and apparent energy digestibility. This
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suggests that while broilers may be more resistant, ducks are extremely sensitive to AFB1,
and that the negative effects from AFB1 primarily result from reduced feed intake for ducks.
Although total protection was not observed, supplementing HSCAS at 0.05% was
effective to partially prevent aflatoxicosis in both broilers and ducks, as shown by
improved performance (weekly but not cumulative in both species), restoring the
negatively affected serum measures, and increased relative liver weight. Whether this is a
direct effect on the liver and/or indirect result from reduced AFB1 absorption awaits further
verification. Notably, the tested HSCAS was able to increase the mRNA expression and
protein activity of major hepatic anti-oxidant activity, suggesting stimulated anti-oxidant
function of the animal and likely a better ability to relieve the oxidative stress during
aflatoxicosis.Thus, this may be a direct cause for the relieved liver damage by HSCAS. In
addition to non-nutritive adsorbents, dietary nutrients can also influence the response and
extent of the animal’s response to AFB1 exposure. A significant interaction of dietary crude
protein and AFB1 was found in broilers, where the growth performance and health
impairment (including serum measures, gut permeability, and N and amino acid
digestibility) from aflatoxicosis were augmented when birds were fed a lower CP diet, and
were completely eliminated by a higher CP diet. Higher dietary protein also improved BW
gain and G:F ratio in ducks during aflatoxicosis, but no interaction was observed.
Nevertheless, in both species, feeding low protein diets exacerbated the negative effects of
AFB1, thus extra caution is needed when low CP diets are being fed. In addition, higher
dietary branched chain amino acids (BCAA), key regulators in protein synthesis, improved
all performance measures in broilers during aflatoxicosis, but no interaction was observed
and higher BCAA negatively affected nutrient digestibility and serum measures. These
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observations reveal the complexity of the dynamic relationship between aflatoxicosis and
dietary nutrients.
On the other hand, the question remains whether in vitro response can be used to
predict in vivo toxicity with sufficient accuracy. Good in vitro estimation of the toxicity
potential of sample may be useful in initial screening of feed and feed ingredients. By
exploring the response of fresh primary duck embryonic fibroblasts to various cytotoxins
and mycotoxins, we showed that primary DEF had a higher sensitivity to toxins compared
to HepG2 cells, and thus great potential in serving as a cytotoxicity screening model in
vitro. Further attention should be given to the understanding of additive, synergistic, and
antagonistic effects of multiple mycotoxins in in vitro systems and implications for animal
responses in vivo.

1

CHAPTER 1. LITERATURE REVIEW

1.1

Introduction of Aflatoxins

Aflatoxins (AF) are major mycotoxins that are produced when various Aspergillus
species, primarily A. flavus and A.parasiticus, colonize a food or feed. The synthesis of AF
is considered a ‘secondary’ process because it has no critical physiological functions in the
growth and metabolism of the fungi (Malik, 1982). Corn, peanut, and cottonseed are among
the most susceptible crops to AF contamination, which can occur during crop growth and
harvesting under suboptimal environmental factors. The inoculum of the fungi may
originate from the soil, airborne propagules, or be introduced by insect vectors.
Combination of these sources may also lead to continuous inoculum throughout the
growing season. After successful inoculum and colonization by the Aspergillus fungus, the
production of AF depends heavily on the environmental conditions, including weather
(temperature and humidity), crop maturity, and plant response to fungal infestation. It is
possible that the inoculum remains quiescent, or AF formation may be absent even with
extensive fungal growth. However, favorable conditions such as warm humid climates lead
to AF production; hence in temperate regions, severe contamination can be seen during
extreme weather conditions such as drought or precipitation. Generally, dry and hot
conditions favor AF production during crop growth, while wet conditions favor its
production after crop maturation (Cotty and Jaime-Garcia, 2007). The optimum
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temperature range for AF production is from 25 to 30 ⁰C. However, while at lower
temperatures, equal amounts of AFB and AFG are formed (1:1 ratio for AFB and AFG
production at 15 to 18 ⁰C, respectively), the production of AFB predominates that of AFG
at higher temperatures (12:1 for AFB and AFG production, respectively, at 32 ⁰C) (Ellis et
al., 1991). On the other hand, plants can become more vulnerable to fungal infection when
under stress during extreme weather situations (Wu et al., 2011). If fungi inoculum is
present with high relative humidity, AF production can also occur during storage and
processing of the crops (Eaton and Groopman, 2013).

Figure 1.1. Chemical structure of AFB1, AFB2, AFM1, AFM2, AFG1, and AFG2 (Zain,
2011)
Chemically, AF are difuranocoumarin compounds and include aflatoxin B1, B2, G1,
G2, M1 and M2 depending on their structures (Figure 1.1; Zain, 2011). The letters B (blue)
and G (green) represent the color of the fluorescent emissions from these AFs (Nesbitt et
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al., 1962). Isolation and characterization of the major four AF, namely AFB1, B2, G1, and
G2, was first reported by Hartley et al. (1963). Molecular formulas for the 4 AFs are closely
similar: C17H12O6 (B1), C17H14O6 (B2), C17H12O7 (G1), and C17H14O7 (G2). Aflatoxin M1 (4hydroxy-AFB1) and M2 (4-hydroxy-AFB2), on the other hand, are metabolites of AFB1 and
AFB2, respectively (Holzapfel et al., 1966). They are mainly found in milk (small quantities
of AFM1 have been reported in eggs). Despite the similar chemical structures, different
toxicity potentials exist for the different AF, with AFB1 considered the most toxicogenic
and is classified as a human carcinogen (Yunus et al., 2011), while others are considerably
less toxic to animals and humans.

1.2

Prevalence of AF Contamination

Aflatoxin contamination in animal feed and feed ingredients has been a worldwide
concern for decades, and due to the great adaptability of these fungi species, it is becoming
an increasingly prevalent and serious risk to the livestock industry globally (Grenier and
Applegate, 2013). The much-cited FAO (Food and Agriculture Organization of the United
Nations) estimates suggested that up to 20% of the worlds food production is lost due to
mycotoxin contamination (FAO, 1997). Conversely, according to a worldwide mycotoxin
survey from 2004-2013 (Streit et al., 2013a), 72% feed and feed ingredient samples
contained at least one mycotoxin and 38% contained multiple mycotoxins out of the 17,316
samples tested. In the same survey program, 4,230 samples tested AF positive
(approximately 27%), with an average concentration of 13 μg/kg and a maximum
concentration of 6, 323 μg/kg (Murugesan et al., 2014). In finished feeds, approximately
20% of the samples were AF positive from 2,090 samples tested, with an average
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concentration of 11 μg/kg and a maximum concentration of 2,454 μg/kg. From 2005 to
2009, the percentage of aflatoxin-positive samples increased from 16% to 33% globally.
Notably, in south-east Asia, the percentage of AF positive samples has continuously
increased since 2005 (32 % in 2005 versus 65 % in 2011); the average contamination of
AF in corn also rose from 45 μg/kg (2005) to 183 μg/kg (2009). Among all crops, corn is
generally considered the most vulnerable to mycotoxin contamination. While the
contamination pattern of other mycotoxins (e.g. deoxynivalenol (DON), fumonisins B (FB),
and ochratoxin A (OTA)) remained fairly steady, AF showed a significant increased from
11% positive to 45% positive from 2005 to 2009 in corn. On the other hand, although Asia
has been known to be the primary region for high AF contamination, the share of Asian
AF-positive samples of all AF-positive samples has significantly decreased from 97 % in
2005 to 55 % in 2001, primarily due to the raising AF prevalence in America, which
provided the second biggest share of AF-positive samples as of 2011 (Streit et al., 2013).
In addition, the presence of more than 1 mycotoxin was detected in 60% of the finished
feed samples, posing a challenge for animals because simultaneous exposure to multiple
mycotoxins may potentially lead to synergistic interactions (CAST, 2003).
The prevalence of AF contamination in the agricultural raw materials used as feed
ingredients raises a huge challenge for international trading. The maximum concentrations
of AF according to these surveys markedly exceeded the European Union (EU) guideline
for the maximum AF concentration in animal feed (Table 1.1; EC 2006), which is 0.05
mg/kg for raw ingredient (when moisture content is at 12%) and 0.02 mg/kg for complete
feed for poultry. According the U. S. Food and Drug Administration (FDA) guideline,
AFB1 concentration in corn and peanut products should not exceed 0.02 and 0.1 mg/kg for

5
immature and mature poultry, respectively, with a maximum AFB1 in cottonseed meal at
0.3 mg/kg. By far, China has the most extensive and detailed regulation (Table 1.1).
Allowable concentrations of AFB1 are ≤ 0.05 mg/kg in corn, peanut meal, cottonseed meal,
and rapeseed meal, ≤ 0.03 mg/kg in soybean meal, ≤ 0.02 in complete feeds for broilers
and layers, ≤ 0.015 in complete feeds for ducks and layers, and ≤ 0.01 in complete feeds
for young poultry. These regulatory limits have implications for international trade in grain
crops and, in some instances, can result in a barrier for the export or import of commodities
from different parts of the world. Importantly, FDA and EU generally do not permit corn
containing AF to be blended with uncontaminated corn to reduce the AF content of the
resulting mixture to levels acceptable for use as human food or animal feed. However, on
occasion, FDA has relaxed its “no-blending” policy in response to widespread outbreaks
of AF (as occurred in 1988) or in response to state-specific requests to address local
outbreaks (as was allowed in several U.S. states during the 2012 harvest).
Crop contamination of mycotoxins has resulted in substantial economic losses
(estimated > $ 900 million annually), in addition to the approximately $460 million loss
from regulatory testing, enforcement, and quality control measures (CAST, 2003).
Considering the impacts of global climate change which favors AF production, continuous
increase of AF contamination is possible (Streit et al., 2013). The community structure of
the AF-producing fungi may alter and the quantity of AF-producing fungi in the
environment may change as climate shifts. Climate fluctuations may also affect crop
development and insect activity, leading to altered predisposition of fungal hosts for AF
contamination (Cotty and Jaime-Garcia, 2007). With the progress of global warming and
continuously more erratic weather patterns, AF contamination may be further prevalent
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worldwide, and thus require better understandings and novel solutions to prevent and
control AF formations in feeds and feed ingredients and minimize animal production losses
due to intake of AF-contaminated feeds.

1.3

Aflatoxicosis in Poultry

The discovery and isolation of AF can be traced back to the mysterious “TurkeyX” disease in 1960, which resulted in the loss of several thousand turkey poults in the
United Kingdom (Blount, 1961). Shortly after the occurrence of turkey-X disease, similar
symptoms were reported in chickens and ducklings, which included acute hepatic failure,
bile duct hyperplasia, and significant reduction in appetite, slow growth, and mortality
(Blount, 1961, Asplin and Carnaghan, 1961). Later, the toxins were characterized
chemically and were designated the name aflatoxins (Asao et al., 1963).
Ever since their discovery, aflatoxins have been given considerable attention because
of their demonstrated carcinogenic potential and hepatotoxic effects in both humans and
animals. Generally, adverse effects of AF in poultry include reduction in growth rate and
feed efficiency, decreased egg production and hatchability, changes in organ weights,
impaired liver functions, and immunosuppression, and increased susceptibility to disease.
In addition, residues of AF from animals can appear in edible animal products for human
consumption (e.g. milk and egg), which raises public health concerns (Edds and Bortell,
1983; Leeson et al., 1995; Ledoux et al., 1999; Devegowda and Murthy, 2005; Yarru et al.,
2009; Andretta et al., 2011). Aflatoxins are considered biosynthetic inhibitors both in vivo
and in vitro, with demonstrated ability of affecting energy metabolism (by inhibiting major
enzyme activity), carbohydrate metabolism (through inhibiting glycogenesis), as well as
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lipid metabolism (Ellis et al., 1991; Moss and Smith, 1985). But primarily, AF is known
to interfere with nucleic acid and protein metabolism and thus a potent inhibitor of protein
synthesis and activity, leading to disruptions of a wide range of biological functions of an
animal.
The severity of aflatoxicosis depend on many factors, including the constitution of AF
subtypes, dose and exposure time, the animal species, age, and health status. Importantly,
the primary threat of AF to the poultry industry is not from acute clinical aflatoxicosis
(often sudden death) upon exposure to high doses of AF, but rather, it’s from subclinical
aflatoxicosis with chronic intake of low levels of AF. The latter is characterized primarily
as slower growth and impaired health of the animals without high mortality, yet may lead
to substantial production losses to producers due to lower-than-target market body weight,
wasted feeds, and animal losses from higher susceptibility to diseases. Therefore,
understanding of the effects and mechanisms of AF in poultry is vital in order to develop
effective counteractive strategies to aflatoxicosis. A more detailed elucidation of the known
effects and mechanisms of AF on performance, hepatic health, immune functions, serum
biochemistry, and gastrointestinal tract will be discussed below.

1.3.1

Biotransformation of Aflatoxins

Aflatoxins are absorbed at a high rate (80 – 90%) in the upper part of the small
intestine (duodenum and upper jejunum) in poultry (Grenier and Applegate, 2013).
Following absorption, AFB1 undergoes an extensive transformation into various
metabolites primarily in the liver (Figure 1.2). In fact, AFB1 is not toxic per se, but requires
metabolic oxidation by hepatic enzymes to the metabolically active metabolite exo-AFB1-
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8, 9-epoxide (AFBO) to exert its toxicity. The cytochrome P450 enzyme family (CYP450),
particularly CYP 3A4, 1A1, 1A2, and 2A6, are the major hepatic enzymes responsible for
AFB1 bio-activation, but prostaglandin synthase and lipoxygenases may also participate in
the process (Gallagher et al., 1996; Guengerich et al., 1999). The AFBO is the only known
genotoxic product of AFB1, it is highly active and is capable of covalently binding to
cellular macromolecules, including protein, RNA, and DNA, which leads to the formation
of pro-mutagenic adducts (Bennett et al., 1981). The major damaging adduct is the AFBN7-guanine adduct, a chemically highly unstable compound. Potentially, it can develop
into carcinogenic compound upon localization in transcriptionally active DNA regions, if
not removed by DNA repair enzymes in time. Therefore, AFBO is considered to be the
active form that is responsible for the carcinogenicity and mutagenicity of AF (Bedard and
Massey, 2006; Gross-Steinmeyer and Eaton, 2012).
Besides AFBO, AFB1 can also be oxidized by the CYP450 enzymes into other
metabolites, including AFB2, AFM, AFQ, and AFP. Formation of these metabolites are
considered to be detoxification reactions because they contain substantially lower toxicity
and carcinogenicity compared to AFB1 (Hsieh et al., 1984). Meanwhile, AFB1 can also be
reduced by the cytosolic dehydrogenase into aflatoxicol (AFL); however, this reaction is
reversible by liver cytosolic NADPH2 reductase, and thus AFL is considered to be a storage
pool for AFB1 instead of a detoxification product. On the other hand, AFBO can be
detoxified mainly through conjugation reactions with glutathione S-transferase (GST), and
to a lesser extend with epoxide hydrolase (EH). Formation of the conjugates protect DNA
from forming carcinogenic AFB-DNA adducts, and facilitate the excretion of AFBO
through the urine in the form of AFB-mercapturic acid (Diaz and Murcia, 2011; Kelly et
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al., 2002). Previous research has suggested the existence of species difference in terms of
GST activity, where in rats and mice, GST is highly effective in trapping AFBO, but in
other animals (including humans), there is a lack of measurable activity of GST toward
AFBO (Eaton and Gallagher, 1994). This difference in detoxification enzyme activity, and
possibly in bioactivation enzyme activities, may be an important contributor to the different
interspecies and interindividual susceptibilities to aflatoxicosis.
Figure 1.2. Biotransformation reactions of aflatoxin B1 in poultry and mammals (Diaz
and Murcia, 2011)
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1.3.2

Effects of AF on Performance

Research from the past few decades has illustrated the negative effects of AF on
poultry performance; the severity depends on many factors including animal species, age,
source and concentration of the AF fed, and exposure time. Further, the different feeds and
nutritional compositions used in different studies make it difficult to generalize the doseresponse relationship regarding performance. However, there is a general agreement that
dietary AF reduces weight gain and feed intake, and worsens feed efficiency.
A summary of broiler performance in response to dietary AF exposure is shown in
Table 1.2, where the effects of AFB1 concentration ranging from 0.02 to 5 mg/kg were
evaluated in broilers fed for 3 to 7 weeks. Generally, negative effects of AF are more
noticeable in younger birds (≤ 3 wk). At 5 mg/kg, AFB1 from either purified or cultured
sources reduced 21 and 24 d BW gain by 8.9 and 8.5 g/d, respectively (Randall and Bird,
1979; Kubena et al., 1998). At lower levels of 1, 2, 2.5, 3, 3.5, and 4 mg/kg AFB1, reduction
of BW gain averaged to 5.4 g/d (Verma et al., 2004, Denli et al., 2009; Zhao et al., 2010;
Gowda et al., 2008), 5.7 g/d (Basmacioglu et al., 2005; Zhao et al., 2010), 7.7 g/d (Miazzo
et al., 2000); 2.4 g/d (Valdivia et al., 2001), 4.7 g/d (Kubena et al., 1997), and 6.9 g/d
(Ledoux et al., 1999; Edrington et al., 1997), respectively. Natural contamination of
feedstuffs by AF is often lower than the concentrations used in research (Dersjant-Li et al.,
2003), yet little attention has been paid to the chronic ingestion of small amounts (≤ 1
mg/kg) of AF. Interestingly, a review of studies conducted prior to the 1980s concluded
that AFB1 would not have a negative effect on broiler performance up to 1.25 mg/kg
(Patterson, 1977). However, research in the last decade have accentuated the potential of
low levels of AFB1 (≤ 1 mg/kg) to negatively affect broiler performance. Kana et al. (2010)
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fed 21 to 49 d broilers with 0.02 mg/kg AFB1 from cultured peanut, and found a reduction
in BW gain at 4 g/d and feed intake at 11 g/d. Similarly, Raju and Devegowda (2000)
reported a 12 g/d decrease in BW gain in 35 d broilers fed 0.3 mg/kg AFB1. Others who
evaluated AFB1 (mainly in the form of cultured material) at 0.4 to 0.8 mg/kg all observed
significant decrease in BW gain primarily due to reduced feed efficiency (Sodhi et al., 1996;
Verma et al., 2004; Manafi et al., 2012; Doerr et al., 1983; Tedesco et al., 2004; Giambrone
et al., 1985a). A recent review by Dersjant-Li et al (2003) on the impact of low AF
concentrations in poultry suggested that with each mg/kg increase of dietary AF, the
growth rate decreases by 5% for broilers. Based on the meta-analysis of 98 papers from
1980-2009, Andretta et al. (2011) concluded that an average AF concentration of 0.95
mg/kg reduced both feed intake and daily weight gain by 11 percent, and worsened feed
conversion by 6 percent. A possible explanation for the higher susceptibility of birds from
more recent studies could be that modern broilers have more efficient nutrient conversion
demanding faster hepatic metabolism, which in turn results in a higher metabolism of AFB1
(Yunus et al, 2011). Interestingly, a biphasic nature, namely hormesis, of aflatoxicosis was
suggested by Diaz et al (2008), which indicated an improvement of performance at low
doses of AF while reduction at higher doses. In the review by Diaz et al. (2008), when
broilers were exposed to low AFB1 concentration, 3-4% improvement in weight gain can
be seen. Similarly, a 13% increase in BW gain of broilers fed 0.8 mg/kg AFB1 was reported
by Tedesco et al. (2004), but weight gain of these birds started to decline after 2 wk of
feeding. Therefore, both the concentration and length of exposure to AFB 1 could impact
the type of response in terms of performance. However, these improvements in weight gain
do not justify the acceptability of feeding AF-contaminated feeds at low concentrations,
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because of the compromised health and welfare (liver functions, immunosuppression, etc.)
of these animals.
Feed contamination with AF also can affect laying hens and lead to reduced egg
production, poor egg quality, or increased mortality of challenged hens. Early studies
generally used high doses of AFB1 (up to 20 mg/kg AFB1), where reductions in BW gain
(Sims et al., 1970), egg production (Sims et al., 1970; Hamilton and Garlich., 1970), and
egg weight (starting from 2.5 mg/kg AFB1; Hamilton and Garlich, 1970) were often
observed. In addition to egg production and egg weight, AFB1 (at 2.5 mg/kg) may
adversely influence egg shell thickness and yolk pigmentation deposition; the latter might
be attributed to the interference of AFB1 with lipid metabolism (Zaghini et al., 2005).
However, in general, laying hens are more resistant to AF compared to broilers, primarily
due to the difference in age and metabolic rate. More recent studies feeding AFB1 less than
2.5 mg/kg generally did not yield significant changes in BW gain, feed intake egg
production, or egg weight (Oliveira et al., 2000; Applegate et al., 2009). However, although
some found no AF residues in eggs from hens fed AF-contaminated diets (Brown and
Abrams, 1965; Abrams; 1965; Zaghini et al., 2005), AF transmission to eggs have
happened in several cases as reported by Wiseman et al. (1967) while feeding 0.4 mg/kg,
by Trucksess et al., (1983) while feeding 8 mg/kg AF for 7 d, by Fernandez et al. (1994)
while feeding 5 mg/kg for 5 wk, and by Oliveira et al. (2000) while feeding 0.5 mg/kg
AFB1 for 8 wk. The latter study demonstrated that AFB1 residue in eggs was approximately
0.1 μg/kg from hens fed 0.5 mg/kg AFB1, based on which the authors suggested that the
feed to egg AFB1 transmission ratio was approximately 5000:1. Therefore, it is very
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important to control AF concentration in laying hens’ feed to ensure the absence of AF
residue in egg products and therefore consumer safety.
The sensitivity to AF has been shown to differ among poultry species, partly
associated to the different efficacy of hepatic AF biotransformation. Ducks are reported to
be the most susceptible poultry species to AF, followed by turkeys, broilers and laying
hens. Ducks exhibit 100% mortality at 1 mg/kg AF (Muller et al., 1970) and have the ability
to develop hepatic carcinoma (Diaz and Murcia, 2011; Bintvihok, 2001). One explanation
for the high sensitivity of ducks to AFB1 could be that the enzymes (cytochrome P450
family) responsible for bio-activation of AFB1 have higher activities than in chickens,
turkeys or quail (Diaz and Murcia, 2011), as well as a lower activity of hepatic enzymes
responsible for cellular detoxification and excretion of a variety of toxic substances. The
majority of the previous studies on ducks used naturally contaminated corn (Feng, 2010;
He et al., 2012), where reduction of BW gain and feed intake by up to approximately 40 %
were found in 14 d or 35 d ducks fed diets containing ≤ 0.15 mg/kg AFB1. In these studies,
feed efficiency was either not affected or slightly improved by AFB 1, which is on the
contrary to research with broilers. In the study of He et al. (2012), mortality was up to 40%
in 28 d Cherry Valley ducks fed naturally contaminated diet that contained 0.15 mg/kg
AFB1. When Cherry Valley ducks were fed lower concentrations of AFB1 (0.02 and 0.04
mg/kg) for 42 d, BW gain and feed intake incrementally decreased with increasing dietary
AFB1 (by 11 and 23% for BW gain and 1 and 8% for feed intake in birds fed 0.02 and 0.04
mg/kg AFB1, respectively) (Han et al., 2008). However, in disagreement with others (He
et al., 2012; Feng et al., 2010), feed efficiency was also reduced in this study by up to 16%
(Han et al., 2008). Compared with broilers, there is limited research on AFB1 toxicity in
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ducks. Duck production is a rapidly growing industry worldwide, with the consumption
being 6-fold greater than it was in the 1960s. In 2010, worldwide duck-meat production
reached 3.9 million tonnes, with more than 50,000 tonnes produced in the United States,
wherein Pekin ducks account for 95% of the consumption (Huang et al., 2012). Therefore,
more information on AFB1 toxicity in this species is justified.
In turkeys where aflatoxicosis was first discovered, the effects of graded
concentrations of AFB1 (0 to 1 mg/kg) at 21 and 42 d were evaluated by Rauber et al.
(2007). Results revealed that 21 d feed intake and BW linearly decreased with increasing
AFB1 starting at 0.1 mg/kg. At 42 d, feed intake and BW also decreased with increasing
dietary AFB1, but this difference only became significant at 0.2 mg/kg dietary AFB1. The
reduction of BW were 38 and 44% for turkey poults at 21 d and 42 d, respectively, when
fed 1 mg/kg AFB1. Similarly, 0.75 mg/kg AFB1 led to a 39% reduction in BW gain in
turkey poults fed from hatch to 21 d (Kubena et al., 1995); while AFB1 at 0.2 mg/kg
reduced 21 d BW gain by 14% (Weibking et al., 1994). However, results from the study of
Kubena et al. (1991) showed a morality rate as high as 88% when turkey poults were fed 1
mg/kg AFB1 for 3 wk. Collectively, these results suggest that the susceptibility of turkeys
to AF is intermediate to that of broilers and ducks.

1.3.3

Effects of AF on Liver and Serum Biochemistry

In addition to the primary site for AF metabolism, the liver is also a major target
organ of aflatoxins. Increased relative liver weights in chickens and ducks have been
reported by many researchers (Kubena et al., 1989; Fernandez et al., 1994; Miazzo et al.,
2000; Pimpukdee et al., 2004). Histological analysis revealed that the enlarged liver during
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aflatoxicosis can be primarily attributed to necrosis, bile duct proliferation, fat infiltration,
and enlarged liver cells (Yunus et al., 2011). Many of these changes can be the result of
induced oxidative stress in hepatic cells upon AF exposure. More specifically, AF is able
to negatively shift the oxidative/anti-oxidative balance (partly due to the high oxidative
potential of AFBO), leading to the accumulation of free radicals (i.e. reactive oxygen
species, ROS) and induction of oxidative stress in animals (Sies, 1986). Meanwhile, AFB1
is also found to induce hepatic lipid peroxidation as reported by Shen et al., (1994). In the
study, products of lipid peroxidation, including malonaldehyde (MDA) and conjugated
dienes, were increased in a dose-dependent fashion in liver homogenate after AFB1
administration in rats. This increase in lipid peroxidation and oxidative stress in liver cells
may lead to cell membrane damage and therefore may be the underlining mechanism of
AFB1-induced cell injury. Antioxidant enzymes, including superoxide dismutase (SOD),
catalase (CAT), and glutathione-S-transferase (GST), are vital players in the relief of
oxidative stress. Hepatic SOD converts O2− into hydrogen peroxide, which can then be
detoxified into water and O2 by GST and CAT. Eraslan et al. (2004) found that AFB1
inclusion at 1 mg/kg decreased hepatic SOD, CAT, and GST activities, while increased
products of lipid peroxidation in broilers at 45 d; similar results were reported by others
(Khan et al. ,2010; Shi et al., 2006; Rastogi et al., 2001). Therefore, AF not only can
increase oxidative stress in animals, but also decreases the animal’s ability to cope with the
stress by impairing major anti-oxidant enzymes. The latter is partially due to the ability of
AFBO to inhibit protein synthesis (through binding with DNA) as well as activities (by
interacting with proteins), yet the exact effects on transcription, translation, or post-
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translational process on the anti-oxidant enzymes are unknown, as the modulation of AFB1
on hepatic gene expression is less studied in poultry (Yarru et al., 2009).
Serum biochemical measures can often help diagnose aflatoxicosis even before
depressed performance is present (Keçeci et al., 1998). A summary of recent reports on the
serum biochemical effects of AFB1 in poultry is shown in Table 1.3. The strong inhibitory
capability of AFB1 on hepatic protein synthesis is evident in reduced serum protein
concentrations based on previous research in broilers, quails, laying hens, as well as turkey
poults (Table 1.3). From the presented data, this decrease in serum protein concentrations
is a consistent response in broilers fed AFB1-contaminated feed from 0.3 mg/kg (Raju and
Devegowda, 2000) to 5 mg/kg (Kubena et al., 1998). However, another possible cause for
the reduced serum albumin during aflatoxicosis may be due to the binding of AFBO to
serum albumin, resulting in long-lived AFB-lysine adducts (Sabbioni et al., 1987).
Elevation in serum enzymes, including aspartate amino transferase (AST), alanine
transferase (ALT), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT),
were also reported by several researchers (Manning and Wyatt, 1990; Valdivia et al., 2001;
Allameh et al., 2005; Denli et al., 2009). This is usually an indication of hepatocyte damage,
similar with what occurs when the liver is damaged by viral hepatitis. Consistently,
Méndez-Albores et al. (2006) reported that ducklings fed a 0.1-mg/kg AFB1 diet showed
significantly increased AST, ALT, and AST:ALT ratio; the latter is an indication of liver
function and is positively correlated with the stage of liver fibrosis (Sheth et al., 1998).
Meanwhile, reduction in serum Ca and P concentrations upon AF exposure has been found
in broilers (Ledoux et al., 1999; Zhao et al., 2010; Gowda et al., 2008; etc.), which may
suggest adverse effects of AFB1 on bone integrity. Decreased serum glucose (Huff et al.,

17
1988; Zhao et al., 2010; Kasmani et al., 2012) is largely due to the reduced feed intake in
birds during aflatoxicosis; while an increase in serum urea N (Kubena et al., 1995, 1998;
Kasmani et al., 2012) is likely an indication of lower utilization of dietary proteins, which
may contribute to reduced protein synthesis (Coma et al., 1995). Further, low serum
creatinine level is associated with severe hepatic disease (Takabatake et al., 1988), which
has been observed by Kubena et al. (1998). In general, changes in serum concentration of
the proteins and enzymes are in alignment with performance responses and are reliable
indicators of hepatic damage and impaired protein synthesis, but may also suggest other
damaging effects of AF on bone (Ca and P) or muscle (creatinine) integrity.

1.3.4

Effects of AF on Immune Functions

Secondary to hepatic toxicity, the immunosuppressive characteristics of AFB 1 are
also well documented. Immunity is vital to a living organism as it represents the ability to
resist and overcome infection. The immune system in an animal can be divided into 3
categories: the humoral, cell-mediated, and non-specific immunity. The latter is also
known as the innate immune system, meaning that it is the natural resistances of a person
or an animal; as opposed to the acquired immune system that includes humoral and cellmediated immunity. The non-specific immunity is the first line of defense against foreign
invaders, which involves both cellular and non-cellular components, such as the
complement system. Cells participate in this system include macrophages, neutrophils (or
heterophils in avian species), natural killer cells, and thrombocytes. On the other hand, the
humoral and cell-mediated immunity are stimulated by antigens, and the response is
specific for that particular antigen. In the humoral immune response, the primary
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participants are the bursa derived lymphocytes (B cells), whereas the thymus derived
lymphocytes (T cells) serve as the primary participants in the cell-mediated immune
response (Banchereau and Steinman, 1998). In a specific immune response, the antigen is
first processed by an antigen presenting cell (APC) from the dendritic cell system; the APC
phagocytizes the antigen so that the antigen is placed on the APC surface next to a selfmajor histocompatibility complex (MHC) protein. The MHC protein is required for B and
T lymphocytes to recognize the antigen. Once the antigen is presented to the B and T cells,
the appropriate helper T cell attaches via its antigen receptor, and then recruit its particular
T cytotoxic, T suppressor, and B cells to be activated. The activated B cells go through
multiple divisions to produce plasma cells (antibody secreting cells) and a group of
memory cells. The antibodies then bind the antigen and the complexes are removed from
the blood by the liver and the spleen. The T cells also divides to produce effector cells and
memory cells, but they use lymphokines, such as interleukins, rather than antibodies to
communicate with other cells (P. Wakenell, Purdue University, unpublished).
Hence, both innate and acquired immune systems are regulated by a highly
interactive network of chemical communications, and are heavily dependent upon an
adequate availability and ability of protein synthesis for immune response, including
synthesis of cytokines, antibodies, and acute phase proteins (Kim et al., 2007).
Unfortunately, dividing cells and tissues with a high protein turnover such as the immune
system can be most susceptible to the toxic effects of AF, a strong inhibitor of protein
synthesis. In this regard, exposure to AF has been demonstrated to suppress the immune
responses in poultry. According to previous reports, AF can depress the development of
the thymus gland and influence the relative weight of the bursa of Fabricius, which may
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result in serious deficiencies in both cellular and antibody responsiveness of the chicken
immune system (Celik et al, 2000; Verma et al., 2004). Inhibition of macrophage functions,
T lymphocyte activity, or cytokine expression by AF result in vaccine failure or pathogen
persistence, as exemplified in many studies by reduced immunoglobulin production
(Verma et al, 2004; Yunus et al, 2011). In general, the dietary concentration of AFB 1
needed to affect the immune system is less than that required to elicit a reduction in
performance. The threshold dose of AFB1 is reported to be approximately 0.4 and 1 mg/kg
for the negative effects on cell-mediated and humoral immunity, respectively, in broilers
(Yunus et al, 2011). Therefore, chronic consumption of feed contaminated with low AF
content may pose a serious risk to animal health, increasing susceptibility to infections and
reducing vaccination efficacy. Earlier studies revealed that upon AFB1 exposure ranging
from 0.1 to 2.5 mg/kg, decreased complement activity (Shivachandra et al., 2003;
Campbell et al., 1983) and decreased antibody titers against Newcastle disease or
Infectious Bronchitis are found in broilers (Shivachandra et al., 2003; Ibrahim et al., 2000;
Stewart et al., 1985; Oğuz et al., 2003). In consonance with this, recent epidemiological
data indicated a high correlation between AF contamination and Newcastle disease
outbreaks in broilers (Yunus et al., 2008, 2009). Similarly for cell mediated immunity,
broilers and laying hens fed AFB1-contaminated feeds (from 0.1 to 1 mg/kg) showed
impaired responses to DHST (delayed hypersensitivity skin test) (Giambrone et al.,
1985a,b; Shivachandra et al., 2003; Kadian et al., 1988). However, the data discussed
herein are mostly dated; the susceptibility of modern broilers and other poultry species
regarding immuno-toxicity of AFB1 remain to be further studied. On the other hand, AFB1
is likely to have a hormesis effect on humoral immunity in birds, where the type of response
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of broilers against Newcastle disease could be improved or worsened depending on the AF
concentration and exposure time (Yunus et al., 2011). Nevertheless, abnormal size of
lymphoid organs in birds is often found during aflatoxicosis, where lymphoid cell depletion
in such organs (bursa of Fabricius, thymus, and spleen) is also observed (Yunus et al., 2011;
Shivachandra et al., 2003). One primary cause for such suppression could be the production
inhibition of antibody as well as other protein participants in the immune response by AFB1.
This may also lead to increased turnover of serum antibodies, resulting in decreased
antibody half-life (Yunus et al., 2011).
Therefore, if a bird were to be exposed to both AF and bacterial or viral infections,
higher susceptibility to infection and/or augmented severity are likely to be the
consequences. Ruff and Wyatt (1978) reported that when broilers were challenged with
Eimeria acervulina while on a diet containing 2.5 mg/kg AFB1, plasma depigmentation
was greater than with either challenge alone in certain coccidial strains. A more recent
study revealed similar responses, where the combination of 1 mg/kg AFB1 and coccidial
(Eimeria species) challenge resulted in higher mortality rate, increased oocyst output,
lower body weight and feed efficiency, as well as a greater reduction in serum proteins and
minerals concentration than birds exposed to AFB1 or coccidia only (Toulah, 2007).
Consistently, in turkey poults that were fed 0.25 mg/kg AFB1, Eimeria adeonoeides
challenge led to a significant reduction in weight gain, increased lesion score, and highest
mortality compared to any other treatments (Witlock and Wyatt., 1982). In Mallard ducks,
Hurley et al. (1999) found that birds fed AFB1 (12 to 33 μg/kg) had significantly reduced
mitogenic responses upon Escherichia coli O55 lipopolysaccharide challenge. Further,
progeny chicks from hens that have been exposed to AF-contaminated feeds (from 1 to 5
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mg/kg) showed decreased antibody levels following SRBC injection and reduced
macrophage production, thus may have increased susceptibility to diseases where humoral
and cellular immunity are required (Qureshi et al., 1998). Even after proper vaccination,
broiler chicks that were exposed to 0.5 mg/kg AFB1 showed increased severity of Marek’s
disease lesions upon Marek’s disease virus challenge (Batra et al., 1991). The authors
estimated a 50-70% reduction in the protective efficacy of the vaccine in AFB1 birds
compared to control, suggesting that dietary AFB1 may also reduce vaccine efficacy in
poultry.

1.3.5

Effects of AF on the Gastrointestinal Tract

A healthy gastrointestinal tract (GIT) plays a vital role in ensuring the health and
welfare of an animal. With the multiple functions of the intestine, including gut barrier,
nutrient digestion and absorption, gut immunity, and microbial activity, the GIT of an
animal can consume 20% of all incoming energy (Cant et al., 1996). A great portion of the
consumed energy can be attribute to the rapid protein turnover rate of intestinal cells, which
ensures the capacity of nutrient delivery (Cant et al., 1996). In chickens, the rate of protein
synthesis of the GIT can be as high as 50-77% per day (Bryan et al., 1983; Muramatsu et
al., 1987; Hiramoto et al., 1990). The metabolic activity of the GIT determines the nutrient
supply to all other tissues in the body. As livestock production relies heavily on feed
efficiency, the health of the GIT must be guaranteed in order to optimize the utilization of
dietary nutrients and thus maximize the performance and welfare of the animal.
Although often neglected, it is a fact that the gastrointestinal tract is the first organ
coming into contact with mycotoxins of dietary origin, and may be affected by AFB1 with
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greater potency as compared to any other organs. The biotransformation of AFB1 to its
toxic form aflatoxin B1-8, 9-epoxide (AFBO) occurs primarily in the liver, but a recent
study revealed that this activation also takes place in the intestinal tract (Sergent et al.,
2008). Additionally, because AFBO is a potent inhibitor of protein synthesis and activity
through its interaction with DNA, RNA, and proteins, the rapidly dividing intestinal
enterocytes with high protein turnover can become a major target (Grenier and Applegate,
2013). However, the gut health aspect of aflatoxicosis is the area that is much neglected in
mycotoxin research. Based on a comprehensive review by Grenier and Applegate (2013),
only 14 studies in total were published (as of 2013) on the topic of AF’s impact on intestinal
processes; this included all animal species as well as in vitro studies, yet available data are
not conclusive.
As the first barrier against ingested contaminants, the intestinal barrier, formed
primarily by tight junction complex, protects the luminal end of the intercellular space and
regulates ions, water, and molecular transport through this paracellular route (Anderson
and Van Itallie, 1995). The tight junctions (TJ) act as a fence that blocks the free diffusion
of protein and lipids between the apical and basolateral membranes. Three integral proteins
are components of TJ: claudin, occludin, and the junctional adhesion molecule (JAM).
Among them, multiple isoforms of the claudin family are the key components of TJ and
major determinants of paracellular characteristics (Gonzalez-Mariscal et al., 2003).
Alteration in claudin expression and activity can lead to impairment of the tight junction
network, and consequently increase permeability and allow higher translocation of luminal
antigens. Previous in vitro studies showed that exposure of CaCo-2 cells to DON and OTA
resulted in decreased claudin expression and impaired intestinal barrier (McLaughlin et al.,
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2004; Pinton et al., 2009). Similarly, Gratz et al. (2007) found that AFB 1 impaired the
integrity of CaCo-2 cells by measuring the trans-epithelial resistance. Therefore, increased
entrance of luminal antigens, including unabsorbed mycotoxins, is allowed; consequently,
higher susceptibility to various infections would not be a surprise. By far, very limited
information is available on how AFB1 affects the expression, activity, and location of
claudins and other tight junction proteins. Also, more in vivo effects need to be explored
considering all previous data in this regard were from in vitro studies.
Mycotoxin-induced disturbance of digestive enzyme and nutrient transporters may
lead to intestinal disorders, resulting in alteration of nutrient digestibility and growth of
animals. However, it is difficult to reach a consensus from previous research on changes
in nutrient digestibility and enzyme activities in poultry during AFB1 challenge (Han et al.,
2008; Applegate et al., 2009; Matur et al., 2010). Han et al. (2008) observed increased
digestive enzyme activities (protease, amylase, chymotrypsin, and trypsin) yet decreased
apparent digestibility of crude protein in 42 d ducks fed 0.02 and 0.04 mg/kg AFB1.
Conversely, laying hens fed up to 2.5 mg/kg AFB 1 for 14 d did not show altered apparent
digestibility of dry matter and N, but apparent digestible energy was significantly reduced
in those hens compared to control (Applegate et al., 2009). In breeder hens, feeding 0.1
mg/kg AFB1 for 30 d led to increased pancreatic amylase and chymotrypsin activity, but
reduced lipase activity (Matur et al., 2010). The authors indicated that the increased enzyme
activity may be either a consequence of the pathological effect of AF on the pancreas or a
compensatory response to reduced feed intake during aflatoxicosis; while the decreased
lipase activity, similar with that reported by Osborne and Hamilton (1981) of broilers,
might be the cause for inefficient lipid digestion and thus steatorrhea in birds exposed to
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AF. Certain changes in enzyme activity may also reflect changes in intestinal villi
morphology, as the small intestine villus expresses considerable sucrase and maltase
activity (Uni et al., 1998). In the study of Applegate et al. (2009), hens fed AFcontaminated diets showed increased jejunal maltase activity, which agrees with the
increased villus height observed in those birds. Changes in intestinal villi histology can be
an indication of AF on nutrition absorption, as the villi along the small intestinal wall form
the major site for nutrient absorption by increasing the intestinal surface are. If this surface
area is compromised, effectiveness of nutrient transport may be subsequently affected.
Little is known on the changes in enterocyte differentiation and migration rates along the
villus during AF challenge. However, changes in villi height, crypt depth, and villi
hight:crypt depth have been observed in birds during mycotoxicosis. Reduced villi height
is mostly found after Fusarium toxins (fumonisins B1 and deoxynivalenol) challenge
(Awad et al., 2006, 2011; Yunus et al., 2012; Girgis et al., 2010); while the limited literature
on AF revealed increased villi height in AF-challenged laying hens (Applegate et al., 2009)
but decreased villi height and villu:crypt ratio in ducklings fed 0.1 mg/kg AFB 1 (Wan et
al., 2013). For broilers, the unit absorptive surface of the small intestine may be impaired
based on a recent study by Yunus et al. (2011), where broilers were fed 0.07 mg/kg AFB1
for 4 wk. However, in the same study, the authors observed a compensatory response of
the birds by increasing the length of small intestine during wk 4 of exposure. Clearly, the
intestinal adaptability to chronic AF exposure warrants further attention. On the other hand,
as of today, studies focusing on the direct effects of AFB1 on absorptive processes are rare.
Reduced short-circuit current after glucose addition in chick jejunal epithelium cells treated
AFB1 is the only reported result regarding direct changes of nutrient uptake upon AFB 1
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exposure, which might be an indication of altered glucose uptake (Yunus et al., 2010). No
information is available on the changes in nutrient transporters (mRNA expression, protein
activity, location, etc.) upon AFB1 exposure in poultry, while other mycotoxins,
particularly DON, have been found to decrease intestinal mRNA expression of nutrient
transporters (Awad et al., 2011; Maresca et al., 2002; Dietrich et al., 2012).
Therefore, based on the aforementioned studies (summary shown in Table 1.4), there
is a lack of consensus on how AFB1 affects gut barrier, nutrient digestion, and absorption
in poultry species and the mechanisms behind it. The discrepancies present in the literature
can be due to the differences in experimental animals (species, genetic lines, and age),
source and concentration of AF, exposure time, nutritional composition of the diets,
sampling site, etc. Nevertheless, the current available data point to a direct and/or indirect
impact of AF on the gut functions, especially nutrient digestibility and absorption. On the
other hand, accurate estimation of protein and amino acid digestibility requires the
correction for endogenous losses; the latter include gastric, pancreatic, and biliary
secretions, sloughed intestinal cells, and mucosal cells. This endogenous loss might be
altered with changes in health conditions induced by AFB1, yet literature addressing this
matter is currently unavailable. Hence, evaluation of the influence of AFB1 on endogenous
amino acid loss is required in order to provide a more accurate estimation of nutrient
digestibility during aflatoxicosis.
Besides nutrient digestion and absorption, the GIT also play essential roles in immune
responses; it owns its own immune system and that up to 70% of the immune defenses are
located in the GIT (Grenier and Applegate, 2013). The major players in the intestinal
immune responses include the GALT (gut-associated lymphoid tissue), Peyer’s patch
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(aggregated lymphoid nodule located in ileum), mesenteric lymph nodes, and cecal tonsils,
which are responsible for producing immunocompetent cells upon infection. Additionally,
localized responses along the GIT are facilitated by the mucus, intraepithelial immune cells,
and epithelial cells (Grenier and Applegate, 2013). Although the immunosuppressive
property of AF is well accepted, the modulation of GIT immune system has been less
studied. The study by Watzl et al. (1999) in which no significant effects on the GALT and
no damage on the intestinal epithelium were found in rats fed 1 mg/kg AFB1 represents the
only published result regarding the direct effect of AF on gut immunity, while such effects
have not been explored in poultry species. However, studies using other mycotoxins have
revealed modulation on the immune balance and intestinal immune responses during
parasitic, bacterial, and viral infections. Broiler breeder pullets fed diets containing
Fusarium mycotoxins (at a concentration that was lower than that could negatively affect
performance) showed impaired intestinal recovery from enteric coccidial lesions (Girgis et
al., 2010), whereas broilers exposed to Ochratoxin A had higher lesion and oocyst in the
intestine upon coccidial challenge by Eimeria acervulina (Koynarski et al., 2007 a, b) and
higher number of Salmonella typhimurium in duodenum and cecum, with the presence of
acute enteritis (Fukata et al., 1996) compared to control birds. Considering the potent
toxicity of AFB1 and its inhibitory effect on protein synthesis and activity, it is expected
that feeding AF-contaminated feeds can interfere with gut immune responses similar with
or more intense than those seen with other mycotoxins, and thus awaits further research.
Indeed, a very recent study by Jiang et al. (2015) first revealed that AF exposure (0.6 mg/kg)
can decrease the IgA cell numbers and negatively affect the mRNA expression of IgA,
pIgR, IgM, and IgG in 21 d broilers.
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With extensive research in recent years, it is well accepted that intestinal microflora,
consisting of greater than 10 times the animal’s own cells, play an essential role for animal
health. These microflora are closely linked with the host via metabolic products of
microbial fermentation or through immune responses (Grenier and Applegate, 2013). By
evaluating the effects of fusarium mycotoxins on microbial metabolism and protein
synthesis in dairy cows, Danicke et al. (2005) suggested that mycotoxins may affect the
microbial communities as well as undergo microbial metabolism in the intestine. Boguhn
et al. (2010) reported an increase in the count of aerobic bacteria after DON inclusion in
the ration of dairy cows, which may potentially promote the growth of a group of microbial
species (e.g. genus clostriudium) that are related to chronic intestinal inflammation.
However, there is still a lack of information on how AF affects intestinal microbiota in any
animal species; partially because of the complexity and impreciseness of investigating
microbial community shift (Grenier and Applegate, 2013). On the other hand, existing data
suggest the need to explore microbial activities in terms of mycotoxin detoxification
(Schatzmayr et al., 2006) as potential counteractive approaches against mycotoxicosis. In
this regard, Gratz et al. (2007) have found that a probiotic Lactobacillus rhamnosus GG is
able to reduce AFB1 uptake and metabolism in Caco-2 cells; but further in vivo studies are
needed to evaluate its efficacy in susceptible animal species.
Based on the discussion above, it is highly likely that AF may directly and/or indirectly
affect multiple gut functions, yet direct evidence or data are still limited as of today. There
is a close association between performance and intestinal health and functions, thus
elucidation of how AFB1 modulates these processes awaits much future research.
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1.4

Impact of Dietary Modifications on Aflatoxicosis
1.4.1 Mycotoxin Adsorbents

Because of the high prevalence of AFB1 in feedstuffs worldwide and their many
adverse effects on poultry performance and health, much attention has been given to find
methods to overcome these damages. The best strategy today is to minimize AF production
and animal exposure to AF, rather than to try to minimize the adverse effects after AF
exposure. In this regard, one of the most used approaches today is the addition of the nonnutritive mycotoxin adsorbents, which can be inorganic (mainly clay minerals) or organic
(microbial), that bind AF in the gastrointestinal tract and thus prevent its absorption into
other parts of the body (Huwig et al., 2001; Phillips et al., 2002). The low inclusion
requirement and easy management of AF adsorbents have led to the development of diverse
products including zeolites, charcoal, aluminosilicate, etc., and a variety of organic
constituents such as yeast products, algae, and plant extracts. An overview of selected in
vivo studies on the efficacy of major adsorbents in ameliorating aflatoxicosis in poultry is
summarized in Table 1.5.
The inorganic adsorbents, or ‘clays’, are chemically made of silicates. This
category includes a variety of products, including hydrated sodium calcium
aluminosilicates (HSCAS), bentonite and zeolite (from volcanic origin), and
phyllosilicates (primarily montmorillonite). The efficacy of HSCAS has been extensively
studied in poultry species, majority of which were conducted by the Phillips’ research
group at Texas A&M University. The majority of the in vivo evaluation of HSCAS in
chicks and turkeys indicate that at an inclusion level of 0.25 to 0.50%, improved
performance and serum measures, as well as reduced relative organ weights can be
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achieved compared to birds exposed to AF only (Kubena et al., 1989, 1990, 1991, 1993,
1998; Phillips et al., 1988). However, Kubena et al. (1991) suggested that efficacy partly
depended on the concentration of AFB1, as 0.5% HSCAS was able to efficiently protect
birds against aflatoxicosis when exposed to 0.5 mg/kg AF, but not 1 mg/kg. The capability
of HSCAS to reduce urinary output of AF metabolites and AF residues in liver and kidney
were also reported (Neeff et al., 2013; Edrington et al., 1996). Evaluation of HSCAS in
other poultry species, including ducks, has been limited compared to those in broilers.
Nevertheless, Khajarem et al. (1990) found that when HSCAS was included at 0.25% or
0.5%, reduced morality rate, relative liver weight, and liver lesions were found in ducks
fed up to 0.12 mg/kg AFB1. The high efficacy of HSCAS to prevent or attenuate
aflatoxicosis is primarily due to its high affinity to interact with AF (optimal between 25⁰
C and 37⁰ C in a pH range of 2 to 10); existing evidence suggest that this interaction may
occur on multiple sites, primarily the interlayer region, but also at basal surfaces and the
edges of the adsorbent. However, because of the broad family of aluminosilicates and
different processing methods, the available HSCAS products may not possess the same
physicochemical properties, and thus must be evaluated individually to determine its
efficacy in animals (Grenier and Applegate, 2012).
Alternatively, bentonite and zeolite are also commonly used AF adsorbents. The
binding mechanism of the former depends on the interchangeable cations in the layers, with
sodium and calcium bentonite being the two major types; while that of the latter is via
molecular sieves and ion changes resins. Partial or total recovery of growth, and
improvements of relative organ weights, hepatic health, and serum biochemistry measures
have been reported primarily in broilers exposed to 2.5 to 5 mg/kg AFB1 by zeolite
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(Ibrahim et al., 2000; Miazzo et al., 2000; Harvey et al., 1993; Santurio., 1999) or bentonite
(Oğuz and Kurtoglu., 2000; Miazzo et al., 2005; Ortatatli and Oğuz, 2001; Rosa et al., 2001)
at an inclusion rate of 0.2 to 2.5%. As with HSCAS, efficacy of zeolite or bentonite
adsorbents depends on the characteristics of the individual product. For instance, in the
study of Harvey et al. (1993), only one product showed protective role against AF in
broilers out of the 4 zeolite products evaluated. Conversely, in 21 d ducklings fed 0.1 mg/kg
AFB1, zeolite inclusion did not improve growth performance and only partially improved
serum measures (Li et al., 2012). One cause for the inefficacy might be the low zeolite
inclusion rate (0.1%) compared to that used in other studies (generally 0.5%), but the AFB1
concentration was also very low in this study (0.1 mg/kg). Further studies evaluating
adsorbent efficacy and optimal inclusion rate in species other than broilers are warranted.
In addition to inorganic clays, various organic adsorbents, including activated
carbon, yeast cell walls, and bacterial cells, have also been used in poultry production as
approaches to prevent AF exposure. With its high surface to mass ratio (500-3500 m2/g),
activated carbon has been used as a general toxin adsorbing agent (Whitlow, 2006).
Because of this, inclusion of such products seems to be less specific against aflatoxicosis
in vivo, and controversial responses have been reported. Although earlier studies using
0.02 to 0.10% activated charcoal was effective in improving performance, serum measures,
and hepatic enzyme activities in broilers upon AF challenge (Jindal et al., 1994; Dalvi and
Ademoyero, 1984, Dalvi and McGowwan, 1984), others found no such beneficial effects
even at higher inclusion rate (0.5%) (Edrington et al., 1996; Kubena et al., 1989). As
opposed to the inefficacy to ameliorate aflatoxicosis in vivo, activated carbon has very high
binding capacity for AF in vitro (Grenier and Applegate, 2012). Therefore, it is important
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that decisions of using such product in practice should not be made depending on in vitro
data solely. Yeast and yeast components, primarily the cell walls from Saccharomyce
cerevisiae, are more recently discovered approaches and have been suggested to be able to
remove AF under mild conditions, without using harmful chemicals (Oğuz, 2012). Their
efficacy has been less studied in vivo, but exiting data suggest the potential of 0.05 to 0.2%
yeast cell wall products to improve performance and reduce liver damage in broilers
exposed to 1 to 2 mg/kg AFB1 (Zaghini et al, 2005). While further evaluation is needed for
yeast cell wall products, Jans et al. (2012) pointed out that these organic adsorbents may
be more efficient to bind a wider range of mycotoxins rather than specific to AF, and thus
may be more suitable for multi-contaminated feeds.
With the wide variety of AF adsorbents available today, it is important to rigorously
evaluate each potential product in vitro and in vivo to ensure their effectiveness and safety
in mycotoxin-sensitive animals. Meanwhile, particular attention needs to be paid to the
potential of such products to interact with nutrients in the diet, such as proteins, lipids,
vitamins and minerals. Adsorbents, especially those that are unspecific yet have high
binding capacity (i.e. activated carbon), need to be evaluated for their influence on nutrient
utilization in vivo in addition to the efficacy of preventing aflatoxicosis. In this regard,
available data suggest that HSCAS do not interfere with the utilization of dietary minerals
(phosphorus, manganese) and certain vitamins (riboflavin, vitamin A); but there is still a
dearth of information in this regard to draw definite conclusions. Therefore, criteria of a
‘good’ AF-adsorbent product not only include demonstrated safety and efficacy in animal
species, the absence of other hazardous substances, but also the confidence of knowing that
no harmful interactions between the absorbent and dietary nutrients would occur (Grenier
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and Applegate, 2012). Noticeably, as of today, the FDA has not approved any AF adsorbent,
or mycotoxin adsorbent in general, to claim prevention and/or treatment of mycotoxicosis.
Thus many of these products are currently sold as anti-caking agents or pellet binders.
Further understanding of the mechanisms of various adsorbents in poultry species and their
potential interactions with dietary nutrients are needed to ultimately allow effective
counteraction against aflatoxicosis.

1.4.2

Aflatoxin-Dietary Nutrients Interactions

In addition to the non-nutritive AF adsorbents, other components (i.e. nutrients) in the
feed may also interact with aflatoxin before and after intestinal absorption. The
participation of various proteins is vital in all the structural units and biological processes
of an animal, yet a major mechanism of AFB1 toxicity is its inhibitory effect on protein
synthesis (Sporn et al., 1966; Garvican et al., 1973). Therefore, whether altering nutrient
supply may influence protein synthesis and subsequently performance and health of an
animal during aflatoxicosis remains to be answered. Further, exposure to AF has been
reported to effect nutrient metabolism, including energy, protein, carbohydrate, and lipid,
which partially attributes to reduced feed efficiency and subsequently impaired growth
(Ellis et al., 1991); hence nutritional status of an animal may also determine the severity of
aflatoxicosis. The known interactive effects between AF and the major nutrients are
discussed in details below.
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1.4.2.1 Dietary Protein
Early studies (Rubin and Lieber, 1968; Preston et al., 1976) have pointed out the
important role of nutritional status in determining the susceptibility of an organism to AF.
Dietary protein concentration, as a critical factor to determine nutritional composition of
the feeds, has been reported to impact aflatoxicosis in livestock animals. Smith et al. (1971)
found that when dietary protein was raised from 10 to 30%, the reduction in body weight
of chicks fed 5 mg/kg AFB1 was completely diminished. The question then remained to as
if the improvement was a result of lower threshold concentration of AF during protein
deficiency, or due to a greater slope of the response curve of the animal if dietary protein
was deficient (the same question applies to all factors interacting with AF). In an attempt
to answer this question, Richardson et al. (1987) investigated the dose-response
relationships of performance and hepatic health during aflatoxicosis (12 AF concentrations
ranging from 0 to 2.3 mg/kg) in chicks fed 10 or 12.5% dietary protein for 2 wk. Results
showed that the low protein diet (10%) decreased the minimum effective concentration of
AF (1.21 and 2 mg/kg for 10 and 12.75% protein diets, respectively) and increased the
slope of the linear response of the birds (i.e. with the same increment of AF concentration,
birds fed the low protein diet would have a greater BW reduction in response to AF
compared to those fed a higher protein diet). Based on these results, the authors concluded
that dietary protein concentration is indeed one of the factors that determines the minimum
effective dose of aflatoxin. Similar performance enhancement from raising dietary protein
or augmentation of the AF’s negative impact by low protein diet were also observed in pigs
during aflatoxicosis. Sisk and Carlton (1972) reported increased toxic effects of AF in 10wk old pigs fed a less than optimal protein concentration; younger pigs at 4 wk of age were
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even more sensitive to the changes in dietary protein concentration during aflatoxicosis.
Consistently, Coffey et al. (1989) evaluated the impact of 0.18 mg/kg AFB 1 on 28 d pigs
fed either a 18 or 20% crude protein diet for a consecutive 28 d. Results revealed significant
interaction of AF and protein concentration on BW gain, feed intake, and feed efficiency,
where 20% protein diet prevented depressed performance due to AFB 1. Therefore, the
authors concluded that interactions indeed exist between nutrient and the response of swine
to AF, thus future studies on aflatoxicosis should consider the concentrations of important
dietary nutrients. Further, protein quality, in addition to protein quantity, may also alter the
severity of aflatoxicosis (Schulsinger et al., 1989). Clearly, the studies discussed herein are
quite dated. More recent studies investigating this issue are rare, with only one report from
1994 evaluating the effect of raising crude protein (from 23.7 to 26.3%) on performance in
broiler chicks. However, a very low dose of AFB1 (0.05 mg/kg) was used, and consequently
there was no statistical difference in growth performance between the positive and negative
control birds (Abdelhamid et al., 1994). Commercial poultry strains today, especially
broilers, are very different from what were raised before the 90s, primarily due to genetic
selection, improved management practice, and changes in feed ingredient composition.
Importantly, there are fundamental changes in the birds beyond just faster growth, which
include changes in FCR, composition of gain, and bone characteristics (Applegate and
Angel., 2014). Accordingly, investigation of the interaction of dietary protein
concentration as well as quality with aflatoxicosis in today’s birds warrants further
attention.

35
1.4.2.2 Dietary Amino Acids
As the key constituents of dietary crude protein, various amino acids are also involved
in determining the responses of an animal to AF exposure; however, there is scarce
information regarding the interaction of AF with dietary amino acids, especially in poultry
species. Glutathione, a sulfur amino acid metabolite, plays a vital role in AFB1
detoxification. Supplementation of sulfur amino acids (from 66 to 134% of NRC total
sulfur amino acid recommendation) completely recovered BW of broiler chicks fed 1.25
mg/kg AFB1 (Veltmann et al., 1981). In pigs, methionine supplementation (at 0.15%) also
partially alleviated the depression of BW gain caused by 0.18 mg/kg AFB 1 (Coffey et al.,
1989). Conversely, addition of methionine (from 0.15 to 0.45% to a basal that contained
0.3% methionine) did not improve the immune responses measured in weaned pigs
exposed to up to 0.28 mg/kg AFB1 (Van Heugten et al., 1994). To date, no reports are
available on the impact of other amino acids on aflatoxicosis in any animal species.
However, certain amino acids, such as the branched-chain amino acids (BCAA), have
important regulatory functions in the process of protein synthesis, and thus may potentially
ameliorate the severity of aflatoxicosis by enhancing the synthesis of key proteins.
Certainly, further research investigating this potentiality of BCAA and the possible effects
of other amino acids during aflatoxicosis is required.

1.4.2.3 Dietary Lipids
As a biosynthetic inhibitor, AFB1 is known to interfere with lipid metabolism (Ellis et
al., 1991; Moss and Smith, 1985). Depressed pancreatic lipase activity is often seen in birds
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exposed to AF, which can lead to impaired lipid digestions and, in some cases, steatorrhea
(Osborne and Hamilton, 1981; Matur et al., 2010). Meanwhile, the ability of AF to cause
hepatic lipid peroxidation is a major contributor for the AF-induced cell membrane damage
(Shen et al., 1994; Eraslan et al., 2004). Hence, it is highly possible that dietary lipid content
and/or composition may in turn influence the extent of aflatoxicosis. In broilers fed 5 mg/kg
AF, increasing the lipid content of a diet from 2% to 16% reduced mortality to the level of
control birds; however, the growth rate was not improved unless the dietary lipid was high
in unsaturated fatty acids (Smith et al., 1971). Similarly, Hamilton and Garlich (1972)
reported a reduced turkey mortality and restored relative bursal weight by addition of
dietary fat at 18% (in the form of cottonseed oil; compared to 0, 2, or 5% fat) during
aflatoxicosis induced by up to 1 mg/kg AFB1. In this study, 1 mg/kg AF significantly
decreased the serum lipid and phospholipid concentrations, but the inclusion of 18%
dietary fat reversed these measures to normal values. Thus the authors suggested that AF
may interfere with lipid metabolism, and in turn, dietary lipid level can indeed impact the
severity of AF toxicity in birds. Consistently, improved feed conversion rates in broilers
and pigs during aflatoxicosis by increased dietary linoleic acid or total lipid concentration,
respectively, have been observed (Lanza et al., 1981; Coffey et al., 1989). Richardson et
al. (1987) reported that the adverse effect of AF (16 concentrations ranging from 0 to 3.8
mg/kg) in chicks was greater when broiler chicks were fed a low fat diet (2%) compared
to a higher fat diet (4%). These results again demonstrated that the minimum effective
dose of AF depends on several variables, which include the concentration of major dietary
nutrients.
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1.4.2.4 Dietary Vitamins and Minerals
Aflatoxicosis is often associated with reduced fat absorption, which leads to the
assumption that increasing the supply of fat-soluble vitamins (A, D, E, and K) may aid in
ameliorating the adverse effects (Waldroup, 1997). Indeed, several studies demonstrated
that AF exposure reduced serum retinol concentrations and liver vitamin A content (Reddy
et al., 1989; Pimpukdee et al., 2004). By evaluating DNA damage rate in rats fed 0, 5, 50,
or 500 IU of retinyl palmitate during aflatoxicosis (induced by 1 mg AFB1/kg BW),
Decoudu et al. (1992) found that the vitamin A status of animals can influence the AFB1
genotoxic activity in vitro and in vivo, which might be a protective mechanism of vitamin
A at the cytosolic or nuclear levels. Verma et al. (2001) found that addition of vitamin A
(125 to 1250 IU/ml medium) can reduce the AF-induced hemolysis in erythrocytes in vitro.
In broilers, however, previous in vivo research has demonstrated that addition of increased
fat-soluble vitamins provided no protection against the growth inhibitory effect of AF; this
is primarily because the majority of the commercial broiler feeds already contain these
vitamins at a concentration that is several fold greater than their requirement (Hamilton et
al., 1974; Waldroup, 1997).
Vitamin D might be an exception, because the typical vitamin D supplementation in
poultry feeds requires metabolic conversions in the liver and kidney, two major target
organs by AF, to become its active metabolite (Waldroup, 1997). Abbas and Ali (2001)
found that camels with aflatoxicosis had reduced plasma retinol concentrations. In broiler
chicks, AF exposure at 1 mg/kg can reduce plasma 25-hydroxyvitamin D and 1, 25dihydroxy vitamin D concentrations (Glahn et al., 1991). In turn, it has been suggested that
the vitamin D requirement of broiler chicks increased by 8.84 ICU/kg with 1 mg/kg AFB1
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in the diet (Bird, 1978). In line with that, chicks that were fed a vitamin D deficient diet
became more sensitive to lower concentrations of AF (Hamilton et al., 1974). Therefore,
vitamin D status may indeed interact with AF exposure and influence the symptoms and
severity of aflatoxicosis in poultry species. Vitamin E is an antioxidant that is known to be
involved in the protection of cell membranes against lipid peroxidation by scavenging the
free radicals (Choct and Naylor, 2004), and thus may ameliorate the oxidative stress
induced by AF. However, Shlig (2009) reported that vitamin E supplementation at 10 IU
did not show any protective effects for broiler chicks exposed to 2.5 mg/kg AFB1. Similarly,
He et al. (2011) evaluated the effects of 50 IU vitamin E with 0.2 mg/kg selenium in 28 d
ducks fed 0.13 mg/kg AFB1; results showed partial improvement on feed intake and
mortality rate by vitamin E and selenium addition, but not on BW gain or immune measures.
In regard to other vitamins, no beneficial effects of vitamin K was observed in broiler
chicks during aflatoxicosis (Hamilton et al., 1974). However, unexpectedly, a thiamine
deficiency showed a protective role against the growth inhibitory effect of dietary aflatoxin,
which might be explained by the stimulated fatty acid oxidation upon thiamine deficiency,
while AF is known to inhibit lipid transport from the liver (Hamilton et al., 1974).
Dietary mineral supply is another factor that may interact with aflatoxicosis. Previous
studies demonstrated that AFB1 in broilers can directly or indirectly affect Ca and P
metabolism (which may be related to altered vitamin D and parathyroid hormone
metabolism) (Glahn et al., 1991). By evaluating the bone health in broilers chicks fed 0 to
10 mg/kg AFB1, Huff et al. (1980) observed a negative effect on the material properties of
bones (e.g. breaking strength, reduction in diameter) by as low as 2.5 mg/kg AFB1; because
Ca and P metabolism is extensively involved in guaranteeing bone health, it is very likely
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that aflatoxicosis may increase the requirement for Ca and P. Altered serum zinc status has
also been reported in broilers (Kalorey et al., 1996), pigs (Mocchegianni et al., 2001), and
rats (Doyle et al., 1977; Ikegwuone, 1985) upon AF challenge. Adequate concentration of
zinc is essential for maintaining a healthy immune system, as zinc is required for activating
thymic hormones that is responsible for cell-mediated immunity; thus a subsequent
negative impact on immune responses following aflatoxicosis during zinc deficiency was
not a surprise (Mocchegianni et al., 2001). In turn, zinc supplementation (60 ppm
supplementation to a basal containing 40 ppm zinc) significantly improved growth
performance and relative organ weights in broilers injected 2.6 mg AFB1/kg of BW
(Hegazy and Adachi, 2000). Similar interaction has been observed for selenium and AFB1,
where exposure to AF is negatively associated with serum selenium status (Chen et al.,
2000), while dietary selenium supplementation (1 ppm) improved growth performance and
immune response in broiler chicks exposed to AF (Hegazy and Adachi, 2000).
Nevertheless, there is relatively little information on nutrition-aflatoxin interaction in
poultry species; more information on the possible relations between nutritional factors and
AF exposure is required to obtain a full picture of aflatoxicosis.

1.5

Current Analytical Methods to Assess Mycotoxins (Generalized to All Mycotoxins)
Accurate determination of mycotoxins and their metabolites in the feed is a crucial

step in understanding and preventing mycotoxicoses in animals. A wide variety of methods
currently exist for detecting aflatoxins and mycotoxins in general; they can be divided into
three main categories: chromatographic, immune-chemical, and biological methods.
Regardless of the method used, the analytical procedure includes the following steps:
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sampling and sample preparation, extraction, purification/clean-up, development/
separation, and quantification (Ellis et al., 1991). Each of these steps must be properly
performed to ensure collection of representative samples, good homogeneity, correct
extraction and clean-up, and subsequent valid quantification of the mycotoxins present in
a given sample. In addition to accuracy, fast analytical speed, high sensitivity, and the
ability to simultaneously determine multiple toxins are also desired.

1.5.1

Chromatographic Methods

Several chromatographic methods are available today for mycotoxin determination;
the most commonly used ones include thin layer chromatography (TLC), high performance
liquid chromatography (HPLC), and gas chromatography (GC).
Thin-layer chromatography has been the a popular method traditionally, as it offers
a fast screening of large numbers of samples at a low operating cost (Turner et al., 2009).
The quantification step of TLC can be fluorescent and/or densitometry. Previous reports
indicated its application in determining aflatoxins in foods (Stroka et al., 2000),
zearalenone (Medina et al., 1992), and trichothecenes in grains and animal feeds
(Sokolović and Šimpraga. 2006)), with a limit of detection (LOD) of 30 to 50 ng per
injection (Turner et al., 2009). However, TLC inherently requires for sample preparation
using a specific clean-up protocol depending on the characteristic of the toxin of interest,
and thus may limit the spectrum of mycotoxins that can be detected using this tool. Further,
due to its intensive lab procedures, the need for large quantities of solvent, and often a lack
of automation, TLC is not commonly used today without combination with other tools. Gas
chromatography is another chromatographic method used to identify and quantify
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mycotoxins, often in combination with mass spectrometry (MS), flame ionization detector
(FID), or infrared spectroscopy (IR) (Turner et al., 2009). Because most mycotoxins are
not volatile, a derivatization step is required to use GC. However, this presents a major
limit of using GC for mycotoxin analysis as the samples need to be volatile or must be able
to be converted into volatile compounds. Additionally, GC is not used commercially
because of its slower turnaround time and higher cost. Instead, today’s mycotoxin analysis
relies heavily on HPLC, often with the employment of normal or reversed-phase columns
for sample separation and purification and UV or fluorescence detectors for quantification
(Turner et al., 2009). Aflatoxins, along with some other toxins such as ochratoxin, have
natural fluorescence and thus can be directly detected by HPLC-fluorescent detector
(HPLC-FD), while others (e.g. fumonisins) require derivatization either pre- or postcolumn for detection (EMAN., 2003; Shephard., 1998). Combination of HPLC and mass
spectrometry (HPLC-MS) has also been applied for mycotoxin detection, which has high
selectivity and sensitivity but a high equipment cost. Regardless, HPLC provides high
automation, low LOD, and the potential to combine multiple detection systems (e.g. UV,
fluorescent, MS), which allows concurrent analysis of more than one compound from
sample. Therefore, the use of HPLC have many advantages over other methods, including
TLC and GC.
Recently, the application of a LC-MS/MS based multi-screening method that
allows simultaneous multi-toxin detection has increased (Murugesan et al., 2014). This
method is considered the most selective, sensitive, and accurate method available to date,
with a power to detect 139 different fungal secondary metabolites in feedstuffs (Streit et
al., 2013b). The most recent example showed the capability of it to identify and quantify
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295 fungal metabolites in various foods and feeds (Malachova et al., 2014). However, the
use of a single solvent mixture may compromise the extraction process because in
determination of single analytes, specific optimal solvents can be used. In addition,
restricted clean-up options are available for such multi-toxin method due to the diverse
chemical properties of mycotoxins (Murugesan et al., 2014). Nevertheless, further
calibration and standardization will increase the application and the analytical power of the
promising LC-MS/MS based methods.

1.5.2

Immunochemical Methods

Due to their relatively low cost, ease to perform, and high commercial availability,
various ELISA (enzyme-linked immunosorbent assay) kits have become a very popular
tool for mycotoxin detection in recent years (Morgan., 1989; Goryacheva et al., 2007).
Briefly, this method is based on the specific binding of an enzyme-linked primary antibody
to the target molecule; the complex then interacts with a chromogenic substrate and
therefore generate measurable results (Morgan., 1989; Stanker et al., 2008; Pestka and
Abouzied., 1995). Both direct and indirect ELISA have been used for mycotoxin detection.
The former uses only one antibody and thus is faster, but may have lower immunoreactivity, whereas the latter employs a secondary antibody for cross-reaction, and is
generally more sensitive because the binding of labeled secondary antibody with the
primary antibody aids in signal amplification (Turner et al., 2009). The LOD of ELISA for
AFB1 can reach as low as 4 μg/kg (Zheng et al., 2005). Comparative study using HPLC
and ELISA showed that ELISA tended to underestimate ochratoxin content in biological
samples compared to HPLC, but was much faster for initial screening. Advantages of
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ELISA not only include the rapid turnaround, ease to use, but also high specificity to the
toxin of interest. However, since these kits are designed for a single specific toxin and are
for single use, costs may add up if multi-toxin screening is desired. In addition, due to the
narrow sensitivity of small-size antibodies, ELISA provides a limited detection range. To
that end, HPLC still serves as the commercial standard for mycotoxin analysis, but ELISA
is undoubtedly a useful tool for rapid screening if an individual mycotoxin is of interest.

1.5.3

Biological Methods

Although modern analytical methods, such as HPLC-MS, are able to identify and
quantify different compounds with excellent sensitivity and accuracy. However, these
methods can be less powerful when the sample contains unknown toxins (where no
standards are available) or contains multiple toxins that have interactive effects (e.g.
additive or synergistic effects of two mycotoxins). Bioassays that involving live animals,
tissues, or cells are capable of determining the overall toxicity of a sample regardless of
the chemical characteristics or the underlying mechanism. The chicken embryo bioassay
was once used as an official method for confirming AFB1 toxicity (AOAC, 1984), where
the dissolved toxin is injected to fertilized eggs in the beginning of incubation, and death
of the embryo is considered as positive test. A similar method, named the brine shrimp
larvae assay, involves the incubation of larvae in a solution of aflatoxin and calculation of
mortality (Moss and Smith, 1985). However, these methods are highly non-specific as
other factors may be responsible for the mortality (Bullerman, 1987).
Compared to the use of live animals (expensive, labor-extensive, and may have welfare
issues) or tissues (difficulty in obtaining and maintaining tissues in vitro), the use of cell
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culture models to assess cytotoxicity of xenobiotics has gained its popularity as it is capable
of high-throughput screening when combined with microplate assays (Crepi, 1995). It is
important to note that the use of cell culture models is more an estimation of the total
toxicity of a given sample and thus allow interpretation of its toxic potential in vivo, rather
than identifying and quantifying individual toxins present. In such bioassay, mycotoxins
from a feed sample are extracted, dissolved, and added at graded concentrations into the
cells. After a certain incubation time, cell viability is determined and a dose-response curve
is generated, from which the IC50 value for a given sample can be calculated. Although the
relevance of in vitro cytotoxicity results to in vivo responses remains an important issue,
the IC50 value, concentration of a toxin that inhibits 50% of the cell viability in vitro, may
help predict in vivo toxicity (Clemedson and Ekwall., 1999; Ekwall et al., 2000). Multiple
researchers have determined the IC50 for various mycotoxins in vitro using different cells,
primarily using the MTT assay. The IC50 for DON was shown to be 21.5 μM in CaCO-2
cells (Kouadio et al., 2005), while Creppy et al. (2004) reported that IC50 values of FB1
were 45, 31, and 64 μM in C6 glioma cells, Caco-2 cells, and Vero cells after 48 h
incubation. However, cytotoxicity of AF is studied more in human cells, such as human
epithelioid lung cell line (Palanee et al., 2001), bronchial epithelial cells (Yang et al., 2012),
or lymphocytes (Al-Hammadi., 2014). Exploration of AF toxicity, especially
determination of the IC50 values, are rare in cells from poultry species.
Whether in vitro IC50 values can be used to predict in vivo toxicity with sufficient
accuracy has received much interest yet is still a challenging question. Creppy et al. (2004)
used IC50 obtained from 3 cell lines to estimate starting doses for in vivo acute toxicity of
FB1 using the following prediction model: log (LD50 [mmol/kg])=(0.435 log
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IC50[mmol/l])+0.625, and their estimated in vivo LD50 for FB1 were 671 to 923 mg/kg.
While these concentrations might be relevant for broilers, they can be significant
overestimations for pigs, as a contamination ≥ 20 mg/kg in final feed can significantly
reduce growth of pigs (Dersjant-Li et al., 2003). Based on the review by Gutleb et al. (2002)
which summarized 149 cytotoxicity studies for Fusarium mycotoxins, remarkable
discrepancies of the IC50 values exist between cell lines even for the same mycotoxin. Thus,
future research should focus on the identification of sensitive cell models for a particular
mode of action and subsequent exploration of species-specific prediction models for in
vivo toxicity. For such purpose, several critical points of a bioassay must be strictly defined
in order to allow more consistency in the results and better comparability between
laboratories (Gutleb et al., 2002; Cheli et al., 2014). Additionally, further attention should
be given to the understanding of additive, synergistic, and antagonistic effects of multiple
mycotoxins in in vitro systems and implications for animal responses as well as feed and
food safety regulations.

1.6

Summary

Aflatoxins (AF), especially AFB1, are major agriculture-relevant mycotoxins with
high prevalence in feeds and feed ingredients, posing serious risks to the livestock industry
globally. Despite their demonstrated carcinogenic potential and hepatotoxic effects, the
primary threat of AF to the poultry industry comes from subclinical aflatoxicosis upon
chronic intake of low levels of AF, which is characterized primarily as slower growth and
impaired organ functions, and higher susceptibility to diseases without high mortality.
Extensive research reports are available on the adverse effects of AF on performance, liver
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functions, and immune functions in broilers, but information about AF effects on the GIT
is rare and non-conclusive on how AFB1 affects gut barrier, nutrient digestion, and
absorption in poultry species and the mechanisms behind it. There is a close association
between performance and intestinal health and functions, therefore, elucidation of how
AFB1 modulates these processes awaits more future research. Among poultry species,
ducks are the most susceptible to AF toxicity. Despite the growing duck industry and its
great economic impact, compared with broilers, limited research is available on AF toxicity
in ducks. Hence, further studies evaluating the multiple AF effects, including that on
performance, liver functions, gut functions, in ducks are required.
In order to minimize the adverse effects of AF, one of the most used approaches
today is the addition of the non-nutritive mycotoxin adsorbents that bind AF in the
gastrointestinal tract and thus prevent its absorption into other parts of the body; among
which HSCAS is considered the most effective adsorbent for AF. However, because of the
diverse types of aluminosilicates and different processing methods, the available HSCAS
products may not possess the same physical properties, and thus must be evaluated
individually to determine their efficacy in animals. In addition to the non-nutritive AF
adsorbents, dietary nutrients may also interact with aflatoxin before and after intestinal
absorption. Studies investigating this issue are relatively limited, but existing evidences
suggest that AF can interact with dietary proteins, amino acids, lipids, vitamins and
minerals, and that nutritional status of an animal is a major factor in determining the
severity of aflatoxicosis. Most literature sources in this regard are dated, therefore,
evaluation of such interactive effects of nutrients and AF is needed for modern poultry,
which are fundamentally very different from birds before the 1990s. On the other hand, a
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key step in understanding mycotoxin effects and intervening effective counteractive
strategies is the accurate analysis of mycotoxins or good estimation of the toxicity potential
of a mycotoxin-containing sample. In recent years, cell culture models have been used
extensively in assessing in vitro toxicity of various toxins. However, cytotoxicity of AFB1
is less studied in cells from poultry species. Future research should focus on the
identification of sensitive cell models for a particular mode of action and subsequent
exploration of species-specific prediction models for the in vivo toxicity. Developing
comprehensive understanding of both the effects and mechanisms of aflatoxin exposure
and the interactions of AF with dietary modifications is imperative, as it ultimately will
provide the tools for developing strategies for effective control of aflatoxicosis and
ensuring the health of animals and profitability of the poultry industry.

Table 1.1. The limit concentration (mg/kg) for aflatoxin B1 in poultry feeds by the European Union (EU), the U.S. Food and Drug
Administration (FDA), and China
Class of Animal
Feed
FDA
EU
China
Immature poultry

Corn, peanut products, and other animal feeds and feed ingredient

0.02

\

\

Young poultry

complete, complementary, and concentrated feeds

\

\

0.01

Mature poultry

Corn, peanut products

0.1

\

0.05

Poultry (all ages)

Cottonseed meal

0.3

\

0.05

Poultry (all ages)

Raw ingredient

\

0.05

\

Poultry (all ages)

Complete feeds

\

0.02

\

Ducks and layers

complete, complementary, and concentrated feeds

\

\

0.015

Broilers and layers

complete, complementary, and concentrated feeds

\

\

0.02

Mature poultry

rapeseed meal

\

\

0.05

Mature poultry

Soybean meal

\

\

0.03
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Table 1.2. Summary of selected studies on the effects of dietary aflatoxins (AF) on
growth performance in broiler chicks.
Changes in performance1
AFB1
(mg/kg)
0.02

ADG
(g/d)
-4.0

ADFI
(g/d)
-11.0

Feed/Gain
ratio
0.0

AF source
Cultured material

Age2
21-49

Reference
Kana et al., 2010

0.08

-2.8

-5.2

0.0

Cultured material

8-42

Yunus et al., 2011b

0.3

-11.8

-14.3

0.1

Cultured material

35

Raju and Devegowda, 2000

0.4

-5.5

---

---

Unknown origin

49

Sodhi et al., 1996

0.4

0.7

-1.9

-0.1

Cultured material

28

Kermanshahi et al., 2007

0.5

-1.4

-0.2

0.1

Cultured material

49

Verma et al., 2004

0.5

-4.6

No effect

0.2

Cultured material

35

Manafi et al., 2012

0.7

-2.3

---

---

Cultured material

49

Doerr et al., 1983

0.8

-0.5

-0.2

0.1

Natural contamination

35

Giambrone et al., 1985

0.8

-11.0

---

0.5

35

Tedesco et al., 2004

0.8

-1.0

-0.8

0.0

Purified AFB1
contaminated
Cultured material

28

Kermanshahi et al., 2007

0.8

-12.9

-21.1

0.0

Cultured material

8-42

Yunus et al.,2011

1.0

-5.1

-5.2

0.3

Cultured material

49

Verma et al., 2004

1.0

-8.5

-9.0

0.1

Cultured material

21

Gpwda et al., 2008

1.0

-8.5

06.0

0.2

Cultured material

7-42

Denli et al., 2009

1.0

-4.0

-6.0

0.0

Cultured material

21

Zhao et al., 2010

1.1

-2.6

0.2

0.1

Natural contamination

42

Shi et al., 2006

1.2

-4.8

-8.6

0.0

Cultured material

28

Kermanshahi et al., 2007

2.0

-3.7

---

---

Cultured material

21

Basmacioglu et al., 2005

2.0

-8.3

-14.0

-0.1

Cultured material

21

Zhao et al., 2010

2.5

-7.7

---

No effect

Cultured material

21-42

Miazzo et al., 2000

3.0

-2.4

---

0.2

Purified AFB1

21

Valdivia et al., 2001

3.5

-4.7

---

0.1

Cultured material

21

Kubena et al., 1997

4.0

-4.4

-6.3

-0.1

Cultured material

21

Edrington et al., 1997

4.0

-9.3

-10.4

0.0

Purified AFB1

21

Ledoux et al., 1999

5.0

-8.5

---

0.4

Purified AFB1

24

Randall and Bird, 1979

5.0

-8.9

-11.7

-0.1

Cultured material

21

Kubena et al., 1998

1 Changes

in performance by AFB1 compared to control birds. ADG= average daily gain;
ADFI = average daily feed intake; --- indicates no reported data.
2 Age of the bird exposed to AF starting from hatching in days, unless otherwise specified.
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Table 1.3. Summary of selected studies on the effects of dietary aflatoxins (AF) on serum
biochemistry in poultry
Poultry
species

Age 2 (d)

Broiler

21

AFB1
(mg/k
g)
0.3

Broiler

35

Broiler

Significant changes in serum concentrations
by AF1

Reference

 TP, Chl

Raju and Devegowda. 2000

0.3

 AST, Chl, GGT, P

Raju and Devegowda. 2000

14-49

0.8

 ALT

Tedesco et al., 2004

Broiler

21

1

 TP, albumin, Chl, Ca

Gowda et al., 2008

Broiler

42

1

 ALP

Denli et al., 2009

Broiler

21

1

Zhao et al., 2010

Broiler

42

1.3

Broiler

21

2

 TP, albumin, globulin
 TP, albumin, Chl, Ca, P, UA, ALP;
AST
 TP, albumin, globulin, Glu, Ca, P, ALP

Broiler

21

2.5

 TP, albumin, glucose, Chl, Ca, ALP

Huff et al., 1988

Broiler

28

2.5

 TP, albumin, globulin, Chl, Ca; GGT

Manning and Wyatt., 1990

Broiler

21

3

 TP, ALT; AST

Valdivia et al., 2001

Broiler

21

3.5

 TP, albumin, Chl, creatinine, Ca

Kubena et al., 1998

Broiler

21

4

 TP, Urea N, Chl,

Edrington et al., 1997

Broiler

21

4

 TP, albumin, globulin, Chl, Glu, Ca, P

Ledoux et al., 1999

Broiler

21

5

 TP, albumin, Chl, Uric acid, Ca; CK

Bailey et al., 1998

Broiler

21

5

 TP, albumin, Chl; CK, Urea N

Kubena et al., 1998

Breeder hens

45-50wk

0.1

 ALP

Matur et al., 2010

Duck

42

0.04

 AST, ALT

Han et al., 2008

Duck

40-47

0.1

 AST, ALT, AST:ALT ratio

Méndez-Albores et al., 2006

Duck

21

0.1

 CK, AST

Li et al., 2012

Duck
Japanese
quails
Laying hens

21

0.1

 TP, albumin, globulin

Wan et al., 2013

21-49

2.5

 TP, albumin, Chl, TG, Glu; UA, UN

Kasmani et al., 2012

for 32 d

5

 TG, Ca, P, ALT;  GGT

Fernandez et al., 1994

Turkey poults

21

0.75

 TP, albumin, Chl, UA, TG, Ca; UN

Kubena et al., 1995

1

Allameh et al., 2005
Zhao et al., 2010

TP = total protein; Chl = cholesterol; ALT= alanine transferase; ALP=alkaline phosphatase; AST= aspartate amino
transferase; CK-creatinine kinase; GGT= gamma-glutamyl transferase; UA = uric acid; UN= urea N; Glu = glucose
2
Age of the bird exposed to AF starting from hatching in days, unless otherwise specified.

Table 1.4. Summary of studies on the effects of dietary aflatoxins (AF) on gut barrier, nutrient digestion, and nutrient absorption in poultry

Age
\
\

Broiler

8-42

0.75

lipid retention

Broiler
Broiler

8-42
28

0.07
0.28

 ileal digestion of essential AA

Broiler

28

1.2

 digestibility of DM, organic
matter, Ca, and P; AME; no
effect on lipid and protein
digestibility

Kermanshahi et al., 2007

Broilers

21

1.25

 pancreatic amylase, trypsin,
lipase

Osborne and Hamilton,
1981

Duck

42

0.02, 0.04

 duodenum activity of protease,
chymotrypsin, trypsin, amylase
apparent CP digestibility

Han et al., 2008

Duck
Duck

21
14

0.1
0.28

Breeder hen

45-50wk

0.1

Laying hen

20-22wk

0.6, 1.2, 2.5

1

AFB1
(mg/kg)
150 uM
3.75 mg/ml

Significant changes compared to control animals2
Nutrient digestion
Nutrient absorption

Poultry
species
CaCo-2 cells
CJE cellss2

Barrier
 TEER

 short-circuit current after
glucose addition
 duodenum & jejunum length;
 duodenum & jejunum weight
No effect on SI length or weight

 villi height & villus-crypt ratio
 apparent CP dig; N balance;
energy balance; ileal digestion of
essential AA
 pancreatic amylase &
chymotrypsin activity;  pancreatic
lipase activity
 intestinal maltase activity
(quadratically); no change in DM
and N digestibility (per hen per
day);
 apparent digestible and AMEn

Reference
Gratz et al., 2007
Yunus et. al., 2010
Yunus et al. 2011
Yunus et al. 2011
Ostrowski-Meissner et al.,
1983

Wan et al., 2013
Ostrowski-Meissner et al.,
1983
Matur et al., 2010

 crypt depth linearly

Applegate et al., 2009
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Laying hen
42-49wk
1, 2
 ME and protein retention
Verma et al., 2007
1
Age of the bird exposed to AF starting from hatching in days, unless otherwise specified. 2 CP= crude protein; TEER = transepithelial electric resistance;
AME = apparent metabolizable energy; AMEn = N-corrected apparent metabolizable energy;

Table 1.5. Overview of selected studies on the efficacy of major mycotoxin adsorbents in ameliorating aflatoxicosis in poultry
Adsorbent
category
HSCAS

Poultry
species
Broiler

AFB1
(mg/kg)
2.5

Age1
21

Broiler
Broiler
Broiler
Broiler

3.5
3.5
3.5
5

21
21
21
21

Broiler
Broiler
Broiler
Broiler
Turkey
Duck

5
2.5, 5
7.5
7.5
0.75
0.03, 0.06,
0.12
5

21
21
21
21
44-46
?

0.50
0.50
0.50
0.25,
0.375
0.50
0.50
0.50
0.50
0.50
0.25, 0.5

28

0.50

7.5

28

0.5, 1

Broiler

Efficacy of adsorbent (compared to AF-fed group)
 AF residues in liver and kidney; no effect on hepatic
lesions
 BW gain, serum measures;  relative organ weights,
 BW gain;  relative organ weights
Total protection against AF
 BW gain, feed efficiency;  relative organ weights

Reference
Neeff et al., 2013

3 products were evaluated; only 1 product  BW gain
 BW gain, relative organ weights, serum measures
 Growth, recovered liver histological lesions
 BW gain;  relative organ weights
 Urinary AFM1 output
 Mortality rate, relative liver weight, liver lesions
 BW gain, serum measures; relative organ weights

Bailey et al., 1998
Kubena et al., 1993
Phillips et al., 1988
Kubena et al., 1989
Edrington et al., 1996
Ratanasethakul et al.,
1990
Kubena et al., 1989

0.50

 BW gain;  liver lesions.

Phillips et al., 1988

21

0.50

Kubena et al., 1991

2.5

28

0.2, 0.4,
0.6

 BW gain, serum measures and enzyme activities; 
relative organ weights (in birds fed 0.5 mg/kg AF, but not 1
mg/kg AF)
 Immune functions (phagocytosis and Newcastle disease
antibody formation)

Broiler

2.5

23-50

0.30

Broiler

3

42

0.25, 0.5

Leghorn
chick
Leghorn
chick
Turkey

Bentonite
(Montmorll
onite)

Inclusion
rate (%)
0.50

Kubena et al., 1990
Huff e tal., 1992
Kubena et al., 1993
Kubena e tal., 1998

Ibrahim et al., 2000

52

 BW gain, serum measures; relative organ weights, liver Miazzo et al., 2005
lesions
BW gain, feed intake, and feed efficiency by 0.5%
Santurio et al., 1999
inclusion rate but not 0.25%.
No effect on relative organ weights or serum measures.

Table 1.5. Continued
Broiler

Zeolite/
Clinoptiloli
te

Activated
carbon

Yeast cell
walls

1

5

30-52

0.30

 BW gain, moderate improvement on serum measures;
No protection on hepatic lesions.

Rosa et al., 2000

Duck

0.1

21

0.10

No effect on performance; Partially improved hematological
and serum biochemical measures

Li et al., 2012

Broiler
Broiler

2.5
2.5

21-42
21

1
1.5, 2.5

Total recovery of BW gain;  relative liver weight
Partially improved serum measures

Miazzo et al., 1999
Oğuz et al., 2000

Broiler

2.5

21

1.5, 2.5

Partially improved immune organ lesions

Ortatatli and Oğuz, 2001

Broiler

3.5

21

0.50

1 product improved BW gain, liver weight, and serum
measures; other 3 products had no effect

Harvey et al., 1993

Broiler

0.5

42

0.02

 BW gain, feed intake, serum measures

Jindal, et al., 1994

Broiler

10

56

0.02

 Feed intake, hepatic enzyme activity

Broiler

2.5, 5, 10

56

0.10

BW gain, feed intake, hepatic enzyme activity

Turkey

0.75

44-46

0.50

Leghorn
chick
Broiler
Broiler

5

28

0.50

1
1, 2

35
21

0.20
0.1, 0.2

Broiler

2

21

0.05, 0.1

No effect on performance, relative organ weights, or serum
measures
No effect on performance, relative organ weights, or serum
measures
No effect on performance, antibody titers
 Performance and  liver damage in birds fed 1 mg/kg
AFB1, but not 2 mg/kg
Partially improved liver pathological changes

Dalvi and Ademoyero,
1984
Dalvi and McGowwan,
1984
Edrington et al., 1996

Broiler

2.5

28

0.11

protein content in albumin  liver residue of AFB1

Kubena et al., 1989
Santin et al., 2003
Zhao et al., 2010
Karaman et al., 2010
Zaghini et al., 2005

Age of the bird exposed to AF starting from hatching in days, unless otherwise specified.
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CHAPTER 2. EFFICACY OF A HYDRATED SODIUM CALCIUM
ALUMINOSILICATE TO AMELIORATE THE ADVERSE EFFECTS OF
GRADED LEVELS OF AFLATOXIN B1 IN BROILER CHICKS

2.1

Abstract

The objective of this study was to evaluate the efficacy of a hydrated sodium
calcium aluminosilicate (HSCAS) adsorbent to ameliorate the adverse effects of 0.5 to 2
mg/kg aflatoxin B1 (AFB1) in broiler chicks. The study consisted of 8 dietary treatments,
including 4 concentrations of AFB1 (0, 0.5, 1, and 2 mg/kg) with or without HSCAS (0.05%)
fed to 8 replicate cages per diet (6 males chicks per cage) from 0 to 21 d of age. Cumulative
feed intake, BW gain (P < 0.0001), and gain: feed ratio (P = 0.004) of birds fed 2 mg/kg
AFB1 diet were significantly lower in comparison to birds fed 0 to 1 mg/kg AFB1. Relative
liver weight was increased in the 2 mg/kg AFB1 group (P < 0.0001). Dietary HSCAS
improved cumulative BW gain (main effect P = 0.06), particularly from 14 to 21 d of age
(P = 0.037). Dietary HSCAS also reversed the increase in relative liver weight for birds
fed AFB1 (P = 0.019). Dietary AFB1 negatively affected major serum parameters (albumin,
total protein, globulin, phosphorus, glucose, alkaline phosphatase, and creatine
phosphokinase); whereas supplementation with HSCAS partially alleviated the affected
serum biochemistry. In addition, serum complement activity and liver gene expression
were negatively affected
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by 2 mg/kg AFB1. HSCAS supplement increased the liver expression of catalase and
superoxide dismutase (P < 0.05). Results from this study indicate that dietary
supplementation with HSCAS can effectively improve the BW gain and partially
ameliorate aflatoxicosis for broiler chicks fed AFB1-contaminated feeds.

2.2

Introduction

Suboptimal environmental factors, such as drought, insects, and poor storage
conditions, can lead to aflatoxin (AF) production during crop growth and storage, resulting
in the contamination of animal feedstuffs and human foods. Aflatoxin B1 (AFB1), as an
active hepatocarcinogen and the most toxic AF, is known to depress performance and
production, impair the immune system, and induce liver diseases and metabolic disorders
in poultry species (Giambrone et al., 1985; Azzam and Gabal, 1998; Andretta et al., 2011).
The natural contamination of feedstuffs by AF is often lower than the concentrations used
in research (Dersjant-Li et al., 2003), yet limited studies have evaluated the effects of
aflatoxin at low levels (≤ 1 mg/kg) in broilers. A recent meta-analysis concluded that 0.95
mg/kg AFB1 was the threshold concentration to induce growth depression in broilers
(Andretta et al., 2011). In addition, because liver is both a major target organ and the
primary site for AFB1 bio-activation, modern broilers may be more susceptible to AFB1
because they have more efficient nutrient conversion which demands faster hepatic
metabolism (Yunus et al., 2011). Therefore, it is likely that dietary AFB 1 lower than 1
mg/kg could negatively impact the health of broilers. Serum biochemical measures can
often help diagnose aflatoxicosis even before depressed performance is evident (Kececi et
al., 1998), for instance, decreased serum protein concentration is a dependable biomarker
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of hepatotoxicity induced by AF (Kubena et al., 1990; Kececi et al., 1998). Decreased
serum glucose (Harvey et al., 1993; Zhao et al., 2010), and calcium and phosphorus (Glahn
et al., 1990) have also been reported during aflatoxicosis. In addition, as crucial
components of the immune system and a first line of defense against foreign invaders, the
activity of serum natural antibody and complement system can also provide information
on the changes in the innate immune system during aflatoxicosis (Cotter, 2012).
In order to minimize the considerable economic losses caused by AF contaminated
crops (Hengry et al., 1999), various non-nutritive adsorbents have been employed for
reducing or inactivating AF in poultry feeds. Hydrated sodium calcium aluminosilicates
(HSCAS), which reduce AF absorption by binding with the β-carbonyl portion of AF
molecules, have been shown to be effective in preventing aflatoxicosis (Phillips et al.,
1990; Scheideler, 1993; Ledoux et al., 1999). The efficacy of a HSCAS depends on its
surface characteristics. Engage-M (JBS United, Inc., Sheridan, IN) is a processed HSCAS
product that has increased surface area per gram of material. Therefore, it is hypothesized
that Engage-M can effectively ameliorate aflatoxicosis in growing broilers. In addition, as
the major site of AF metabolism, the liver contains multiple enzymes that are involved in
AF bio-activation and detoxification, for example, cytochrome P450 family, epoxide
hydrolase (EH), and glutathione S-transferase (GST). With the participation of superoxide
dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), the liver is also
involved in extensive anti-oxidation reactions to defend against increased free radicals and
lipid peroxidation during aflatoxicosis (Chen et al., 1994). Although the protective effect
of HSCAS against aflatoxicosis has been extensively studied, to date, few reports are
available on liver gene expression changes in response to AF exposure (Yarru et al., 2009),
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and no studies have been published on the effects of HSCAS in this respect. The gene
expression data of major liver molecules may help explain the effects and mechanisms of
AFB1 and HSCAS in broiler chicks. Therefore, the objectives of this study were to
determine the effects of 0.5 to 2 mg/kg AFB1 and to evaluate the efficacy of a HSCAS
adsorbent (Engage-M) in preventing aflatoxicosis in young broilers by measuring
performance, serum biochemical characters, as well as liver antioxidant status and gene
expression.

2.3
2.3.1

Materials and Methods

Experimental Birds and Diets
The animal care and use protocol was reviewed and approved by the Purdue

University Animal Care and Use Committee. A total of 384 male broiler chicks (Ross 708)
were obtained from a commercial hatchery, weighed, and randomly allotted to 8 treatments,
8 replicate cages per treatment, and 6 chicks per cage. All chicks were housed in battery
cages in an environmental controlled room and fed to 21 d of age. Feed and water were
provided ad libitum. Mortality was recorded as it occurred, and birds were inspected daily
for any health-related problems. The eight dietary treatments were arranged in a 4 x 2
factorial with 4 AFB1 concentrations (0, 0.5, 1, and 2 mg/kg) with or without Engage-M (a
processed HSCAS compound with an inclusion rate of 0.05 %, JBS United Inc.). A cornsoybean meal based basal diet was formulated to meet or exceed the nutritional
requirements of chicks from hatch to 21 d of age as recommended by NRC (1994) (Table
2.1). Eight premixes, contributing 3.33% of the final diets by weight, were prepared with
graded amounts of AFB1 with ground corn with or without 1.48% HSCAS, and then
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blended with the basal diet to create the 8 treatment diets, respectively. The cultured
aflatoxin with a concentration of 60 mg/kg was supplied by Aspergillus parasiticus (NRRL
2999) as described by Gowda et al. (2008). The AF concentrations of cultured material,
including AFB1, AFB2, AFG1, and AFG2, were analyzed by High Performance Liquid
Chromatography (HPLC) at Romer labs (Union, MO) (Trucksess et al., 1994). The
concentrations of other mycotoxins, including fumonisins, deoxynivalenol, T-2 toxin, and
zearalenone, were analyzed using HPLC and a combination of gas chromatography or mass
spectrometry at the Veterinary Diagnostic Laboratory at North Dakota State University
(Fargo, ND) (Raymond et al., 2003).

2.3.2

Sample Collection
Individual BW was measured on d 7, 14, and 21. On d 21, total feed consumption

was recorded for each cage. Average feed intake and BW gain were corrected for mortality
when calculating feed conversion for each cage. On d 21, all chicks were euthanized using
CO2 inhalation, and 8 chicks from each treatment (1 chick per cage) were randomly
selected for blood collection. Liver and spleen weights were recorded for 1 bird per cage;
relative liver weight and relative spleen weight were calculated as a percentage of BW. A
section of liver sample from one chick per cage was collected, preserved in RNAlater
(Ambion, Austin, TX), and stored at -80 ⁰C for quantitative real-time PCR analysis.
Another section of liver tissue was collected for antioxidant status analysis.
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2.3.3

Serum Chemistry and Complement Analysis

Blood was collected from 1 bird per cage (8 birds per treatment) via jugular vein after
euthanasia for serum chemistry and complement system analysis. Collected blood was
centrifuged at 1,400 x g at 8 ⁰C for 15 min to serum separation, and the serum was
preserved at –20 ⁰C until submitted for biochemical analysis. All serum samples were
analyzed for albumin, globulin, total protein, glucose, urea N, creatinine, K, Cl, Ca, P,
alanine amino transferase (ALT), alkaline phosphatase (ALP), aspartate amino
transferase (AST), γ-glutamyl transferase (GGT), creatine phosphokinase (CPK), and uric
acid at the Veterinary Medical Diagnostic Laboratory of University of Missouri
(Columbus, MO) using an auto-analyzer (Kodak Ektachem Analyzer, Eastman Kodak
Co., Rochester, NY).
In addition, one serum sample (approximately 0.5 mL) per cage was analyzed for
natural antibody and serum complement activity as described by Cotter (2012). The sera
were tested by microtiter for the capacity to agglutinate and lyse rabbit (Rb), human
(HuO), and horse (HO) erythrocytes. Three agglutination types [HA1 (strong), HA2
(weak), and H45 (very weak)] for natural antibody activity, and two degrees of lysis [L100
(complete lysis) and L50 (half lysis)] for the complement activity were visually evaluated
using the end-point (log2 dilutions) (Cotter, 2012).

2.3.4

Liver Antioxidant Status

Collected liver tissue (1 bird per cage) was diluted at a ratio of 1:9 with phosphate
buffered saline, homogenized, and centrifuged at 10,000 x g, 4 ⁰C for 15 min. The clear
supernatant was obtained and preserved at –80 ⁰C until antioxidant status was determined.
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The content of total protein (Sigma kit # TP0400), total antioxidant capacity (Sigma kit #
CS0790), aqueous and organic peroxide (Sigma kit # PD1), superoxide dismutase (SOD)
(Sigma kit # 19160), and catalase (CAT) (Sigma kit # CAT100) were determined using
respective assay kits (Sigma Diagnostics, Sigma Chemical Co., St. Louis, MO).

2.3.5

Liver Gene Expression

Hepatic expression of interleukin 6 (IL-6), interleukin 1β (IL-1β), interferon-gamma
(IFN-γ), catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx),
cytochrome P450 1A1 (CYP 1A1), epoxide hydrolase (EH), and glutathione S-transferase
(GST) were determined using quantitative real-time PCR (MyiQ real-time PCR detection
system, Bio-Rad, Hercules, CA, USA) with SYBR mix (Bio-Rad, Hercules, CA, USA).
Briefly, total ribonucleic acid (RNA) from hepatocytes (8 samples per treatment) was
extracted using TRIzol® (Invitrogen, Carlsbad, CA, USA). Extracted RNA was quantified
at an absorbance of 260 nm (ND-1000, Nanodrop Technologies Inc., Wilmington, DE) and
reverse transcription was carried out using the M-MLV reverse transcriptase (Promega,
Madison, WI, USA). Water served as a negative control. All reactions were analyzed in
duplicate and formation of a single PCR product was confirmed by melting curves. The
primer sequences used were based on a previous report (Yarru et al., 2009) or designed
using Primer3 software (http:// primer3.wi.mit.edu) (Table 2.2). The mRNA expression
was determined from the threshold cycle (Ct) for respective genes and the expression level
was calculated using the 2-ΔΔ Ct method (Livak and Schmittgen, 2011) normalized using
glyceraldehyde phosphate dehydrogenase (GAPDH) expression.
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2.3.6

Statistical Analysis
All data were analyzed as a 2-way ANOVA using the GLM procedure of SAS

system (9.3). The model included main effects of AFB1 level, HSCAS level, and their
interaction. Cage was the experimental unit. The means showing significant (P ≤ 0.05) and
trending (0.05 < P ≤ 0.10) treatment differences in the ANOVA were then compared using
Fisher’s protected least significant difference procedure. All data were tested for normality
using the UNIVARIATE procedure and common variance using the GLM procedure of
SAS (9.3). Non-normal data were transformed using the optimal Box-Cox transformation.

2.4
2.4.1

Results

Aflatoxin analysis
The analyzed dietary AFB1 concentrations were < 0.02 (control), 0.58 (0.5 mg/kg

AFB1), 1.3 (1.0 mg/kg AFB1), 2.3 (2.0 mg/kg AFB1), 0.05 (Control + HSCAS), 0.87 (0.5
mg/kg AFB1 + HSCAS), 1.2 (1.0 mg/kg AFB1 + HSCAS), and 3.1 mg/kg (2.0 mg/kg AFB1
+ HSCAS) for the 8 dietary treatments, respectively. The AFB2 was ≤ 0.12 mg/kg for all
treatments, and AFG1 concentrations were approximately 20% of AFB1 concentrations.
Dietary AFG2 was below the detection limit (0.8 μg/kg) under the analytical conditions
used.

2.4.2

Growth performance and organ weight

The cumulative performance and relative organ weights are shown in Table 2.3. Based
on the factorial analysis, cumulative feed intake (FI) (P < 0.0001), BW gain (P < 0.0001)
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and gain: feed ratio (P = 0.0037) of birds fed 2 mg/kg AFB1 diet were significantly lower
in comparison to birds fed the other 3 diets. Birds fed 2 mg/kg AFB1 only consumed 83%
feed and achieved 75% BW gain of those fed control diet. Both 0.5 and 1 mg/kg AFB 1
lowered BW gain of broilers compared to control group (P < 0.05), but FI and gain: feed
ratio were not affected by 0.5 or 1 mg/kg AFB1. No statistical main effect of HSCAS was
observed on performance. However, the main effect of supplementation with HSCAS had
a trend towards improving the cumulative BW gain (P = 0.06). During wk 2 and wk 3,
birds fed 2 mg/kg AFB1 diet showed lower BW gain than those fed 0 to 1 mg/kg AFB1
diets (P < 0.0001; Table 2.4). Supplementation with HSCAS significantly improved BW
gain for broilers from 14 to 21 d (342 vs. 328 g/chick, P = 0.037).
Relative liver weight (Table 2.3) was significantly higher in the 2 mg/kg AFB1 group.
The HSCAS reversed the increased relative liver weight for birds fed AFB1 (P = 0.02), and
a significant interaction was observed between AFB1 and HSCAS (P = 0.03). Relative
spleen weight was not affected by dietary treatments (data not shown).

2.4.3

Serum Biochemistry
Compared with birds fed the control diet, feeding AFB1 to broilers resulted in

significant reductions in serum glucose, anion gap, albumin, total protein, globulin, P, and
ALP (P < 0.05, Table 2.5). Based on the main effect means, this adverse effect started from
1 mg/kg AFB1 for glucose and albumin, and from 2 mg/kg AFB1 for total protein, globulin,
ALP, and P. Serum urea N and Cl levels were increased by 2 mg/kg AFB1 (P < 0.05).
The HSCAS supplement reversed the increase of CPK levels induced by AFB1 (5464
vs. 7367 U/L, P = 0.039), but did not have statistical main effects on any other serum

81
measures. A significant interaction of AFB1 and HSCAS was observed on serum albumin,
P, ALP, and AST (P ≤ 0.04). The HSCAS supplement improved serum albumin levels for
birds fed 1 mg/kg AFB1, restored ALP activity for only birds fed 1 mg/kg AFB1, and
decreased AST activity for only birds fed 2 mg/kg AFB1 (P < 0.05).

2.4.4

Liver Antioxidant Status
The total antioxidant capacity, total protein, catalase, peroxide, and SOD activity

were determined using liver samples from 21-d old chicks. No main effect of AFB1 was
found, except a trend towards decreasing organic peroxide level from 0 to 2 mg/kg AFB1
inclusion (P = 0.06) (data not shown). The HSCAS supplement showed a significant main
effect in improving liver SOD activity (P = 0.046) (Figure 2.1). There was no significant
interaction between AFB1 and HSCAS on any antioxidant status measures.

2.4.5

Natural Antibody and Serum Complement Activity
The natural antibody and serum complement activity results are shown in Table 2.6.

When tested against rabbit erythrocytes, the L50 value was reduced by 2 mg/kg AFB 1 (P
< 0.02), and HA1 and HA2 values were increased by 2 mg/kg AFB1 (P ≤ 0.03). No
significant main effect of HSCAS or 2-way interaction were observed. The natural
antibody and serum complement activity were not affect by dietary treatment when tested
using human and horse erythrocytes.
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2.4.6

Liver Gene Expression
The expression of IL-6, IL-1β, IFN-γ, CAT, SOD, GPx, CYP1A1, EH, and GST

were determined (Table 2.7). The expression of GAPDH was not different across
treatments. Dietary AFB1 had a significant main effect of up-regulating IL-6, GPx, EH,
and GST, and down-regulating SOD and CYP1A1 expression (P < 0.001). The HSCAS
supplement showed a significant main effect of increasing IL-1β, CAT, SOD, and CYP1A1
expression (P ≤ 0.034). Significant interaction of AFB1 and HSCAS was found for the
expression of CAT, SOD, GPx, and GST (P < 0.05), wherein SOD expression was downregulated by AFB1 but was up-regulated by HSCAS.

2.5

Discussion

Since their discovery 50 years ago, aflatoxins have become a ubiquitous threat to
poultry production, leading to considerable economic losses (Rawal et al., 2010; Kensler
et al., 2011). Research in the last ten years have accentuated the potential of low levels of
AFB1 to negatively impact broiler performance (Dersjant-Li et al., 2003; Andretta et al.,
2011; Yunus et al., 2011). Hydrated sodium calcium aluminosilicates (HSCAS) have been
demonstrated to be effective in binding AF molecules in the gastrointestinal tract, making
them unavailable for adsorption and consequently alleviating aflatoxicosis (Phillips et al.,
1990; Sheideler, 1993). This current study aimed to evaluate the efficacy of a HSCAS in
ameliorating aflatoxicosis induced by graded levels of AFB1 in growing broilers.
In the current study, 0.5 and 1 mg/kg AFB1 did not affect feed intake (FI) or gain: feed
(G:F) ratio. Although 0.5 and 1 mg/kg AFB1 did show significant main effects of reducing
cumulative BW gain, when no HSCAS was added, there was no statistical difference in
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BW gain of birds fed 0.5 to 1 mg/kg AFB1 compared to birds fed control diet (686, 658,
and 655 g/chick for birds fed control, 0.5, and 1 mg/kg AFB1 diets, respectively). On the
contrary, others have found that 0.2 to 1 mg/kg cultured AFB1 can significantly depress
growth in broilers (Mani and Sundaresan, 1998; Raju and Devegowda, 2000; Verma et al.,
2004; Zhao et al., 2010). In these studies, the broilers were fed 5 to 7 wk, compared to 3
wk in the current study. Because existing data revealed no adaptive responses of broilers
to prolonged AFB1 intake (Dersjant-Li et al., 2003), it is possible that 0.5 and 1 mg/kg
AFB1 can exert a greater growth depression effect if the birds were fed to commercial age.
The FI and BW gain were significantly decreased by 2 mg/kg AFB1 compared with control
by 17.3 and 25.0%, respectively. Similarly, Zhao et al. (2010) reported a 28% decrease in
FI and 21% decrease in BW gain observed in broilers that were fed 2 mg/kg AFB1 for 3wk.
However, in the current study, the G: F ratio was also decreased by 9.2% by 2 mg/kg AFB1
(P < 0.05), while others did not find such effects (Gowda et al., 2008; Zhao et al., 2010).
The effects of AF on feed efficiency are not always consistent due to different diet
composition, particularly different protein sources and levels, which were reported to alter
protein utilization and animal response to AF in poultry and swine (Ostrowski -Meissner,
1983; Richardson et al., 1987; Coffey et al., 1989). In addition, it is suggested that AFB 1
may generate a more profound toxicosis in modern broiler strains, as the more rapid growth
of modern birds demand faster hepatic metabolism (Yunus et al., 2011). A meta-analysis
(Andretta et al., 2011) using 98 papers ranging from 1980 to 2009 showed that an average
of 0.95 mg/kg AF could reduce both FI and daily weight gain by 11%. However, under the
conditions of the experiment described herein, birds were not susceptible to AFB1 lower
than 1 mg/kg.
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The HSCAS used in the current experiment was able to numerically restore the BW
gain of birds fed from 0 to 2 mg/kg AFB1 (P = 0.06), and the improvement was significant
during wk 3 (P < 0.05). Dersjant-Li et al. (2003) suggested that the effects of AF intake
were generally greater in older animals due to a higher rate of protein retention. Kubena et
al. (1990) reported that an HSCAS adsorbent significantly improved BW gain of broilers
fed AFB1 starting from wk 2, with the improvement greater during wk 3 than wk 2 (21%
vs.14% of control BW gain for wk 3 and wk 2, respectively). In this study, the improvement
in BW gain due to HSCAS became significant during wk 3. If the birds were fed to
commercial age, the main effect of HSCAS of improving BW gain is likely to become
significant; but follow up studies using broilers fed to 5 to 7 wk are needed for verification.
In addition, HSCAS reversed the increased relative liver weight induced by 2 mg/kg AFB1.
Enlarged liver is a commonly found symptom of aflatoxicosis and can be primarily
attributed to necrosis, bile duct proliferation, fat infiltration, and enlarged liver cells (Yunus
et al., 2011; Safameher, 2008).
Chronic aflatoxicosis has been shown to impair protein synthesis (Kubena et al., 1990;
Ledoux et al., 1999; Zhao et al., 2010). As expected, significantly decreased serum proteins
due to dietary AFB1 were observed in this current study. When no HSCAS was
supplemented, serum albumin was decreased starting from 0.5 mg/kg AFB1, and total
protein was decreased starting from 1 mg/kg AFB1, indicating that although low levels of
AFB1 did not influence performance, there was impaired protein synthesis. Other
researchers also suggested that chronic mycotoxicosis could be diagnosed by changes in
serum biochemistry before major symptoms could be observed (Kececi et al., 1998; Oguz
et al., 2003). An interaction of AFB1 and HSCAS was found for serum albumin, with
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HSCAS restoring the serum albumin level of birds fed 1 mg/kg AFB 1 (P < 0.05). Serum
glucose was also decreased by 2 mg/kg AFB 1, which might be a consequence of
dramatically reduced FI in that group or reduced activity of carbohydrate utilization
enzymes due to impaired protein synthesis (Zhao et al., 2010). An alteration in P
metabolism caused by AF may be a result of altered renal, intestine, and parathyroid
regulation of P (Glahn et al., 1990; Kececi et al., 1998), and HSCAS reversed the decreased
serum P for birds fed 2 mg/kg AFB1 (8.68 vs. 7.34 mg/dL, P < 0.05). Alkaline phosphatase
(ALP),

predominately

originating

from

liver

and

bone,

is

responsible

for

dephosphorylation reactions in many cells. Its serum activity is a signal for various disease
states involving particularly the liver and bone (Coleman, 1992). Reduced serum ALP
concentrations in broiler chicks fed 1 to 2.5 mg/kg AFB1 were observed in previous studies
(Huff et al., 1988; Bailey et al., 2006; Zhao et al., 2010). Consistently, a decreased serum
ALP with increasing AFB1 was found in the current study (P < 0.0001), which was partially
ameliorated by HSCAS (11175 vs. 5914 U/L for birds fed 1 mg/kg AFB1 with or without
HSCAS, respectively; P < 0.05). The creatine phosphokinase (CPK) is found almost
exclusively in muscle, thus high serum CPK level is typically associated with muscle
damage due to impaired cell membranes by AFB1-induced lipid peroxidation (Ebbeling
and Clarkson, 1989; Rastogi et al., 2001). Supplementation with HSCAS was able to
reduce the high CPK levels from birds fed AFB1 (P = 0.039), Collectively, HSCAS showed
a protective effect on major serum biochemical parameters, including improved protein
synthesis and improved cell integrity.
The complement system, consisting of approximately 20 proteins that are primarily
synthesized from the liver, is a bridge between the innate and adaptive immunity and the
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first line of defense against foreign invaders (Koppenheffer et al., 1999; Ochsenbein and
Zinkernagel. 2000). Stewart et al. (1984) reported that 2.5 mg/kg AFB1 significantly
impaired total complement activity. From our results, the L50 value, representing the
alternative pathway of the complement system, was decreased by AFB1 (P = 0.016).
However, unlike previous reports where the antibody production were also impaired by
AFB1 (Qureshi et al., 1998; Oguz et al., 2003), the natural antibodies including IgM and
IgY in this study (represented by Rb HA1 and HA2 values) were increased by AFB1. The
supplementation of HSCAS did not affect the serum natural antibody or the complement
system.
Aflatoxins, along with other toxic compounds, may also negatively shift the oxidative/
anti-oxidative balance, leading to the accumulation of free radicals and induce oxidative
stress in animals (Sies, 1986). Anti-oxidant enzymes, including SOD and catalase, are vital
to relieve oxidative stress. Hepatic SOD converts O2— into hydrogen peroxide, which can
then be detoxified into water and oxygen by glutathione peroxidase and catalase. Previous
data have shown that AFB1 inclusion may decrease SOD activity, thus decreasing the
animal’s ability to cope with oxidative stress (Shi et al., 2006). In this study, HSCAS
supplementation significantly increased the hepatic SOD activity for birds fed AFB 1 (P =
0.0455), indicating that the birds may have better ability to relieve oxidative stress during
aflatoxicosis.
The effect of AFB1 on the expression of hepatic genes is less studied in poultry, with
only one report available on broilers (Yarru et al., 2009). The liver is a principal target
organ of AFB1 and is also responsible for detoxification of AFB1 (Miazzo et al., 2000). In
this study, the expression of 9 genes in response to AFB1 and HSCAS were determined,
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including genes involved in immune system (IL-6, IL-1β, IFN-γ), antioxidant function
(CAT, SOD, GST-α), and biotransformation of AFB1 (EH, GPx, CYP1A1). Interleukin 6
(IL-6) and IL-1β are leukocytic cytokines secreted by activated macrophages, which can
act in the communication between lymphocytes; IFN-γ is originated from the T helper cells,
natural killer cells, and macrophages, and functions as an anti-viral agent. These cytokines
are released in response to infections to induce inflammatory reactions and mediate the
immune responses (Klasing, 1994). The expression of IL-6 was significantly increased by
2 mg/kg AFB1, which was reversed by HSCAS, indicating that HSCAS can partially
ameliorate the inflammation induced by AFB1. Similarly, Yarru et al. (2009) showed that
1mg/kg AFB1 significantly up-regulated IL-6 expression. No data are available on the
changes of IL-1β and IFN-γ expression in response to AFB1 or HSCAS in birds, while in
mice, decreased expression of IL-1 and unaffected IFN-γ were found in response to 0.7
mg/kg AFB1 (Dugyala and Sharma, 1996). Both CAT and SOD play a key role in relieving
the oxidative stress. Supplementation with HSCAS showed significant main effects (P <
0.05) of up-regulating the expression of both CAT and SOD, the latter is in agreement with
the liver anti-oxidant status result. The function of GPx is similar to that of CAT,
conversion of H2O2 to H2O with selenium as a co-factor. Expression of GPx was upregulated by AFB1, but was not affected by dietary HSCAS. On the contrary, Yarru et al.
(2009) did not observe a significant change of GPx expression in response to AFB1.
Following rapid absorption, AFB1 has to undergo extensive transformation in the liver
into its metabolically active form, the exo-AFB1-8, 9-epoxyde (AFBO), to exert toxicity.
CYP1A1 is a member of the CYP450 enzyme family and is one of the enzymes that's
responsible for activating AFB1. The AFBO can be detoxified primarily by GST enzymes
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by forming glutathione conjugates, or to a lesser extent by EH through a conversion to
AFB1-dihydrodiol (Eaton and Gallagher et al., 1994). The conjugates or dihydrodiol can
then be excreted through the bile (Sawhney et al., 1973; Tiemersma et al., 2001). The
CYP1A1 expression was down-regulated by AFB1 (P = 0.0003), but was increased by
HSCAS supplementation (P = 0.0026). On the contrary, the expression of CYP1A1 was
significantly increased by 1 mg/kg AFB1 in the study of Yarru et al. (2009). Because there
are multiple members in the CYP450 enzyme family, it is possible that other enzymes,
such as CYP1A2, CYP2A6, and CYP3A4, were activated for AFB1 transformation in the
current study. Interestingly, birds fed 2 mg/kg AFB1 showed up-regulated expression of
EH and GST compared to control birds, which might imply that there was an increase in
AFBO accumulation.
Results from the current study showed that 0.5 and 1 mg/kg AFB1 did not depress
performance of broilers fed to 21 d of age, but negatively impacted serum protein
concentrations. Feeding 2 mg/kg AFB1 resulted in significantly reduced FI, BW gain, and
G: F, with enlarged livers and impaired liver functions. Serum complement activity and
liver gene expression were also negatively affected by 2 mg/kg AFB 1. Supplementing
HSCAS effectively improved BW gain from 14 to 21 d, and partially ameliorated
aflatoxicosis by reducing relative liver weight, stimulating anti-oxidant functions, and
partially restoring the negatively affected serum biochemistry measures in young broilers.
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Table 2.1. Ingredient composition of final diet 1
Ingredient

Composition (%)

Corn

50.45

Soybean meal, 48% CP

38.00

Soybean oil

3.75

Monocalcium phosphate

1.45

Limestone

1.55

NaCl

0.47

L-lysine·HCl

0.23

DL-methionine

0.32

L-threonine

0.10

Vitamin-mineral premix2
Corn/AFB1/HSCAS
Calculated analysis

premix1

0.35
3.33

ME, kcal/kg

3,159

CP, %

23.10

Lysine, %

1.45

Thr, %

0.97

Met, %

0.67

Met+Cys, %

1.15

Ca, %

1.00

Non-phytate P, %
0.44
A ground corn, aflatoxin (AFB1) culture, and/or Engage-M (JBS United, Inc.; a
hydrated sodium calcium aluminosilicate) premix was added to final diets to obtain 0,
0.5, 1.0, or 2.0 mg AFB1/kg diet with or without 0.05% Engage-M.
2 Provided per kg of diet: iron, 71.6 mg; copper, 11.0 mg; manganese, 178.7 mg; zinc,
178.7 mg; iodine, 3.0 mg; selenium, 0.4 mg; vitamin A (retinyl acetate), 18,904.3 IU;
vitamin D3 (cholecalciferol), 9,480.0 IU; vitamin E (DL-α-tocopheryl acetate), 63.0 IU;
vitamin K activity, 6.4 mg; thiamine, 3.2 mg; riboflavin, 9.4 mg; pantothenic acid, 34.7
mg; niacin, 126.0 mg; pyridoxine, 4.7 mg; folic acid, 1.6 mg; biotin, 0.5 mg; vitamin
B12, 35.4 μg; choline, 956.9 mg.
1
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Table 2.2. Primer sequences (5’ → 3’) used in quantitative real-time PCR
Gene

Forward primer

Reverse primer

GAPDH

TCCTAGGATACACAGAGGACCA

CGGTTGCTATATCCAAACTCA

SOD

AGGGGGTCATCCACTTCC

CATTTGTGTTGTCTCCAA

EH

AAAGGGACAGAAGCCTGACA

CCTCCAGTGGCTCAGTGAAT

IL-6

GAATGTTTTAGTTCGGGCACA

TTCCTAGAAGGAAATGAGAATGC

IL-1b

GCATCAAGGGCTACAAGCTC

CAGGCGGTAGAAGATGAAGC

IFN-γ

CAAGTAATTCGGATGTAGC

GCGTTGGATTTTCAAGCC

CAT

GGGGAGCTGTTTACTGCAAG

TTTCCATTGGCTATGGCATT

GPx

TTGTAAACATCAGGGGCAAA

TGGGCCAAGATCTTTCTGTAA

GST

GCCTGATGCACTTGCAAAA

AAAATTGCCATCAGTCTTGGT

CYP1A1 CACTTTCTGCCTGCTCCTG
1GAPDH

GGTCCTTCCTCAGCTCCAG

= glyceraldehyde phosphate dehydrogenase; SOD = superoxide dismutase; EH
= epoxide hydrolase; IFN-γ = interferon-γ; CAT = catalase; GPx = glutathione
peroxidase; GST = glutathione S-transferase; CYP1A1 = cytochrome P450 1A1.

Table 2.3. Cumulative performance and relative organ weights of chicks from 0 to 21 d of age fed varying concentrations of
aflatoxin culture (AFB1) with or without hydrated sodium calcium aluminosilicate (HSCAS)
Feed intake1
(g/chick)
916
886
908
757
917
916
896
778
26.0

BW gain1
(g/chick)
686
658
655
514
696
666
674
541
12.7

Gain:feed ratio1
(g/g)
0.749
0.742
0.722
0.680
0.760
0.748
0.753
0.696
0.020

Relative liver weight2
(% BW)
3.23 bc
3.18 bc
3.15 c
4.52 a
2.97 c
3.08 c
3.25 bc
3.64 b
0.19

Dietary treatment
Control
0.5 mg/kg AFB1
1 mg/kg AFB1
2 mg/kg AFB1
Control + HSCAS
0.5 mg/kg AFB1+ HSCAS
1 mg/kg AFB1+ HSCAS
2 mg/kg AFB1+ HSCAS
SEM
Main effect means
AFB1, mg/kg
0
916 a
691 a
0.754 a
3.10 b
0.5
902 a
664 b
0.745 a
3.13 b
a
b
a
1.0
901
665
0.737
3.20 b
2.0
768 b
528 c
0.688 b
4.08 a
HSCAS level, %
0
867
628
0.723
3.52 a
0.5
877
645
0.739
3.23 b
Source of variation
---------------------------------------------------- Probability ------------------------------------AFB1
<0.0001
<0.0001
0.0037
<0.0001
HSCAS
0.53
0.06
0.23
0.02
AFB1 * HSCAS
0.78
0.91
0.92
0.03
a-c
1
Means with different superscripts in a column differ significantly (P < 0.05). Simple effect means represent 8 cages per
treatment, 6 birds per pen.2 Simple effect means represent 8 cages per treatment, 1 bird per pen.
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Table 2.4. Periodic body weight gain of broiler chicks from 0 to 21 d of age fed varying
concentrations of aflatoxin culture (AFB1) with or without hydrated sodium calcium
aluminosilicate (HSCAS) 1
Dietary treatment

0-7d
BW gain

7-14d
BW gain

14-21d
BW gain

--------------------------- (g/chick) ---------------------83.8
232
370

Control
0.5 mg/kg AFB1

76.8

229

352

1 mg/kg AFB1

83.6

235

337

2 mg/kg AFB1

85.8

175

253

Control + HSCAS

82.9

241

372

0.5 mg/kg AFB1+ HSCAS

83.4

233

354

1 mg/kg AFB1+ HSCAS

84.8

221

369

2 mg/kg AFB1+ HSCAS

86.0

182

274

SEM

4.37

8.3

10.8

0

83.4

237 a

371 a

0.5

80.1

231 a

354 a

1.0

84.2

228 a

353 a

2.0

85.9

178 b

264 b

0

82.5

218

328 b

0.5

84.3

219

342 a

Main effect means
AFB1, mg/kg

HSCAS level, %

Source of variation
AFB1

------------------------- Probability ---------------------0.48
<0.0001
<0.0001

HSCAS

0.51

0.80

0.037

AFB1 * HSCAS

0.77

0.34

0.30

a-c Means
1 Simple

with different superscripts in a column differ significantly (P < 0.05)
effect means represent 8 cages per treatment, 6 birds per pen.

Table 2.5. Serum profile of broiler chicks from 0 to 21 d of age fed with or without varying concentrations of aflatoxin culture (AFB1)
and with or without hydrated sodium calcium aluminosilicate (HSCAS) 1, 2
Glucose
Urea N
Na
K
Cl
tCO2
Anion
Albumin tProtein
3
Dietary treatment
mg/dL
mg/dL mEq/L
mEq/L
mEq/L
mEq/L
Gap
g/dL
g/dL
b
a
10.5
Control
299
2.75
150
111
23.6
25.0
0.99
2.78
9.81
0.5 mg/kg AFB1
287
2.38 b
149
111
24.3
23.8
0.88 b
2.51
b
c
9.04
1 mg/kg AFB1
273
2.63
151
112
26.9
21.3
0.69
2.35
b
d
9.04
2 mg/kg AFB1
261
3.00
153
115
26.4
19.6
0.43
1.44
b
ab
10.03
Control + HSCAS
303
2.63
151
112
24.9
24.1
0.95
2.63
b
ab
10.31
0.5 mg/kg AFB1+ HSCAS
308
2.43
150
111
24.3
25.4
0.91
2.69
10.00
1 mg/kg AFB1+ HSCAS
269
3.00 b
150
111
25.3
23.4
0.85 b
2.64
a
d
9.69
2 mg/kg AFB1+ HSCAS
272
4.13
151
115
24.9
21.3
0.33
1.39
1.48
0.05
0.13
SEM
11.0
0.30
1.2
0.47
0.8
1.20
Main effect means
AFB1, mg/kg
0
301 a
2.69 b
150
10.23
111 b
24.3
24.5 a
0.97 a
2.71 a
0.5
296 a
2.50 b
149
10.06
111 b
24.2
24.7 a
0.89 a
2.61 a
1.0
271 b
2.67 b
150
9.52
112 b
26.1
22.4 ab
0.77 b
2.49 a
2.0
267 b
3.60 a
152
9.36
115 a
25.6
20.5 b
0.38 c
1.41 b
HSCAS level, %
0
280
2.68
151
9.54
112
25.3
22.4
0.74
2.26
0.5
288
3.00
150
10.01
112
24.8
23.5
0.77
2.33
---------------------------------------------------------- Probability ---------------------------------------------------Source of variation
-------<0.0001
AFB1
0.0009
0.0003
0.16
0.12
<0.0001
0.21
0.0080
<0.0001
HSCAS
0.26
0.15
0.65
0.14
0.74
0.52
0.25
0.51
0.39
AFB1 * HSCAS
0.63
0.09
0.53
0.38
0.38
0.47
0.68
0.012
0.19
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Table 2.5. continued
Globulin 4
g/dL
1.79
1.64
1.66
1.01
1.70
1.78
1.79
0.97
0.09

Ca
mg/dL
10.49
9.61
10.29
9.84
10.38
10.45
10.71
9.65
0.49

P
mg/dL
10.13 a
9.49 ab
8.65 b
7.34 c
9.00 b
10.24 a
9.41 ab
8.68 b
0.48

ALT
U/L
9.14
10.57
5.00
10.88
10.38
8.29
9.29
7.50
1.83

ALP
U/L
10758 ab
9875 ab
5914 cd
6017 cd
8661 bc
13340 a
11175 ab
3509 d
884.7

AST
U/L
181 ab
200 a
202 a
201 a
205 a
184 ab
188 ab
156 b
13.1

GGT
U/L
11.7
10.4
13.3
12.9
11.3
12.3
12.5
12.4
0.99

CPK
U/L
5764
7054
7429
9789
5196
4207
5115
5389
1438

Uric
Acid
mg/dL
8.20
9.33
9.94
9.44
8.41
10.81
9.26
10.61
0.93

99

Dietary treatment
Control
0.5 mg/kg AFB1
1 mg/kg AFB1
2 mg/kg AFB1
Control + HSCAS
0.5 mg/kg AFB1+ HSCAS
1 mg/kg AFB1+ HSCAS
2 mg/kg AFB1+ HSCAS
SEM
Main effect means
AFB1, mg/kg
0
1.75 a
10.43
9.76 a
9.80
9559 ab
192
11.47
5885
8.31
a
a
a
0.5
1.71
10.03
9.86
9.43
11607
193
11.31
5725
10.07
a
a
b
1.0
1.73
10.50
9.03
7.14
8169
195
12.88
6349
9.60
2.0
0.99 b
9.74
8.01 b
9.43
4763 c
180
12.60
7903
10.03
HSCAS level, %
0
1.52
10.06
9.00
8.97
7073
196
12.03
7367 a
9.26
b
0.5
1.57
10.30
9.33
8.96
8049
183
12.09
5464
9.78
---------------------------------------------------------- Probability ---------------------------------------------------Source of variation
-------AFB1
<0.0001
0.25
0.0003
0.38
<0.0001
0.59
0.18
0.34
0.13
HSCAS
0.51
0.43
0.13
0.99
0.18
0.12
0.92
0.039
0.34
AFB1 * HSCAS
0.54
0.59
0.03
0.11
0.0002
0.044
0.39
0.15
0.53
a-c
Means with different superscripts in a column differ significantly (P < 0.05). 1 Simple effect means represent 8 cages per
treatment, 6 birds per pen. \2 UN= urea N, tProtein = total protein, CREAT = creatinine, ALT = alanine transaminase, AST=
Aspartate transaminase, ALP= Alkaline phosphatase, GGT= Gamma glutamyl transpeptidase, CPK=Creatine phosphokinase. 3
Calculated from K, Na, Cl, and CO2. 4 Calculated from as total protein minus albumin.

100

Table 2.6. Serum natural antibody and complement profile of broiler chicks from 0 to 21 d of age fed with or without varying concentrations of
aflatoxin culture (AFB1) and with or without hydrated sodium calcium aluminosilicate (HSCAS) 1, 2, 3, 4, 5, 6, 7
Rb
Rb
HuO
HuO
HuO
Ho
Ho
Rb
Rb
HuO
HuO
Ho
Ho
Dietary treatment
HA 1
HA 2 HA 1 HA 2 HA 45 HA 1 HA 2 L 100 L 50
L 100 L 50
L 100 L 50
Control
0.25
3.00
0.25
1.00
3.38
0.50 2.25
1.75
3.38
0.13
0.50
1.25
2.38
0.5 mg/kg AFB1
0.00
2.57
0.29
0.57
3.14
0.14 2.14
1.71
3.43
0.00
0.71
1.29
1.71
1 mg/kg AFB1
0.38
2.75
0.13
0.50
2.75
0.13 1.75
1.38
3.25
0.00
0.38
1.25
1.88
2 mg/kg AFB1
0.88
3.63
0.00
0.25
3.00
0.38 1.88
1.00
2.30
0.00
0.50
0.88
1.38
Control + HSCAS
0.29
2.29
0.43
0.29
3.29
0.14 2.29
1.29
2.57
0.14
0.57
1.43
1.71
0.5 mg/kg AFB1+ HSCAS 0.00
2.38
0.13
0.75
3.38
0.00 2.00
1.63
3.50
0.00
0.75
1.38
1.88
1 mg/kg AFB1+ HSCAS
0.38
4.75
0.13
0.50
3.13
0.38 2.50
2.00
3.38
0.13
0.50
1.50
2.13
2 mg/kg AFB1+ HSCAS
1.75
4.50
0.13
0.63
2.88
0.00 2.00
1.13
2.50
0.00
0.13
1.00
1.38
SEM
0.34
0.60
0.14
0.25
0.42
0.19 0.30
0.36
0.33
0.08
0.22
0.27
0.46
Main effect means
AFB1, mg/kg
0
0.29 b
2.64 bc 0.36
0.71
3.43
0.21 2.21
1.43
2.93 ab 0.14
0.57
1.29
2.00
b
c
a
0.5
0.00
2.47
0.21
0.66
3.26
0.92 2.07
1.69
3.46
0.00
0.73
1.33
1.79
b
ab
a
1.0
0.38
3.75
0.13
0.50
2.94
0.25 2.13
1.67
3.31
0.06
0.44
1.38
2.00
a
a
b
2.0
1.31
4.06
0.06
0.44
2.94
1.88 1.94
1.06
2.44
0.00
0.31
0.94
1.38
Source of variation 7
-------------------------------------------------------- Probability ----------------------------------------------------------------AFB1
0.0025 0.027 0.26
0.75
0.70
0.60 0.76
0.29
0.016 0.29
0.31
0.33
0.45
HSCAS
0.35
0.23
0.71
0.86
0.75
0.28 0.36
0.82
0.64
0.51
0.81
0.40
0.87
AFB1 * HSCAS
0.51
0.14
0.64
0.19
0.92
0.36 0.50
0.52
0.44
0.84
0.67
0.99
0.77
a-c
Means with different superscripts in a column differ significantly (P < 0.05). 1 Serum samples were tested for Natural Antibody and
Complement levels against Rabbit (Rb), Human type O (HuO) and Horse (Ho) erythrocytes.2 Rb and HuO were tested using 1% erythrocyte
suspensions and 0.5% for Ho.3 Parameters: = log2 dilutions, representing end point titers; i.e. 3 = 1:8 dilution of serum etc.4 HA1 = strong
agglutination ~IgM, HA2 = weak agglutination ~IgY, HA45 = very weak agglutination ~ IgY. 5 L100 = complete lysis and L50 incomplete lysis
titers, representing the Alternate and Classic lytic pathways respectively. 6 Hb scores = serum coloration due to lysis; 0 = no lysis, etc.

Table 2.7. Liver gene expression of 21-d old chicks fed with or without varying concentrations of aflatoxin culture (AFB1) and
with or without hydrated sodium calcium aluminosilicate (HSCAS) 1, 2, 3
Dietary treatment
IL-6
IL1β
IFN-γ
CAT
SOD
GPx
CYP1A1 EH
GST
b
cd
d
Control
0.87
0.76
1.17
0.56
0.78
0.36
1.11
1.49
1.35 b
ab
bc
cd
0.5 mg/kg AFB1
0.76
0.88
0.65
1.83
1.41
0.69
0.89
0.57
0.70 b
1 mg/kg AFB1
1.01
1.07
1.44
2.36 ab
1.44 abc
2.10 bc
1.55
0.99
0.54 b
2 mg/kg AFB1
3.90
1.16
1.61
2.56 ab
0.53 d
3.83 a
0.40
4.38
2.60 a
a
a
bcd
Control + HSCAS
0.70
1.53
0.94
3.10
2.15
1.26
3.10
0.81
0.76 b
0.5 mg/kg AFB1+ HSCAS 0.97
1.40
1.53
3.30 a
1.79 ab
0.60 cd
2.67
0.87
1.36 b
1 mg/kg AFB1 + HSCAS
1.13
1.30
1.66
2.49 ab
1.97 ab
1.31 bcd
2.24
0.87
0.98 b
ab
d
ab
2 mg/kg AFB1 + HSCAS
1.95
1.64
0.98
2.14
0.52
2.34
0.69
2.17
2.65 a
SEM
0.03
0.21
0.26
0.07
0.06
0.06
0.27
0.25
0.04
Main effect means
AFB1, mg/kg
0
0.79 b
1.09
1.07
1.65
1.43 a
0.78 b
2.04 a
1.17 b
1.08 b
0.5
0.86 b
1.14
1.05
2.51
1.50 a
0.64 b
1.78 a
0.75 b
1.03 b
b
a
b
a
b
1.0
1.07
1.18
1.54
2.43
1.69
1.71
1.92
0.93
0.74 b
2.0
2.85 a
1.40
1.27
2.35
0.52 b
3.03 a
0.55 b
3.28 a
2.63 a
HSCAS level, %
0
1.52
0.96 b
1.21
1.76 b
1.05 b
1.66
0.97 b
1.85
1.27
a
a
a
a
0.5
1.19
1.47
1.28
2.75
1.61
1.38
2.17
1.14
1.44
-------------------------------------------------------Probability
---------------------------------------------------------Source of variation
--AFB1
<0.0001
0.48
0.88
0.39
<0.0001
<0.0001
0.0003
<0.0001
<0.0001
HSCAS
0.62
0.034
0.64
0.025
0.0026
0.31
0.0026
0.11
0.16
AFB1*HSCAS
0.37
0.72
0.13
0.024
0.023
0.037
0.12
0.30
0.0443
a-d
Means with different superscripts in a column differ significantly (P < 0.05). 1 Simple effect means represent 8 cages per
treatment, 1 bird per pen. 2 P-value and SEM are based on Box-cox transformed data. 3 IL-6 = interleukin 6; IL-1b = interleukin
1b; IFN-γ = interferon gamma; CAT = catalase; SOD = superoxide dismutase; GPx = glutathione peroxidase; CYP1A1 =
cytochrome P450 1A1; EH = epoxide hydrolase; GST = glutathione S-transferase.
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Figure 2.1. Liver SOD activity of 21-d old chicks fed varying concentrations of aflatoxin
culture (AFB1) with or without hydrated sodium calcium aluminosilicate (HSCAS).
Means ±SEM represent 8 pens per treatment, 1 bird per pen. One unit of activity is the
amount of enzyme that inhibits the rate of superoxide formation reaction by 100%. Main
effect P-values for AFB1 and HSCAS = 0.65 and 0.0455, respectively. P-value for
interaction between AFB1 and HSCAS = 0.16.
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CHAPTER 3. GROWTH, SERUM BIOCHEMISTRY, COMPLEMENT ACTIVITY,
AND LIVER GENE EXPRESSION RESPONSE OF PEKIN DUCKLINGS TO
GRADED LEVELS OF CULTURED AFLATOXIN B1

3.1

Abstract

A 14-d study was conducted to evaluate the effects of cultured aflatoxin B1 (AFB1)
on performance, serum biochemistry, serum natural antibody and complement activity, and
hepatic gene expression parameters in Pekin ducklings. A total of 144 male Pekin
ducklings were weighed, tagged, and randomly allotted to 4 dietary treatments containing
4 concentrations of AFB1 (0, 0.11, 0.14, and 0.21 mg/kg) from 0 to 14 d of age (6 cages/diet;
6 ducklings/cage). Compared to the control group, there was a 10.9, 31.7, and 47.4% (P <
0.05) decrease in cumulative BW gain with 0.11, 0.14, and 0.21 mg AFB 1/kg diet,
respectively, but feed efficiency was not affected. Increasing concentrations of AFB 1
reduced cumulative BW gain and feed intake both linearly and quadratically, and
regression equations were developed with r2 ≥ 0.73. Feeding 0.11 to 0.21 mg/kg AFB1
reduced serum glucose, creatinine, albumin, total protein, globulin, Ca, P, and CPK linearly,
whereas serum urea N, Cl, ALP, and AST concentrations increased linearly with increasing
AFB1 (P < 0.05). Additionally, 0.11 to 0.21 mg AFB1/kg diets impaired classical and
alternative complement pathways in the duckling serum when tested by lysis of rabbit,
human type O, and horse erythrocytes, and decreased rabbit and horse agglutinins (P <
0.05). Liver peroxisome proliferator activated receptor alpha (PPARα) expression was
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linearly downregulated by AFB1 (P < 0.01). Results from this study indicate that for every
0.10 mg/kg increase in dietary AFB1, cumulative feed intake and BW gain decrease
approximately 230 and 169 g per duckling from hatch to 14 d; and that AFB1 at very low
concentrations can significantly impair liver function and gene expression, and innate
immune dynamics in Pekin ducklings.

3.2

Introduction

Aflatoxins (AF) are metabolites of Aspergillus species, with aflatoxin B1 (AFB1)
being the most toxigenic AF subgroup (Yunus et al., 2011). Feed contamination with AF
affects productivity of livestock and AF residues in animal products are a food safety
concern (Denli et al., 2009; Hengry et al., 1999; Pandey and Chauhan, 2007). In livestock
and laboratory animals, AFB1 affects growth, immunity, egg production, and liver
functions (Andretta et al., 2011; Grenier and Applegate, 2013; Ledoux et al., 1999; Yarru
et al., 2009). Ducks are the most sensitive poultry species to AFB1, who exhibit 100%
mortality at 1 mg/kg AF (Muller et al., 1970) and have the ability of developing hepatic
carcinoma (Diaz and Murcia, 2011; Bintvihok, 2011). It is possible that higher bioactivation of AFB1 by ducks accounts for species differences (Diaz et al., 2010; Diaz and
Murcia, 2011), but other factors may contribute.
Compared with broilers, there is limited research on AFB1 toxicity in ducks. Duck
production is a rapidly growing industry worldwide, with the consumption being 6-fold
greater than it was in the 1960s. In 2010, worldwide duck meat production reached 3.9
million tonnes, with more than 50, 000 tonnes produced in the U.S., and Pekin ducks
account for 95% of the consumption (Huang et al., 2012). Therefore, more information on
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AFB1 toxicity in this species is justified. The majority of the previous studies on ducks
used naturally contaminated corn (He et al., 2012, Feng et al., 2010; Feng et al., 2011).
While this can closely mimic practical situations, studies using purified AFB1 may be
helpful in understanding the complexities of toxicity, eliminating confounding factors such
as grain quality, and help identify mechanisms that explain species differences.
In the past, little attention has been paid to the sub-chronic (14 d) ingestion of low
concentrations of AFB1, and no literature is available on the effects of AFB1 on gene
expression in ducklings. Therefore, the expression of major liver proteins were investigated
including those involved in antioxidant functions [superoxide dismutase (SOD)], AFB
metabolism [epoxide hydrolase (EH)], energy metabolism [carnitine palmitoyltransferase
1A (CPT1A)], carbohydrate metabolism [malate dehydrogenase 2 (MDH2)], lipid and
protein metabolism [peroxisome proliferator-activated receptor-alpha (PPARα)], and
immune response [interferon gamma (IFNγ)]. This study aimed to evaluate the effects of
cultured AFB1 on the growth, liver functions, and innate immune response in Pekin
ducklings by measuring growth performance, serum biochemistry, serum natural antibody
and complement activity, as well as the hepatic gene expression for the major proteins.

3.3
3.3.1

Material and Methods

Experimental Birds and Diets
A total of 144 male Pekin ducklings were obtained from a commercial hatchery

(Maple Leaf Farms, Leesburg, IN), weighed, tagged, and randomly allotted to 24 battery
cages. Ducklings were housed on raised wire floors in standard steel battery cages (516
cm2 floor space per bird) equipped with nipple waterers (Alternative Design Manufacturing
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and Supply Inc., Siloam Springs, AR) in an environmentally controlled room. Feed and
water were provided for ad libitum consumption over the entire study period (0 to 14 d
post-hatch). Ducklings were inspected daily for any health problems, and mortality was
recorded as it occurred. The animal care and use protocol was reviewed and approved by
the Purdue University Animal Care and Use Committee.
A completely randomized design was used with 4 treatments, 6 replicate cages per
treatment, and 6 ducklings per cage. A corn-soybean meal based basal diet (mash form)
was formulated to contain 3,134 kcal/kg metabolizable energy, 22.5% crude protein, 1.46%
lysine, 1.17% Ca, and 0.49% non-phytate P. Four premixes, contributing 0.5% of the final
diets, were prepared with graded amount of cultured AFB1 in ground corn (0%, 42.0%,
66.8%, and 100% of AFB1 in ground corn), and then blended with the basal diet to create
the 4 treatment diets, respectively. The cultured aflatoxin (60 mg/kg) was produced on
ground corn using Aspergillus parasiticus (NRRL 2999) as described by Gowda et al.
(2008). Dietary AF concentrations, including AFB1, AFB2, AFG1, and AFG2, were
analyzed by High Performance Liquid Chromatography (HPLC) at Romer labs (Union,
MO). Briefly, the AF in diet samples were extracted using acetonitrile, purified using
AflaStar R® (Romer Labs, Tulln, Austria) immune-affinity columns, rinsed, and eluted
with methanol followed by deionized H2O. The purified extract was then injected into the
HPLC system, and AF were detected and quantified with a fluorescence detector at 360
nm (excitation) and 440 nm (emission) wavelengths (Trucksess et al., 1994). The presence
of other mycotoxins including fumonisins, deoxynivalenol, T-2 toxin, and zearalenone
were analyzed to ensure they were below cautionary limits before the start of study. These
mycotoxin concentrations were analyzed using derivatization followed by HPLC and
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fluorescence detection at Veterinary Diagnostic Laboratory at North Dakota State
University (Fargo, ND; Raymond et al., 2003).

3.3.2

Sample Collection

Feed intake (FI) and individual BW were measured weekly. At the conclusion of the
experiment (d 14), total feed consumption was recorded for each cage. Average feed intake
and BW gain were corrected for mortality. All ducklings were euthanized using CO 2
asphyxiation, and two ducklings from each cage (12 ducklings per treatments) were
randomly selected for blood collection. Liver weight was recorded for all ducklings, and
relative liver weight was calculated as a percentage of BW. A section of liver sample from
one duckling per cage was collected, preserved in RNAlater (Ambion, Austin, TX), and
stored at -80 ⁰C for real-time quantitative PCR analysis.

3.3.3

Serum Chemistry and Complement analysis

Approximately 2 ml blood per duckling was collected via jugular vein after euthanasia
for serum chemistry, natural antibody, and complement system analysis. Blood was
centrifuged at 1,400 x g at 8 ⁰C for 15 min and serum was separated and preserved at –20
⁰C until submitted for biochemical analysis. Two replicate serum samples per cage (12
samples per treatment, 48 samples in total) were analyzed for albumin, globulin, total
protein, glucose, urea N, creatinine, K, Cl, Ca, P, alanine amino transferase (ALT), alkaline
phosphatase (ALP), aspartate amino transferase (AST), γ-glutamyl transferase (GGT),
creatine phosphokinase (CPK), and uric acid. All biochemistry parameters were
determined at the Veterinary Medical Diagnostic Laboratory of University of Missouri
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(Columbus, MO) using an auto-analyzer (Kodak Ektachem Analyzer, Eastman Kodak Co.,
Rochester, NY).
In addition, one serum sample per cage was analyzed for natural antibody and serum
complement activity as described by Cotter (2012). Briefly, the sera were diluted in PBS
supplemented with Ca and Mg, and tested by microtiter for the capacity to agglutinate and
lyse rabbit (Rb), human (HuO), and horse (Ho) erythrocytes. Rb and HuO were tested using
1% erythrocyte suspensions, and Ho was tested using 0.5% erythrocyte suspension. The
end-point (log2 dilutions) were visually evaluated for three agglutination types: HA1
(strong), HA2 (weak), and HA45 (very weak) for natural antibody activity, and two degrees
of lysis: L100 (complete lysis) and L50 (half lysis) for the complement activity (Cotter, 2012).

3.3.4

Liver Gene Expression

Total ribonucleic acid (RNA) from liver samples (6 samples per treatment) was
extracted by TRIzol® (Invitrogen, Carlsbad, CA, USA). Briefly, the tissue was ground in
TRIzol reagent, incubated with 0.1 mL 1-bromo-3-chloropropane (BCP), and centrifuged
at 13,000 x g at 4 ⁰C for 15 min to collect the clear aqueous layer. The aqueous layer was
then precipitated with isopropanol and centrifuged at 13,000 x g at 4 ⁰C for 10 min to
collect RNA pellet. The RNA pellet was washed with 75% ethanol twice, dissolved in
nuclease-free water, and quantified at an absorbance of 260 nm (ND-1000, Nanodrop
Technologies Inc., Wilmington, DE). Reverse transcription was carried out on the RNA
samples with the M-MLV reverse transcriptase (Promega, Madison, WI, USA). The
expression of SOD, CTP1A, EH, MDH2, PPARα, and IFNγ were determined using
quantitative real-time PCR (MyiQ real-time PCR detection system, Bio-Rad, Hercules, CA,
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USA) with SYBR mix (Bio-Rad, Hercules, CA, USA). The primer sequences used were
based in a previous report (Hérault et al., 2008) or designed using Primer3 software (http://
primer3.wi.mit.edu) (Table. 3.1). All reactions were analyzed in duplicate and formation
of a single PCR product was confirmed by melting curves. Water served as a negative
control. Three segments for reactions were run: 1 cycle at 95 ⁰C for 5 min; 50 cycles at 95
⁰C for 10 s, 55⁰C for 20 s, and 72⁰C for 20 s. and 71 cycles at 60 ⁰C for 10 s. The mRNA
expression was determined from the threshold cycle (Ct) for respective genes and
calculated using the 2-ΔΔ Ct method (Livak and Schmittgen, 2001) normalized using
glyceraldehyde phosphate dehydrogenase expression. The expression of GAPDH was not
different across treatments.

3.3.5

Statistical Analysis
All data were analyzed using the GLM procedure of ANOVA using the SAS (version

9.3, Cary, NC) for completely randomized designs. Orthogonal polynomial contrasts were
used for determining the linear and quadratic effect of increasing AFB 1 concentration
(analyzed basis) on all measurements, and the solutions option was used to generate the
intercept and slope for cumulative feed intake, body weight gain, and serum proteins. Cage
was the experimental unit. All data were tested for normality using the UNIVARIATE
procedure and common variance using the GLM procedure of SAS (9.3). Non-normal data
were transformed using the optimal Box-Cox transformation. A P-value ≤ 0.05 was
considered significant and 0.05< P ≤ 0.10 was considered a trend.

110
3.4
3.4.1

Results

Aflatoxin Concentrations
The analyzed AFB1 concentrations were 0.00, 0.11, 0.14, and 0.21 mg/kg for the four

treatments, respectively. Dietary AFB2, AFG1, AFG2 were approximately 5.3, 37.0, and
2.0% of AFB1 concentrations, respectively.

3.4.2

Growth Performance
The overall growth performance results are shown in Table 3.2. Compared with

control ducklings, those fed 0.11, 0.14, and 0.21 mg/kg AFB1 had linearly and quadratically
reduced FI by 6.0, 30.5, and 44.5%, respectively (P < 0.01). Cumulative body weight gain
(BWG) was also decreased linearly and quadratically with increasing AFB1 (P < 0.01). On
a percentage scale, the reduction was 10.9, 31.5, and 47.8% for 0.11, 0.14, and 0.21 mg/kg
AFB1 diet, respectively. Gain: feed ratio was not affected by treatments. Relative liver
weight tended to decrease quadratically with increasing AFB1 concentration (P = 0.066).
Based on the weekly performance data (Table 3.2), the reduction of FI and BWG in
response to AFB1 started from 0 to 7d, while G:F ratio did not have a significant regression
pattern at all stages. Dietary AFB1 did not affect duck mortality, which averaged 3.5%
across all treatments to 14 d of age. The linear and quadratic regression equations of FI and
BWG are shown in Table 3.

3.4.3

Serum Biochemistry
Feeding 0.11 to 0.21 mg/kg AFB1 to ducklings resulted in linear reduction of

serum glucose, creatinine, albumin, total protein, globulin, Ca, P, and CPK (Table 3.4) (P
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< 0.01). Serum urea N, Cl, ALP, and AST levels were linearly increased by AFB1 (P <
0.05). Serum concentrations of Na, CO2, anion gap, ALT, and GGT did not show
significant regression patterns with the AFB1 concentration tested, while serum K and
uric acid were quadratically related to AFB1 concentration (P < 0.01). The linear and
quadratic regression equations of serum albumin, total protein, and globulin are shown in
Table 3.3.

3.4.4

Natural Antibody and Serum Complement Activity
The natural antibody and serum complement activity results are shown in Table

35. The L100 and L50 values represent complete lysis and half lysis titers, representing the
classic and alternative complement pathways, respectively. The L100 and L50 values were
linearly reduced with increasing AFB1 concentration for all three erythrocytes (rabbit,
human, and horse) (P ≤ 0.019) with the exception of horse L50 value. In addition, the
rabbit HA1 value, which represents strong hemaagglutination, was linearly decreased by
AFB1 (P < 0.001).

3.4.5

Liver Gene Expression
The expression of SOD, EH, CPT1A, MDH2, PPAR-α, and IFNγ were

determined (Table 3.6). Inclusion of 0.11 to 0.21 mg/kg AFB1 linearly decreased the
expression of PPAR-α (P < 0.01), while the expression of SOD and CPT1A tended to
decrease linearly by increasing AFB1 concentration (P < 0.092). There was no effect of
dietary treatments on the expression of EH, MDH2, or IFNγ.
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3.5

Discussion

While extensive information is available on the effects of AF in other livestock
animals, there is less on ducklings, the most sensitive poultry specie (Bintvihok, 2011; Diaz
and Murcia, 2011; Muller et al., 1970). The observations of He et al. (2012) of decreased
performance and decreased liver enzymes in ducklings fed contaminated corn (containing
0 to 0.13 mg/kg AFB1) is consistent with the current observations of hepatotoxicity and
depressed production. In our study, increasing AFB1 concentration also reduced BWG and
FI linearly and quadratically when regressed against the analyzed AFB1 levels (0.00, 0.11,
0.14, and 0.21 mg/kg AFB1). Based on the linear regression equations (Table 3), for every
0.1 mg/kg increase in dietary AFB1, there is approximately 230 and 163 g decrease per bird
in cumulative feed intake and BWG, respectively. These effects started as early as 0 to 7 d
of age. The AFB1 concentrations that are detrimental to ducklings (0.11 to 0.21 mg/kg) are
extremely low compared to broilers. Numerous studies indicate that at least 0.5 mg/kg
AFB1 (cultured or purified) could lead to a significant reduction in BWG (Basmcioglu et
al., 2005; Ledoux et al., 1999; Manafi et al., 2012; Verma et al., 2004). Using the same
cultured AFB1 source fed to broilers, 0.5 and 1 mg/kg AFB1 did not affect FI nor BWG,
whereas only 2 mg/kg AFB1 reduced BWG by approximately 25% on d 21 (P < 0.05; data
not shown).
Dietary AFB1 did not affect G:F ratio in this study, but others have found such
effects (Han et al., 2008; Verma et al., 2004). Nevertheless, reduced FI is responsible for
most of the reduction in BWG. When the ingested AFB1 level (FI * analyzed AFB
concentration) for each treatment was calculated, the ingested level for 0.11 and 0.14 mg/kg
AFB1 treatments were quite similar (Table 3.2), yet the BWG of birds fed the 0.14 mg/kg
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AFB1 diet (ingested AFB1 = 0.10 mg/bird) was significantly lower than those fed 0.11
mg/kg AFB1 diet. Therefore, it is clear that AFB1 suppresses growth primarily by
suppressing feed intake. In ducklings fed 0.14 mg/kg AFB1, FI was reduced by 31.5%,
whereas in chicks fed 2 mg/kg AFB1, the reduction was only 17.4%. Enzymes responsible
for activation of AFB1 (cytochrome P450 family) are higher in ducklings than in chicken,
turkey, or quail (Diaz and Murcia, 2011). While this may account for part of the species
difference, further studies are needed.
In He’s study (2012), there was a linear association between mortality and AFB1
concentrations over the course of their experiment, with mortality mainly occurring after d
14. In our study, the early mortality was low (3.5%). The combined observations suggest
that AFB1 effects are cumulative and high mortality could be anticipated if ducklings were
continuously exposed over the pre-market course. Mortality may be higher in naturally
contaminated diets because of mycotoxin interactions; such deleterious combinations have
been documented by others (Kubena et al., 1997; Manafi et al., 2012; Verma et al., 2004).
Therefore, 0.11 to 0.21 mg/kg dietary AFB1 is expected to be even more detrimental to
ducklings in practical situations if any feed ingredients are naturally contaminated with
mycotoxins and fed chronically for over 2 consecutive weeks.
The serum biochemistry panel results were consistent with performance. As
expected, serum proteins including albumin, globulin, and total protein were all reduced
linearly and quadratically by increasing AFB1 levels. This indicated that AFB1 negatively
affected liver physiology, and caused injury to that organ as a result of impaired protein
synthesis (Zhao et al., 2010). Based on the increase in serum urea N levels, it is likely that
impaired protein synthesis was due to lower utilization of amino acids (Coma et al., 1995).
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Elevation in serum AST, ALT, ALP, and GGT indicates cellular (hepatocyte) damage,
consistent with what occurs when the liver is damaged by viral hepatitis. Manning and
Wyatt (1990) and Abdolamir et al. (2005) reported that blood AST was higher in aflatoxinfed birds as compared to controls. Méndez-Albores et al. (2006) reported that ducklings
fed a 0.1 mg/kg AFB1 diet showed significantly increased AST, ALT, and AST: ALT ratio.
Here, serum ALP and AST concentrations were both elevated linearly in ducklings with
increasing AFB1 (P < 0.05), which agrees with previous research and demonstrated the
cellular damage and hepatotoxic effects of AFB 1. The AST: ALT ratio is an indication of
liver function and is positively correlated with the stage of liver fibrosis (Sheth et al., 1998).
In the current study, the AST:ALT ratio increased from 1.87 in control group to 2.5 in 0.21
mg/kg AFB1 group, indicating that AFB1 increased liver fibrosis in ducklings. Meanwhile,
low serum creatinine level is associated with severe hepatic disease (Takabatake et al.,
1988), which was observed in our study from a dose of 0.11 mg/kg AFB1. In the ducklings
fed 0.21 mg/kg AFB1, the serum creatinine was below the detection limit under the
analytical conditions used; this added another evidence that AFB1 at ≤ 0.21 mg/kg intake
could induce severe liver disease in ducklings. Serum Ca and P were both reduced linearly
by increasing AFB1. This is in agreement with reports on broilers where AFB1 levels at 1
mg/kg or more negatively affected serum Ca levels (Gowda et al., 2008, Kubena et al.,
1997; Zhao et al., 2010). Additionally, AFB1 also reduced serum CPK concentration (linear
effect, P < 0.05). To our knowledge, no reports are available on the serum CPK changes
induced by AFB1 in ducklings. However, this might be a consequence of diminished efflux
of muscle CPK into serum resulting from severely reduced muscle mass; and low serum
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CPK levels have been reported to associate with liver diseases, including acute viral
hepatitis, in human patients (Barnert et al., 1985).
Aflatoxin B1 has also been shown to cause immunosuppression in poultry. The
complement system, consisting of approximately 20 proteins that are primarily produced
by the liver, is a vital component of the immune system and a potent initiator of
inflammatory reactions. There are three different activation pathways of the complement
system. The classical pathway is activated by antibody-antigen complexes, while the
alternative and lectin pathways are part of the innate immune system, and are directly
activated by microorganisms (Koppenheffer et al., 1999). Stewart et al. (1984) compared
the total hemolytic complement activity in chickens fed aflatoxin or normal diets. Results
showed that 2.5 mg/kg AFB1 significantly decreased total complement activity in chickens
that were fed to 42 d of age, but was not affected by 0.625 or 1.25 mg/kg AFB
concentrations. Herein, AFB1 level as low as 0.11 mg/kg can impair the classic and
alternative pathways of the ducklings, as shown by decreased L100 and L50 values. This
finding of impaired complement system was also supported by the reduced serum protein
levels, which is an indication of liver protein synthesis failure. Complement proteins are
mainly liver products, so it is not surprising that AFB1 reduced their activity. Here we show
that AFB1 also affected natural antibody production, especially the natural rabbit agglutinin.
Thus AFB1 is able to suppress a broader spectrum of immune function than that attributed
to its hepatotoxicity. Natural antibodies are important as a wide variety of defense
mechanisms, they enhance acquired immunity, interact with complement, and are crucial
for defense (Ochsenbein and Zinkernagel, 2000). Therefore, if AFB1 affects any of these,
it is likely to increase morbidity and mortality of animals.
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To our knowledge, this is the first study that examined the effects of AFB1 on liver
gene expression in ducklings. Previous studies, although also limited, have used broilers
as the model animal. In our study, we have measured the expression for SOD, EH, CTP1A,
MDH2, PPAR-α, and IFNγ. Selection of these six genes were made because they encode
major proteins that cover the effects on liver anti-oxidant capacity (SOD), energy
metabolism (CPT1A), metabolism of AFB1 (EH), carbohydrate and lipid metabolism
(MDH2 and PPARα), and immune response (IFNγ). Results showed that hepatic
expression of PPAR-α was linearly decreased by AFB1, while SOD and CPT1A
expressions tended to decrease linearly with increasing AFB1 concentrations.
As a nuclear receptor, PPARα is a major regulator of lipid and glucose homeostasis
(Smith, 1996). Activation of PPARα in the liver leads to an increase of the expression and
activity of a lipolysis enzyme, lipoprotein lipase, and therefore promotes the clearance of
triglyceride-rich lipoproteins as well as circulating triglyceride levels (Schoonjans, et al.,
1996). The down-regulation of PPARα by AFB1 indicate that the lipid metabolism of the
ducklings was impaired, which is possibly linked to lipid accumulation during aflatoxicosis.
Moreover, PPARα influences the expression of numerous genes involved in major
pathways of amino acid metabolism. Kersten et al. (2001) reported that fasting PPARαnull mice have increased mRNA levels of four urea cycle enzymes and higher plasma urea
concentration compared to wild type. Collectively, PPARα plays a vital role in glucose,
lipid, and protein metabolism. Thus, impaired PPARα expression and function is likely to
lead to impaired lipid clearance and inefficient protein utilization; the latter was supported
by increased serum urea N from 2.92 to 3.92 mg/dL as mentioned above.
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No statistical changes of hepatic EH, MDH2, or IFNγ expressions were observed.
However, there was a trend of SOD and CPT1A expression towards decreasing with
increasing AFB1 concentrations. The release of free radicals induced by AFB1 can initiate
oxidative stress and cause damage to cell membranes (Rastogi et al., 2001). Superoxide
dismutase is a major anti-oxidant enzyme in the liver; and decreased activity and
expression of SOD have been found during aflatoxicosis (Rastogi et al., 2001; Yarru et al.,
2009). Carnitine palmitoyltransferase I A, encoded by CPT1A, is an enzyme that facilitates
in the transportation of long chain fatty acids from the cytosol into the inter-membrane
space of mitochondria, which then can be transported by CPT2 into the matrix for fatty
acid oxidation (Kerner and Hoppel, 2000). Therefore, the CPT enzymes are crucial in
regulating fatty acid metabolism. We hypothesized that CPT1 expression would be downregulated by AFB1 as lipid accumulation in the liver is common during aflatoxicosis
(Abdolamir, 2005; Hamilton and Garlich, 1971). This lipid accumulation in the liver
cytosol can be induced if less CPT1A is available to facilitate the transportation of fatty
acids. However, the changes of CPT1A expression in response to AFB 1 up to 0.21 m/kg
were not statistically significant in ducklings.
Given the low AFB1 concentrations used in the current study compared to 1.0 to
1.8 mg/kg used in other gene-expression studies (Meissonnier et al., 2008; Yarru et
al.,2009), it is possible that higher AFB1 concentration can induce statistical changes in a
wider array of hepatic genes. However, the dramatic reduction of FI and BW gain caused
by 0.11 to 0.21 mg/kg AFB1 reassures that the primary damage of AFB1 in ducklings is FI
inhibition. Therefore, approaches to prevent adverse effects of AFB1 in ducklings should
focus on reducing AFB1 content in feed before absorption by the ducklings. In this sense,
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proper storage of crops and feed ingredients, regular feed sampling and analysis, and use
of aflatoxin adsorbents are recommended to help ameliorate AFB1 toxicity in ducklings.
The current study is the first to investigate the effects of cultured aflatoxin at graded
concentrations in ducklings. Results indicated that 0.11 to 0.21 mg AFB1 / kg diet could
dramatically depress FI and BWG in ducklings. For every 0.1 mg/kg increase in dietary
AFB1, the reduction in FI and BWG approximates 230 and 163 g/bird from 0 to 14 d,
respectively. Impaired liver function and alteration of serum proteins and enzyme activity
also resulted from exposure to AFB1. Moreover, herein, AFB1 let to impairment of the
innate immunity by decreasing natural antibody and serum complement activities, while
others have noticed such alteration in acquired immunity (Pier, 1981; Ghosh et al., 1991).
Our observations also suggest that poor FI is the most profound harm of AFB1 in duck
growth. Increased leptin and decreased neuropeptide Y levels in response to AFB1 might
be possible contributors to FI reduction (Feng, 2010), but the exact mechanism and species
differences in FI regulation upon AFB1 exposure awaits further research to better
understand different degrees of susceptibility among poultry species.
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Table 3.1. Primer sequences (5’ → 3’) used in real-time PCR.
Gene

Forward primer

Reverse primer

GAPDH

ATGTTCGTGATGGGTGTGAA

CTGTCTTCGTGTGTGGCTGT

SOD

GGCGTCATCCACTTCCAG

AGCAGTCACGTTGCCGAGGTC

EH

AAAGGGACAGAAGCCTGACA

CCTCCAGTGGCTCAGTGAAT

CPT 1A

TGAACACGGCAAACTTTCTG

ATTCATAAGTGGCCGGACTG

MDH2

CTCTACACCTCTGCTACTG

GGGTGATCTTGCCAATGCCTA

IFNγ

CAAGTAATTCGGATG TAGC

GCGTTGGATTTTCAA GCC

PPARα

GCCTTTCAGTTGGAATGTCACATA CTGCCTTCAACTTGGCCTTCT

1GAPDH

= glyceraldehyde 3-phosphate dehydrogenase; SOD = superoxide dismutase;
EH = epoxide hydrolase; CPT1A = carnitine palmitoyltransferase 1 A; MDH2 = malate
dehydrogenase 2; IFN- γ = interferon gamma; PPARα = peroxisome proliferatoractivated receptor-α

Table 3.2. Cumulative and periodic performance and relative liver weight of ducklings fed 0 to 0.21 mg/kg of Aflatoxin from 0 to
14 d of age. 1, 2
Analyzed
AFB13
(mg/kg)

Ingested
AFB14
(mg/bird)

FI
(g/duck)

BW gain
(g/duck)

G:F ratio
(g/g)

Relative
liver Wt
(% BW)

0-7 d
BW gain
(g/duck)

0-7 d
FI
(g/duck)

0-7 d
G:F ratio
(g/g)

7-14 d
BW gain
(g/duck)

7-14 d
FI
(g/duck)

7-14 d
G:F ratio
(g/g)

Control

0.002

0.002

1047

728

0.697

3.79

225

280

0.805

503

766

0.655

0.11 mg/kg AFB1

0.107

0.106

985

648

0.662

4.05

218

277

0.790

431

708

0.612

0.14 mg/kg AFB1

0.144

0.105

727

499

0.683

3.73

191

237

0.807

308

490

0.632

0.21 mg/kg AFB1

0.212

0.123

581

380

0.667

3.48

157

196

0.725

223

347

0.645

---------

0.006
< 0.0001
< 0.0001
< 0.0001

33.2
<0.0001
<0.0001
0.0085

15.8
<0.0001
< 0.0001
0.0017

0.022
0.67
0.44
0.76

0.18
0.11
0.14
0.066

5.2
<0.0001
<0.0001
0.001

8.5
<0.0001
<0.0001
0.0037

0.034
0.30
0.17
0.28

14.0
<0.0001
<0.0001
0.015

20.6
<0.0001
<0.0001
0.0003

0.023
0.59
0.71
0.22

Treatments

SEM
P-value
Linear effect
Quadratic effect
1

Means represent 6 pens per treatment, 6 birds per pen. AFB1 = aflatoxin B1.
Linear and quadratic regression effect was conducted with the analyzed dietary AFB1 concentration.
3
The AFB1 in diet samples was extracted using acetonitrile, purified using AflaStar R® immune-affinity columns, rinsed, and
eluted with methanol followed by deionized H2O. The purified extract was then injected into HPLC system, and AFB1 was
detected and quantified with fluorescence detector at 360 nm (excitation) and 440 nm (emission) wavelengths (Romer Labs,
Union, MO)
4
Ingested AFB1 = Analyzed AFB1 concentration * cumulative feed intake.
2
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Table 3.3. Regression equations relating growth performance and serum proteins to dietary aflatoxin B1 (AFB1) concentration in
Pekin ducklings fed 0 to 14 d of age. 1, 2, 3
Item
Equation
r2
SD
P-value
FI (g/bird)
Linear
Y = -2299 (297) *AFB1 + 1102 (41)
0.73
110.2
< 0.0001
2
Y = -348 (868) *AFB1 -9445 (3992) *AFB1 + 1057
Quadratic
0.79
100.2
0.0085
(42)
BW gain (g/bird)
Linear
Y = -1693 (151) *AFB1 + 760 (21)
0.85
55.9
< 0.0001
2
Quadratic
Y = -543 (419) *AFB1 -5569 (1930) *AFB1 + 734 (20)
0.89
48.4
0.0017
Serum protein
Linear
Y = -11.27 (0.80) *AFB1 + 2.96 (0.11)
0.90
0.30
< 0.0001
(g/dL)
Y = -18.67 (2.02)*AFB1 + 35.85 (9.30) *AFB12 + 3.13
Quadratic
0.94
0.23
0.0004
(0.10)
Serum albumin
Linear
Y = -5.67 (0.42) *AFB1 + 1.21 (0.06)
0.89
0.16
< 0.0001
(g/dL)
Y = -10.20 (0.91) *AFB1 + 21.94 (4.19) *AFB12 + 1.32
Quadratic
0.95
0.11
< 0.0001
(0.04)
Serum globulin
Linear
Y = -5.60 (0.47) *AFB1 + 1.74 (0.07)
0.87
0.18
< 0.0001
(g/dL)
Y = -8.47 (1.40) *AFB1 + 13.91 (6.44) *AFB12 + 1.81
Quadratic
0.89
0.16
0.038
(0.07)
1
AFB1 concentration is in mg/kg.
2
Regression was conducted with the analyzed dietary AFB1 concentration.
3
Values in parentheses are SE.
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Table 3.4. Serum profile of ducklings fed 0 to 0.21 mg/kg aflatoxin B1 (AFB1) from 0 to 14 d of age 1, 2.
Dietary treatment
Control
0.11 mg/kg AFB1
0.14 mg/kg AFB1
0.21 mg/kg AFB1
SEM
P-value
Linear effect
Quadratic effect
Dietary treatment
Control
0.11 mg/kg AFB1
0.14 mg/kg AFB1
0.21 mg/kg AFB1
SEM
P-value
Linear effect
Quadratic effect

Glucose
mg/dL
260
186
168
185

Urea N
mg/dL
2.92
3.00
3.25
3.92

CREAT
mg/dL
0.09
0.04
0.02
0.00

Na
mEq/L
146
149
148
146

K
mEq/L
8.50
7.81
7.25
8.70

Cl
mEq/L
105
109
110
110

CO2
mEq/L
26.00
25.83
24.84
23.42

Anion
Gap3
22.33
22.33
21.92
20.42

Albumin
g/dL
1.28
0.54
0.23
0.16

Total protein
g/dL
3.07
1.67
1.03
0.82

12.8
0.0003
0.0002
0.0078
Globulin 3
g/dL
1.78
1.13
0.81
0.66

0.17
0.0015
0.0005
0.032
Ca
mg/dL
12.03
11.08
10.21
10.15

0.01
0.0002
< 0.0001
0.53
P
mg/dL
13.05
12.22
10.92
10.67

15.7
0.54
0.95
0.064
ALT
U/L
60.33
63.58
58.25
61.42

0.35
0.031
0.86
0.008
ALP
U/L
922
976
1036
1104

0.9
0.0028
0.0009
0.069
AST
U/L
113
131
136
154

0.99
0.26
0.08
0.38
GGT
U/L
2.58
2.83
2.92
2.50

1.38
0.73
0.66
0.69
CPK
U/L
7708
5525
4509
4752

0.04
<0.0001
< 0.0001
< 0.0001
Uric Acid
mg/dL
7.80
4.89
5.13
6.78

0.09
<0.0001
< 0.0001
0.0004

0.06
<0.0001
< 0.0001
0.038

0.26
0.0001
< 0.0001
0.38

0.60
0.035
0.0061
0.99

3.81
0.77
0.85
0.96

61.4
0.21
0.043
0.69

12.7
0.19
0.034
0.83

0.24
0.56
0.98
0.18

1050.8
0.16
0.040
0.40

0.67
0.018
0.17
0.0038

1

Means represent 6 cages per treatment, 6 birds per pen.
CREAT = creatinine, ALT = alanine transaminase, AST= Aspartate transaminase, ALP= Alkaline phosphatase, GGT= Gamma glutamyl
transpeptidase, CPK=Creatine phosphokinase. 3calculated from Albumin and Total protein
2
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Table 3.5. Natural antibody and serum complement profile of ducklings fed 0 to 0.21 mg/kg aflatoxin B1 (AFB1) from 0 to 14 d of
age 1, 2, 3, 4, 5, 6, 7
Rb
Rb
HuO
HuO
Ho
Ho
Rb
Rb
HuO
Dietary treatment
L100
L50
L100
L50
L100
L50
HA1
HA2 HA45
Control
3.17
1.33
2.17
3.83
2.17
2.67
4.00
7.50
4.50
0.11 mg/kg AFB1
1.83
0.67
1.50
2.50
0.50
0.83
4.50
8.33
5.00
0.14 mg/kg AFB1
1.50
0.67
1.17
1.83
0.67
2.33
2.67
8.00
4.67
0.21 mg/kg AFB1
1.33
0.33
1.00
1.67
0.83
1.00
2.16
7.33
4.67

1
2

3
4
5
6
7

Ho
HA45
1.33
2.83
1.33
1.50

SEM
0.30
0.43
0.16
0.32
0.19
0.40
0.40
0.65
0.32
0.38
P-value
0.0026 0.0044 0.0002 0.0003 0.0085 0.0076 0.0008
0.68
0.66
0.0052
Linear effect
0.0003 0.0006 <0.0001 <0.0001 0.019
0.14
0.0009
0.67
0.96
0.91
Quadratic effect
0.26
0.32
0.57
0.43
0.0095
0.75
0.064
0.97
0.37
0.0059
Means represent 6 cages per treatment, 2 birds per pen.
Serum samples were tested for natural antibody and complement activity against Rabbit (Rb), Human type O (HuO) and Horse
(Ho) erythrocytes.
Rb and HuO were tested using 1% erythrocyte suspensions and 0.5% for Ho.
Parameters: = log2 dilutions, representing end point titers; i.e. 3 = 1:8 dilution of serum etc.
HA1 = strong hemaagglutination, HA2 = weak hemaagglutination, HA45 = very weak hemaagglutination.
L100 = complete lysis and L50 = incomplete lysis titers, representing the Classic and Alternate lytic pathways, respectively.
All P-values were based on box-cox transformed data.
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Table 3.6. Liver gene expression of 14 d-old ducklings fed 0 to 0.21 mg/kg aflatoxin B1
(AFB1) from 0 to 14 d of age 1
Dietary treatment
Control
0.11 mg/kg AFB1
0.14 mg/kg AFB1
0.21 mg/kg AFB1

SOD
1.48
1.12
0.93
0.96

EH2
1.53
1.19
0.90
1.11

CPT1A2
1.22
1.25
0.62
0.55

SEM
0.19
0.30
0.31
P-value
0.30
0.48
0.29
Linear effect
0.089
0.33
0.092
Quadratic
effect
0.55
0.46
0.86
1 Means represent 6 cages per treatment, 1 birds per pen.
2 P-value is based on log transformed data.

MDH2
1.12
1.49
1.42
1.41

PPAR-α
1.71
1.25
0.81
0.85

IFNγ
1.39
1.61
0.83
1.01

0.29
0.85
0.51

0.21
0.047
0.0095

0.40
0.31
0.30

0.60

0.53

0.73

130

CHAPTER 4. EFFICACY OF A HYDRATED SODIUM CALCIUM
ALUMINOSILICATE (HSCAS) TO AMELIORATE AFLATOXICOSIS IN
PEKIN DUCKLINGS

4.1

Abstract

A 20-d study was conducted to evaluate the efficacy of a hydrated sodium calcium
aluminosilicate (HSCAS) to ameliorate aflatoxicosis in Pekin ducklings. A total of 90
ducks were randomly allocated into 3 dietary treatments with 6 replicate cages per
treatment and 5 ducks per cage, and were fed from hatch to 20 d of age. The 3 dietary
treatments were control, negative control with 0.2 mg/kg AFB1 (NC), and NC with 0.05%
HSCAS. Feed intake (P = 0.07) and BW gain (P = 0.048) from 0 to 14 d were reduced by
AFB1, but cumulative performance and relative liver weight were not affected by
treatments (P ≥ 0.16). Exposure to AFB1 reduced serum concentrations of glucose,
creatinine, albumin, total protein, and globulin (P < 0.001) and tended to decrease Ca
concentration (P = 0.08), while serum alanine transaminase (ALT) and gamma glutamyl
transpeptidase (GGT) increased (P < 0.01). Serum complement activity was reduced by
AFB1 as measured by lysis titers against rabbit erythrocytes (P ≤ 0.001), and liver lesion
scores were increased by AFB1. The liver antioxidant status and gene expression were not
affected by AFB1. Compared to NC, HSCAS improved 0-14 d feed intake and BW gain,
reversed the reduction of serum Ca and the increase of serum ALT and GGT, but did not
prevent liver lesions. Additionally, HSCAS improved the total anti-oxidant capacity and
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liver SOD activity (P ≤ 0.031), but increased the expression of IFN-ɣ (P = 0.0024). Results
from this study indicate that low concentrations of AFB1 can negatively affect duckling
performance from 0 to 14 d of age, but may become more resistant after 14 d. Feeding
AFB1 also negatively affects serum biochemistry, complement activity, and induces liver
lesion; while 0.05% HSCAS may lead to partial, but not total, protection against
aflatoxicosis in Pekin ducklings.

4.2

Introduction

As a major group of mycotoxins, Aflatoxins (AF) are the secondary metabolites of
the Aspergillus fungi species. Aflatoxin B1 (AFB1), an active hepatocarcinogen, is
considered as the most toxic AF (Yunus et al., 2011). Contamination of AFB1 in animal
feed and feed ingredients has been a worldwide concern for decades, and chronic intake of
low levels of AFB1 is known to lead to reduction in growth performance and production,
impaired liver functions, immunosuppression, and increased susceptibility to diseases in
poultry species. (Ledoux et al., 1999; Devegowda and Murthy, 2005; Yarru et al., 2009;
Andretta et al., 2011; Yunus et al., 2011; Grenier and Applegate, 2013). The sensitivity to
AFB1 has been shown to differ among poultry species, partly associated to the different
efficacy of hepatic AFB1 biotransformation (Diaz and Murcia, 2011). Ducks are reported
to be the most susceptible poultry species to AF, who exhibit 100% mortality at 1 mg/kg
AF and have the ability of developing hepatic carcinoma (Muller et al., 1970; Bintvihok,
2001). However, compared with broilers, there is limited research on AFB1 toxicity in
ducks. Our prior study demonstrated that cultured AFB1 as low as 0.1 mg/kg can
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significantly depress feed intake and BW gain, impair liver functions, and alter immune
measures in 14-d Pekin ducklings (Chen et al., 2014a). Duck production is a rapidly
growing industry globally, with Pekin ducks accounting for 95% of the consumption
(Huang et al., 2012). Therefore, better understanding of the effects and mechanisms of
AFB1 on this species is required.
Because of the high prevalence of AFB1 in feedstuffs worldwide and their many
adverse effects on poultry performance and health, much attention has been given to find
methods to overcome these damages. The best strategy today is to minimize animal
exposure to AF before intestinal absorption, and one of the most used approaches is the
addition of the non-nutritive mycotoxin adsorbents into poultry feeds. Hydrated sodium
calcium aluminosilicates (HSCAS) have been shown to be effective adsorbents in
preventing aflatoxicosis via binding with the β-carbonyl portion of the AFB1 molecule in
the gastrointestinal tract, and thus preventing AF absorption into other parts of the body
(Huwig et al., 2001; Phillips et al., 2002). The efficacy of HSCAS in broilers has been
studied extensively (Kubena et al., 1990, 1993, 1998; Phillips et al., 1988), yet evaluation
of HSCAS in other poultry species, including ducks, has been limited. Further, because of
the broad family of aluminosilicates and different processing methods, HSCAS products
may not possess the same physicochemical properties, and thus must be evaluated
individually to determine its efficacy in animals (Grenier and Applegate, 2012). Therefore,
the aim of this study was to evaluate the efficacy of a HSCAS to ameliorate aflatoxicosis
in Pekin ducklings by measuring growth performance, serum biochemistry, innate
immunity, and liver functions.
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4.3
4.3.1

Material and Methods

Experimental Birds and Diets
The animal care and use protocol was reviewed and approved by the Purdue

University Animal Care and Use Committee. A total of 90 male Pekin ducklings were
obtained from a commercial hatchery (Maple Leaf Farms, Leesburg, IN), weighted, tagged,
and randomly allotted to 18 battery cages. All birds were housed on raised wire floors in
stainless steel battery cages in an environmentally controlled room. Feed and water were
provided for ad libitum consumption from hatching to 20 d. Ducklings were inspected daily
for any health problems, and mortality was recorded as it occurred.
A completely randomized design was used with 3 dietary treatments, 6 replicate
cages per treatment, and 5 ducklings per cage. A corn-soybean meal based basal diet (mash
form) was formulated to contain 3,147 kcal/kg metabolizable energy, 22.5% crude protein,
1.46% lysine, 1.17% Ca, and 0.49% non-phytate phosphorus (Table 1). The three dietary
treatments included a control diet without added AFB1, a negative control (NC) with 0.2
mg/kg AFB1, and a NC with 0.05% HSCAS. Three premixes, contributing 0.4% of the
final diets, were prepared with 82.4% corn or cultured AFB1 with or without 12.26%
HSCAS in corn starch, and then blended with the basal diet to create the 3 dietary
treatments. The cultured aflatoxin (60 mg/kg) was produced on ground corn using
Aspergillus parasiticus (NRRL 2999) as described by Gowda et al. (2008). Dietary AFB1
concentrations were analyzed by HPLC at the Veterinary Diagnostic Laboratory at North
Dakota State University (Fargo, ND). The presence of other mycotoxins including
fumonisins, deoxynivalenol, T-2 toxin, and zearalenone were analyzed to ensure they were
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below cautionary limits before the start of the study. The HSCAS (Engage-M) was
provided by JBS United Inc. (Sheridan, IN).

4.3.2

Sample Collection
Feed intake (FI) and individual BW were measured on d 7, 14, and 20. At the

conclusion of the experiment (d 20), total feed consumption was recorded for each cage.
Average feed intake and BW gain were corrected for mortality. All birds were euthanized
using CO2 asphyxiation, and blood was collected from all ducks via jugular vein for
subsequent serum separation. Liver weight was recorded for all ducks, and relative liver
weight was calculated as a percentage of BW. A section of liver sample from 1 duckling
per cage was collected for determining liver anti-oxidant enzyme activity. Another liver
sample from 1 duckling per cage was collected, preserved in RNAlater (Ambion, Austin,
TX), and stored at – 80 ⁰C for real-time quantitative PCR analysis. In addition, a third liver
sample was ﬁxed in 10% neutral buffered formalin for liver lesion examination.

4.3.3

Serum Biochemistry and Complement Analysis
The collected blood samples were centrifuged at 1,400 x g at 8 ⁰C for 15 min, and

serum was separated and preserved at -20 ⁰C until it was submitted for biochemical
analysis. Two replicate serum samples per cage (12 samples per treatment) were analyzed
for albumin, globulin, total protein, glucose, urea N, creatinine, K, Cl, Ca, P, alanine amino
transferase (ALT), alkaline phosphatase (ALP), aspartate amino transferase (AST), ɣglutamyl transferase (GGT), creatine phosphokinase (CPK), and uric acid. All
biochemistry parameters were determined at the Veterinary Medical Diagnostic Laboratory

135
of the University of Missouri (Columbus) using an auto-analyzer (Kodak Ektachem
Analyzer, Eastman Kodak Co., Rochester, NY).
In addition, one serum sample per cage was analyzed for natural antibody and
serum complement activity as described by Cotter (2012). Briefly, the sera were diluted in
PBS supplemented with Ca and Mg and tested by microtiter for the capacity to agglutinate
and lyse rabbit, human, and horse erythrocytes. Rabbit and human erythrocytes were tested
using 1% erythrocyte suspensions, and horse erythrocytes were tested using 0.5%
erythrocyte suspension. The end-point (log2 dilutions) were visually evaluated for 3
agglutination types: HA1 (strong), HA2 (weak), and HA45 (very weak) for natural
antibody activity, and 2 degrees of lysis: L100 (complete lysis) and L50 (half lysis) for the
complement activity (Cotter, 2012).

4.3.4

Liver Antioxidant Status
A section of liver sample from one chick per cage was collected, diluted at a ratio

of 1:9 with phosphate buffered saline, homogenized, and centrifuged at 10,000 x g, 4 C for
15 min. The clear supernatant was obtained and preserved at – 80 ⁰C until antioxidant
status was determined. The content of total protein (Sigma kit TP0400), total antioxidant
capacity (Sigma kit CS0790), aqueous and organic peroxide (Sigma kit PD1), and
superoxide dismutase (SOD; Sigma kit 19160) were determined using respective assay kits
(Sigma Diagnostics, Sigma Chemical Co., St. Louis, MO)
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4.3.5

Liver Gene Expression
A section of liver sample from one duck per cage was collected, preserved in

RNAlater, and stored at -80 ⁰C for real-time quantitative PCR analysis. The mRNA
expression of superoxide dismutase (SOD), epoxide hydrolase (EH), carnitine palmitoyl
transferase 1A (CPT1A), malate dehydrogenase (MDH2), peroxisome proliferatoractivated receptor alpha (PPARα), and interferon gamma (IFN-γ) were determined and was
normalized using glyceraldehyde phosphate dehydrogenase (GAPDH) within each sample.
The expression of GAPDH was not different across treatments. Briefly, total RNA from
hepatocytes (6 samples per treatment) was extracted using TRIzol (Invitrogen, Carlsbad,
CA). Extracted RNA was quantified at an absorbance of 260 nm (ND-1000, Nanodrop
Technologies Inc., Wilmington, DE) and reverse transcription was carried out using the MMLV reverse transcriptase (Promega, Madison, WI). Water was used as a negative control.
All reactions were analyzed in duplicate and formation of a single PCR product was
confirmed by melting curves. The primer sequences used were based on a previous report
(Yarru et al., 2009; Chen et al., 2014a). The mRNA expression was determined from the
threshold cycle for respective genes, and the expression level was calculated using the 2-ΔΔ
Ct method (Livak and Schmittgen, 2001).

4.3.6

Liver Lesion Score
Liver tissue samples from 1 bird/pen were be ﬁxed in 10% neutral buffered formalin,

and hematoxylin and eosin stained for liver lesion examination. Six criteria were evaluated,
including biliary hyperplasia, architecture, inflammation, fibrosis, cholestasis, and
swelling, based on descriptions of aflatoxin-induced hepatic lesion (Hoerr, 2003). Scoring

137
was based on a 0-3 scale, where 0 indicated no lesion, 1 indicated mild lesion, 2 indicated
moderate lesion, and 3 indicated severe lesion.

4.3.7

Statistical Analysis
Liver lesion score data were analyzed using the NPAR1WAY procedure in SAS.

All other data were analyzed as one-way ANOVA using the GLM procedure of ANOVA
using the SAS (9.3) for a completely randomized designs. Cage was used as experimental
unit. The means showing significant (P ≤ 0.05) and trending (0.05 < P ≤ 0.10) treatment
differences in the ANOVA were then compared using Fisher’s protected least significant
difference procedure. All data were tested for normality using the UNIVARIATE
procedure and common variance using the GLM procedure of SAS (9.3). Non-normal data
were transformed using the optimal Box-Cox transformation.

4.4
4.4.1

Results

Analyzed Mycotoxin Concentration
The analyzed dietary AFB1 concentrations were <0.02 (control), 0.23 (negative

control), 0.26 (NC + HSCAS) mg/kg for the 3 dietary treatments, respectively. The
concentrations of fumonisin B1 were < 2.0 mg/kg and the concentrations of all other
mycotoxins were < 0.5 mg/kg for all diets.

4.4.2

Growth Performance
Mortality was low throughout the experiment (5%). The cumulative performance

and relative organ weights are shown in Table 4.3. There were no statistical differences
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among treatments for cumulative feed intake, BW gain, G:F ratio, or relative liver weight.
However, based on the weekly performance results (Table 4.4), from 0 to 14 d, AFB1
tended to reduce BW gain (P = 0.07) and significantly reduced feed intake (P = 0.048),
while supplementing HSCAS improved both BW gain and feed intake such that they were
not significantly different than the positive control birds. Gain to feed ratio was not affected
by treatments at all times. Unexpectedly, during 14-20 d, ducks fed negative control diet
did not show a depression in feed intake or BW gain compared to ducks fed control diet,
resulting in no differences due to treatment for cumulative performance.

4.4.3

Serum Biochemistry
Compared with birds fed the control diet, feeding 0.2 mg/kg AFB1 to ducks resulted

in significant reductions in serum glucose, creatinine, albumin, total protein, and globulin
(P < 0.001) and tended to decrease Ca concentration (P = 0.08, Table 4.5). Serum ALT
and GGT concentrations were increased by AFB1 (P < 0.05). HSCAS supplement reversed
the reduction of serum Ca and the increase of serum ALT and GGT concentrations induced
by AFB1, but did not affect any other serum measures.

4.4.4

Natural Antibody and Serum Complement Activity
The natural antibody and serum complement activity results are shown in Table

4.8. The serum natural antibody levels (HA1, HA2, HAA45 tested against human, horse,
or rabbit erythrocytes) were not affected by treatment (P ≥ 0.37). For serum complement
activity, the human L50, and rabbit L100 and L50 values were reduced by AFB1 (P ≤ 0.001),
indicating impaired classic and alternative complement lytic pathways. Supplementing
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HSCAS improved the Rb L100 and L50 values to control levels, but did not affect any
other values.

4.4.5

Liver Antioxidant Status
The liver antioxidant enzyme activities are shown in Table 4.6. No significant

effect of AFB1 was found on the total anti-oxidant capacity, aqueous or organic peroxide
activity, or SOD activity. However, compared to birds fed the NC diet, HSCAS
supplementation significantly increased both total anti-oxidant capacity and liver SOD
activity (P ≤ 0.031). Birds fed HSCAS also showed higher peroxide concentrations
compared to birds fed control and NC diets (P ≤ 0.022).

4.4.6

Liver Lesion Score
Ducklings fed 0.2 mg/kg AFB1 showed significantly higher lesion scores for liver

inflammation, swelling, as well as total score (P < 0.05) (Table 4.7). HSCAS did not
improve hepatic lesion scores.

4.4.7

Liver Gene Expression
The hepatic mRNA expression of SOD, EH, CPT1A, MDH2, PPARα, and IFNγ

are shown in Table 4.9. Dietary AFB1 did not affect the expression of any measured genes.
HSCAS significantly increased the expression of IFN-ɣ compared with birds fed control
or NC diets (P = 0.0024), but did not affect any other genes.
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4.5

Discussion

Although extensive information is available on the effects of AF and the efficacy
of HSCAS in ameliorating aflatoxicosis in broiler chicks, there is less on ducks, the most
sensitive poultry species to AF (Muller et al., 1970; Bintvihok, 2011; Diaz and Murcia,
2011). In the current study, the efficacy of a HSCAS was evaluated in Pekin ducklings fed
a diet containing 0.2 mg/kg AFB1 from hatch to 20 d. Consistent to our prior result (Chen
et al., 2014a), 0.2 mg/kg AFB1 significantly reduced 14 d feed intake and BW gain by
approximately 20 and 11%, respectively, in the current study. The decrease in BW gain
can be attributed mostly to the inhibited feed intake, as gain:feed ratio was not affected
throughout the study duration. Similarly, studies using naturally contaminated corn showed
that reduction of BW gain, primarily a consequence from reduced feed intake, can be up to
40% in 14 d or 35 d ducks fed diets containing ≤ 0.15 mg/kg AFB1 (Feng, 2010; He et al.,
2012). Contrast to the current hypothesis, cumulative feed intake and BW gain of the
ducklings were not affected by AFB1 herein, primarily due to recovered feed intake (651
versus 644 g/duck for control and NC birds, respectively) and numerically improved
gain:feed ratio (0.53 versus 0.60 for control and NC birds, respectively) during d 14-20. It
is uncertain why AFB1 did not negatively affect performance during that week, but it is
likely that older birds may become more resistant to AFB1 challenge (Arafa et al., 1981;
Lanza et al., 1980). Lanza et al. (1980) reported that while broilers from 0 to 3 wk or 1 to
4 wk of age had significantly reduced BW gain by 2.5 mg/kg AFB1, depression of BW gain
was not present in birds from 2 to 5 or 3 to 6 wk of age, suggesting that the effect of AFB1
may gradually diminish with age. However, others also observed significantly impaired
growth in ducks older than 14 d by AFB1 (He et al., 2012; Han et al., 2008). Clearly, future
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determination of the age effect on aflatoxicosis in ducks is needed. Although performance
recovered, the adverse effects of AFB1 on serum biochemistry, complement activity, and
liver lesions were still significant at d 20. Serum protein concentrations are probably the
most sensitive criteria for detecting aflatoxicosis, even when performance depression may
not be seen (Lanza et al., 1980). The decreased serum protein concentrations (total protein,
albumin, and globulin) in ducklings fed AFB1 indicated the strong inhibitory capability of
AFB1 on hepatic protein synthesis, which is consistent with previous reports (Chen et al.,
2014; Kubena et al., 1998). In line with this, the complement system, consisting of
approximately 20 proteins that are produced primarily by the liver, was negatively affected
as shown by the decreased Rb L100 and L50 values. Similarly, earlier studies revealed that
upon AFB1 exposure ranging from 0.1 to 2.5 mg/kg, decreased complement activity can
be found in broilers and ducklings (Shivachandra et al., 2003; Campbell et al., 1983; Chen
et al., 2014a). Aflatoxins are known to lead to immunosuppression; according to previous
reports, AFB1 can depress the development of the thymus gland and influence the relative
weight of the bursa of Fabricius, resulting in deficiencies in both cellular and antibody
responsiveness of the chicken immune system (Celik et al, 2000; Verma et al., 2004).
Inhibition of macrophage functions, T lymphocyte activity, or cytokine expression by AF
may also lead to vaccine failure and pathogen persistence, as exemplified in many studies
by reduced immunoglobulin production (Verma et al, 2004; Yunus et al, 2011). The
complement system is extremely important as a first line of defense and a bridge between
the innate and adaptive immunity (Ochsenbein and Zinkernagel, 2000), thus AFB1 is able
to suppress a broad spectrum of immune functions, partially attributed to its hepatotoxicity.
On the other hand, the elevation in serum ALP and GGT concentrations by AFB 1 herein
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suggest liver cellular damage, consistent with the reports by others (Gowda et al., 2008;
Manning and Wyatt., 1999; Fernandez et al., 1994). Consistently, the liver lesion score was
also significantly increased by AFB1 in the current study, suggesting damage including
inflammation and swelling of these cells. A major cause for the cellular damage is often
the induced oxidative stress in hepatic cells upon AF exposure, leading to an increase in
lipid peroxidation and thus cell membrane damage. Previous reports have revealed
negative effects of AFB1 on the hepatic antioxidant enzyme activities, including SOD,
catalase, and glutathione-S-trasnferase, in broilers (Eraslan et al., 2004; Shi et al., 2006;
Rastogi et al., 2001). However, in the current study, the liver antioxidant status was not
affected by AFB1, nor was the liver SOD mRNA expression in ducklings. A possible
explanation is the species difference. Within the literature, no significant effect of AFB1
on antioxidant functions is reported in ducks, but exact mechanisms are still unknown.
Further, in this study, the liver mRNA expression of SOD, EH, CTP1A, MDH2, PPARα,
and IFNγ were determined. These genes encode major proteins that cover liver antioxidant
capacity, energy metabolism, metabolism of AFB1, carbohydrate and lipid metabolism, and
immune response. No significant effects were observed by AFB1 on the genes measured
herein, which is partially consistent with the unaffected mRNA expression by 0.1 to 0.3
mg/kg AFB1 in 14 d ducklings (Chen et al., 2014a), with the exception of PPARα, which
was decreased by AFB1 in the prior study. Prior studies on how AFB1 modulates liver gene
expression are rare, but generally significant changes in hepatic genes may be seen by 1 to
1.8 mg/kg AFB1 in broilers (Meissonnier et al., 2008; Yarru et al., 2009). Thus, it is
possible that higher AFB1 concentrations may induce changes in a wider array of genes.
However, the high sensitivity of ducklings to low AFB1 concentrations indicate that the
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primary damage of AFB1 in ducklings is through an inhibition of feed intake. Therefore,
approaches to prevent aflatoxicosis in ducklings should focus on reducing AFB1 exposure
before intestinal absorption by the animal.
The efficacy of HSCAS to ameliorate aflatoxicosis has been extensively studied in
broilers. The majority of the in vivo evaluation of HSCAS in chicks and turkeys indicate
that at an inclusion rate of 0.25 to 0.50%, improved performance and serum measures, as
well as reduced relative organ weights can be achieved compared to birds exposed to AF
only (Kubena et al., 1990, 1993, 1998; Phillips et al., 1988). However, evaluation of
HSCAS in ducks, has been limited compared to those in broilers. Herein, inclusion of 0.05%
HSCAS improved BW gain and feed intake of 14 d ducks fed 0.2 mg/kg AFB 1 to control
levels, but did not improve their 0-20 d growth performance. The latter may indicate that
while older birds became more resistant to AFB1, reducing AFB1 absorption by HSCAS
may be less influential on the birds’ performance. Supplementation with HSCAS also
improved a few serum measures (Ca, ALT and GGT) and serum complement activity (Rb
L100 and L50 values), suggesting that HSCAS can partially ameliorate the liver cell
damage in ducks during aflatoxicosis. However, there was a lack of effectiveness of
HSCAS in improving the majority of the serum measures as well as the liver lesions.
Compared to previous studies, the inclusion rate of HSCAS was quite low in the current
study (0.05 compared to 0.25-0.5%), therefore, increasing the inclusion rate may lead to a
greater protective role of HSCAS. For instance, Khajarern et al. (1990) found that when
HSCAS was included at 0.25% or 0.5%, reduced morality, relative liver weight, and liver
lesions were found in ducks fed up to 0.12 mg/kg AFB1. Interestingly, HSCAS increased
liver SOD activity and the total anti-oxidant activity. Using the same source of HSCAS,

144
similar improvements in anti-oxidant functions were found in broilers (Chen et al., 2014b).
These observations indicate that this particular HSCAS may stimulate the anti-oxidant
functions of both broilers and ducks, which allows a better ability to relieve the oxidative
stress during aflatoxicosis. Whether this is a direct effect on the liver or indirect result from
reduced AFB1 absorption awaits further verification. Collectively, results of this study
reiterated the high sensitivity of young ducklings to low AFB1 concentration, but they may
become more resistant after 14 d of age; while supplementing 0.05% HSCAS may have
partial, but not total, protective role against aflatoxicosis in Pekin ducklings.
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Table 4.1. Ingredient composition and calculated analysis of basal diet 1.
Ingredient

Composition (%)

Corn

54.49

Soybean meal

36.50

Soybean oil

3.75

Mono-calcium phosphate

1.70

Limestone

1.90

NaCl

0.47

L-lysine HCl

0.30

DL-methionine

0.32

L-threonine

0.12

Vitamin-mineral premix2

0.35

Corn starch

0.10

Calculated analysis

1

ME, Kcal/kg

3,147

CP, %

22.53

Lysine, %

1.46

Thr, %

0.96

Met, %

0.66

Met+Cys, %

1.13

Ca, %

1.17

Non-phytate P, %

0.49

Three premixes, contributing 0.4% of the final diets, were prepared with 82.4% corn or
cultured AFB1 with or without 12.26% HSCAS in corn starch, and then blended with the
basal diet to create the 3 dietary treatments. .
2 Provided per kg of diet: iron from ferrous sulfate, 50.1 mg; copper from copper sulfate,
7.7 mg; manganese from manganese oxide, 125.1 mg; zinc from zinc oxide, 125.1 mg;
iodine from ethylene diamine dihydroidide, 2.1 mg; selenium from sodium selenite, 0.25
mg; vitamin A (retinyl acetate), 13,233 IU; vitamin D3 (cholecalciferol), 6636 IU; vitamin
E (DL-α-tocopheryl acetate) 44.1 IU; vitamin K activity, 4.5 mg; thiamine, 2.21 mg;
riboflavin, 6.6 mg; pantothenic acid, 24.3 mg; niacin, 88.2 mg; pyridoxine, 3.31 mg; folic
acid, 1.10 mg; biotin, 0.33 mg; vitamin B12, 24.8 μg; choline, 669.8 mg.
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Table 4.2. Primer sequences (5’ → 3’) used in real-time PCR.
Gene1

Forward primer

Reverse primer

GAPDH

ATGTTCGTGATGGGTGTGAA

CTGTCTTCGTGTGTGGCTGT

SOD

GGCGTCATCCACTTCCAG

AGCAGTCACGTTGCCGAGGTC

EH

AAAGGGACAGAAGCCTGACA

CCTCCAGTGGCTCAGTGAAT

CPT1A

TGAACACGGCAAACTTTCTG

ATTCATAAGTGGCCGGACTG

MDH2

CTCTACACCTCTGCTACTG

GGGTGATCTTGCCAATGCCTA

IFN-γ

CAAGTAATTCGGATG TAGC

GCGTTGGATTTTCAA GCC

PPARα

GCCTTTCAGTTGGAATGTCACATA CTGCCTTCAACTTGGCCTTCT

1GAPDH

= glyceraldehyde 3-phosphate dehydrogenase; SOD = superixode dismutase;

EH = epoxide hydrolase; CPT1A = carnitine palmitoyltransferase 1 A; MDH2 = malate
dehydrogenase 2; IFN- γ = interferon gamma; PPARα = peroxisome proliferatoractivated receptor-α

Table 4.3. Cumulative performance and relative liver weights of 20-d ducks fed a control, negative control (NC, 0.2 mg/kg
AFB1), or NC+ 0.05% hydrated sodium calcium aluminosilicate (HSCAS) diet. 1

Dietary treatment
Control
NC
NC + HSCAS
SEM
P-value
1

Feed intake
(g/chick)
1449
1285
1342
79.68
0.36

BW gain
(g/chick)
905
897
885
43.50
0.95

Gain : Feed Ratio
(g/g)
0.62
0.67
0.66
0.023
0.29

Relative liver
weight
(% BW)
3.10
3.65
3.63
0.22
0.16

Means represent 6 pens per treatment, 5 birds per pen. AFB1 = aflatoxin B1.
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Table 4.4. Periodic performance of ducklings fed a control, negative control (NC, 0.2 mg/kg AFB1), or NC+ 0.05% hydrated
sodium calcium aluminosilicate (HSCAS) diet. 1

BW gain (g/duck)
7-14 d 0-14 d
378 a
557 a
334 b
496 b

Feed Intake (g/duck)
0-7 d
7-14 d 0-14 d
228
570
798 a
201
477
642 b

Dietary
treatment
Control
NC

0-7 d
179
152

NC + HSCAS

166

350 ab

516 ab

370

172

537

SEM

6.5

13.7

17.3

34.4

27.4

P-value

0.19

0.106

0.071

0.65

0.38

14-20 d
349
395

Gain: feed ratio (g/g)
7-14 d 0-14 d 14-20 d
0.68
0.70
0.53
0.69
0.73
0.60

14-20 d
651
644

0-7 d
0.88
0.84

709 ab

637

0.97

0.65

0.73

0.66

32.1

40.6

64.2

0.086

0.042

0.030

0.075

0.15

0.048

0.99

0.53

0.84

0.65

0.50

a-c
1

Means with different superscripts in a column differ significantly (P < 0.05).
Means represent 6 cages per treatment, 5 birds per pen.
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Table 4.5. Serum profile of 20-d ducks fed a control, negative control (NC, 0.2 mg/kg AFB1), or NC + 0.05% hydrated sodium calcium
aluminosilicate (HSCAS) diet. 1, 2
Dietary
treatment
Control
NC
NC+HSCA
S

Glu
mg/dL
248 a
187 b

Urea N
mg/dL
3.08
3.25

CREAT
mg/dL
0.083 a
0.048 b

Na
mEq/L
148.6
150.1

K
mEq/L
8.48
8.12

Cl
mEq/L
108
109.67

CO2
mEq/L
26.92
27

Alb
g/dL
1.26 a
0.53 b

TP
g/dL
3.10 a
1.74 b

205 b

3.42

0.060 b

147.4

8.73

109.08

25.33

0.64 b

1.98 b

SEM
P-value
Dietary
treatment
Control
NC
NC+HSCA
S

6.7
<0.0001
Globulin 3
g/dL
1.88 a
1.21 b

0.18
0.43
Ca
mg/dL
11.94 a
10.80 b

0.005
0.0005
P
mg/dL
13.08
12.74

0.98
0.19
ALT
U/L
34.9 b
46.8 a

0.40
0.56
ALP
U/L
746.3
824.1

0.79
0.34
AST
U/L
71.6 b
75.2 b

0.75
0.24
GGT
U/L
3.08 b
4.08 a

0.04
<0.0001
CPK
U/L
4252
3164

0.09
<0.0001
Uric Acid
mg/dL
6.03
6.04

1.36 b

11.34 ab

12.7

40.8 ab

724.3

97.8 a

3.50 b

3863

5.83

0.05
<0.0001

0.33
0.08

0.75
0.93

2.2
0.0093

46.9
0.20

7.44
0.05

0.15
0.0008

424.1
0.22

0.89
0.96

SEM
P-value
a-c

Means with different superscripts in a column differ significantly (P < 0.05).
Means represent 6 cages per treatment, 2 birds per pen.
2
CREAT = creatinine, ALT = alanine transaminase, AST= Aspartate transaminase, ALP= Alkaline phosphatase,
GGT= Gamma glutamyl transpeptidase, CPK=Creatine phosphokinase.
3
Calculated from as total protein minus albumin.
1
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Table 4.6. Liver antioxidant enzyme activity of 20-d ducks fed a control, negative control (NC, 0.15 mg/kg AFB1), or NC+ 0.05%
hydrated sodium calcium aluminosilicate (HSCAS) diet. 1

Dietary treatment
Control
NC
NC+HSCAS

Total Anti-Oxidant
Capacity
(mol/mg protein)
2.02 b
2.39 ab
3.07 a

Aqueous Peroxide
(nmole/mg protein)
9.23 b
9.64 b
13.25 a

Organic Peroxide
(nmole/mg protein)
5.53 b
7.44 b
10.46 a

SEM
0.23
0.89
0.80
P-value
0.031
0.022
0.005
a-b
Means with different superscripts in a column differ significantly (P < 0.05).
1
Means represent 8 pens per treatment, 1 bird per pen, AFB1 = aflatoxin B1
2
One unit of activity is the amount of enzyme that inhibits the rate of superoxide formation reaction by 100%

SOD 2
(U/mg protein)
9.23 b
9.64 b
13.25 a
0.89
0.022
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Table 4.7. Liver lesion score from 20-d ducks fed a control, negative control (NC, 0.2 mg/kg AFB1), or NC+ 0.05% hydrated sodium
calcium aluminosilicate (HSCAS) diet. 1,2,3,4
Dietary treatment

Biliary
hyperplasia

Architecture

Inflammation

Fibrosis

Cholestasis

Swelling

1.17

0.50 b

0.17 b

0.33

0.00

0.00 b

0.36

2.17

1.67

ab

1.50 a

1.00

0.17

1.67 a

1.36 a

1.17

1.67 ab

1.17 a

0.83

0.50

1.50 a

1.14 a

0.45

0.47

0.32

0.40

0.22

0.26

0.22

0.22
0.13
0.022
0.47
0.30
0.005
Means with different superscripts in a column differ significantly (P < 0.05).
1
Means represent 6 pens per treatment, 1 bird per pen.
2
Total = sum of biliary hyperplasia, architecture, inflammation, fibrosis, cholestasis, and swelling.
3
Scoring is based on a 0-3 scale: 0=no lesion, 1=mild lesion, 2=moderate lesion, 3=severe
lesion.
4
Data were analyzed using the NPAR1WAY procedure in SAS, means were separated using the GLM procedure in SAS.

0.02

Total 2

Control
b

NC
NC + HSCAS

SEM
P-value
a-b
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Table 4.8. Natural antibody and serum complement profile of 20-d ducks fed a control, negative control (NC, 0.2 mg/kg AFB1), or NC+
0.05% hydrated sodium calcium aluminosilicate (HSCAS) diet. 1, 2, 3, 4, 5, 6,7
Ho
Ho
Ho
HuO HuO
Rb
Rb
Ho
Ho
HA4 HuO HuO
Rb
Rb
Dietary treatment
L100 L50 L100 L50 L100 L50
HA1 HA2
5
HA1 HA2 HA1 HA2
Control

0.67

3.67

2.17

3.83 a

3.17 a

4.50 a

0.00

2.50

4.17

2.00

5.83

5.17

8.00

Negative Control

0.50

2.83

1.67

0.00

2.00

3.83

1.67

5.83

5.17

8.33

NC + HSCAS

0.83

2.83

1.83

2.83 b 2.00 b 3.17 b
2.50
ab
3.00 b
3.63 a

0.50

2.33

4.83

1.67

5.50

5.00

8.50

SEM

0.18

0.25

0.34

1.44

0.02

0.02

0.25

2.91

0.03

0.26

7.47

0.00

0.00

P-value

0.54

0.34

0.17

0.003

0.006

0.001

0.39

1.000

0.50

0.50

0.37

0.62

0.62

a-b

Means with different superscripts in a column differ significantly (P < 0.05)
Means represent 6 pens per treatment, 2 birds per pen.
2
Rb and HuO were tested using 1% erythrocyte suspensions and 0.5% for Ho.
3
Parameters: = log2 dilutions, representing end point titers; i.e. 3 = 1:8 dilution of serum etc.
4
HA1 = strong agglutination ~IgM, HA2 = weak agglutination ~IgY, HA45 = very weak agglutination ~ IgY.
5
L100 = complete lysis and L50 incomplete lysis titers, representing the Alternate and Classic lytic pathways respectively.
6
Hb scores = serum coloration due to lysis; 0 = no lysis, etc.
7
P-value and SEM are based on Box-Cox transformed data.
1
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Table 4.9. Liver gene expression of 20-d ducks fed a control, negative control (NC, 0.2
mg/kg AFB1), or NC+ 0.05% hydrated sodium calcium aluminosilicate (HSCAS) diet. 1, 3
SOD

EH2

CPT1A2

MDH2

PPARα

IFNɣ

Control

1.10

2.17

1.14

1.01

1.81

0.87 b

Negative control

1.41

3.27

1.28

1.52

0.87

0.73 b

NC + aflatoxin B1

1.49

0.63

1.32

2.94

1.67

2.65 a

SEM

0.29

0.44

0.22

0.74

0.33

0.28

P-value

0.61

0.27

0.74

0.37

0.16

0.0024

Dietary treatment

a-b means

with different superscripts in a column differ significantly (P < 0.05).
represent 6 cages per treatment, 1 birds per pen.
2 P-value and SEM are based on log transformed data.
3 SOD = superoxide dismutase; EH = epoxide hydrolase; CPT1A = Carnitine
palmitoyl transferase 1A; MDH2 = malate dehydrogenase 2, PPAR-α = Peroxisome
proliferator-activated receptor alpha; IFN- ɣ = Interferon gamma.
1 means
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CHAPTER 5. INTERACTIVE EFFECTS OF DIETARY PROTEIN
CONCENTRATION AND AFLATOXIN B1 ON PERFORMANCE, NUTRIENT
DGESTIBILITY, AND GUT HEALTH IN BROILER CHICKS

5.1

Abstract

A 20-d trial was conducted to determine the impact of aflatoxin B1 (AFB1) and dietary
protein concentration on performance, nutrient digestibility, and gut health in broiler chicks.
The 6 dietary treatments were arranged in a 2 x 3 factorial with 3 crude protein (CP)
concentrations (18, 22, and 26%) with or without 1.5 mg/kg AFB1. Each diet was fed to 6
replicate cages (6 chicks per cage) from 0 to 20 d of age. Endogenous N and amino acid
loss were estimated from birds fed a N-free diet with or without 1.5 mg/kg AFB1. A
significant interaction between AFB1 and CP concentration was observed for growth
performance, where reduction of BW gain, feed intake, gain:feed ratio, and breast muscle
weight by AFB1 were most profound in birds fed the 18%-CP diet, and were completely
eliminated when birds were fed 26% CP diet (AFB1 by CP interaction; P ≤ 0.023).
Similarly, AFB1 reduced serum albumin, total protein, and globulin concentrations in birds
fed 16 and 22% CP diets, but not in those fed 26% CP (AFB1 by CP interaction; P ≤ 0.071).
Gut permeability was increased in birds fed AFB1-contaminated diets as measured by
serum lactulose/rhamnose ratio (main effect; P = 0.04). Additionally, AFB1 tended to
increase endogenous N loss (P = 0.09), and significantly reduced apparent ileal digestible
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energy and standardized ileal N and amino acid digestibility in birds fed 18% CP diet,
while birds fed higher dietary CP were not affected (AFB1 by CP interaction; P ≤ 0.01).
Further, AFB1 increased the translation initiation factor 4E-binding protein (4EBP1),
claudin1, and multiple jejunal amino acid transporters expression (main effect; P ≤ 0.04).
Results from this study indicate that 1.5 mg AFB1/kg diet significantly impairs growth,
major serum biochemistry measures, gut barrier, endogenous loss, and energy and amino
acid digestibility. Aflatoxicosis can be augmented by low dietary CP, while higher dietary
CP completely eliminated the impairment of performance, serum proteins, and nutrient
digestibility from aflatoxicosis in 0-20 d broiler chicks.

5.2

Introduction

Aflatoxins (AF) are secondary metabolites of Aspergillus species, with aflatoxin B1
(AFB1) being the most toxigenic AF subgroup (Yunus et al., 2011). As an active
hepatocarcinogen, the hepatic toxicity effects, cellular mechanism, and performance
responses of AFB1 have been extensively studied in poultry species (Ledoux et al., 1999;
Yarru et al., 2009; Andretta et al., 2011; Chen et al., 2014a, b). The biotransformation of
AFB1 to its toxic form aflatoxin B1-8, 9-epoxide (AFBO) occurs primarily in the liver, but
a recent study revealed that this activation also takes place in the intestinal tract (Sergent
et al., 2008). Intestinal epithelium cells are the first cells to be exposed to and to interact
with ingested aflatoxins, and often at higher concentrations than other tissues. In addition,
because AFBO is a potent inhibitor of protein synthesis through its interaction with DNA
and RNA, the rapidly dividing intestinal enterocytes with high protein turnover can become
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a major target (Grenier and Applegate, 2013). However, studies focusing on AF effects on
the gut has been extremely limited in livestock species. There is a close association between
performance and intestinal health and functions, therefore it is important to elucidate how
AFB1 modulates these processes including enterocyte integrity, endogenous nutrient loss,
nutrient digestion and/or absorption, or other intestinal functions.
As the first barrier against ingested contaminants, the intestinal barrier, formed
primarily by the tight junction complex, seals the luminal end of the intercellular space and
limits molecular transport through this paracellular route (Anderson and Van Itallie, 1995).
Multiple isoforms of the claudin family are the key components of tight junctions and major
determinants of paracellular characteristics. Alteration in claudin expression and activity
can lead to impairment of the tight junction network, and consequently increase
permeability and allow higher translocation of luminal antigens. Previous in vitro studies
showed that exposure of CaCo-2 cells to deoxynivalenol and ochratoxin A resulted in
impaired intestinal barrier and decreased claudin expression (McLaughlin et al., 2004;
Pinton et al., 2009). Similarly, Gratz et al. (2007) found that AFB1 impaired the integrity
of CaCo-2 cells by measuring transepithelial resistance. However, very limited information
is available on how AFB1 affects claudin and other tight junction proteins, and more animal
studies are necessary considering most of the previous data were from in vitro studies.
Additionally, measuring the gut-permeability in vivo would allow a more direct
observation of how AF affects the intestinal barrier. One approach for such purpose is the
utilization of dual sugar gut-permeability testing (Katouzian et al., 2005), which has been
extensively used in human and companion animals for clinical diagnosis.
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Mycotoxin-induced disturbance of digestive enzyme and nutrient transporters may
lead to intestinal disorders, resulting in alteration of nutrient digestibility and growth of
animals. Previous research has drawn contradictory conclusions on nutrient digestibility
and enzyme activities in poultry during AFB1 challenge (Han et al., 2008; Applegate et al.,
2009; Lessard et al., 2009; Matur et al., 2010). These changes in enzyme activity may
reflect changes in intestinal villi morphology, as the upper half of the villus express
considerably more sucrase and maltase activity than the lower half (Uni et al., 1998). To
date, studies focusing on the effects of AFB1 on absorptive processes are rare; no reports
are available on the changes in nutrient transporters upon AFB1 exposure in poultry.
Therefore, there is a lack of consensus on how AFB1 affects nutrient digestion and
absorption in poultry and the mechanisms behind it. On the other hand, accurate estimation
of protein and amino acid digestibility requires the correction for endogenous losses; the
latter include gastric, pancreatic, and biliary secretions, sloughed intestinal cells, and
mucosal cells. This endogenous loss might be altered with changes in health conditions
induced by AFB1, yet literature addressing this matter is currently unavailable. Evaluating
the influence of AFB1 on endogenous amino acid loss will provide a more accurate
estimation of nutrient digestibility during aflatoxicosis, and will allow a better
understanding of its effects on intestinal health.
In all the structural units and biological processes in the intestinal tract and other body
parts, the participation of various proteins is inevitable. It is well-known that a major
mechanism of AFB1 to impair animal health is through its inhibitory effect of protein
synthesis (Sporn et al., 1966; Garvican et al., 1973). Whether or not raising dietary protein
concentration can attenuate the harm from inhibited protein synthesis during aflatoxicosis
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is of great interest. Previous studies related to this question were mostly out of date
(Newbern et al., 1966; Adekunle et al., 1977), and only supplementation of certain
individual amino acids were considered instead of crude protein. Therefore, for the current
study, our objectives were to explore the influence of AFB1 on intestinal functions, and to
determine the interactive effects of dietary crude protein concentration and AFB1 exposure
in broilers.

5.3
5.3.1

Materials and Methods

Experimental Birds and Diets
The animal care and use protocol was reviewed and approved by the Purdue

University Animal Care and Use Committee. A total of 288 male broiler chicks (Ross 708)
were obtained from a commercial hatchery, weighed, and randomly allotted to 8 treatments,
6 replicate cages per treatment, and 6 chicks per cage. All chicks were housed in battery
cages in an environmental controlled room and fed to 20 d of age. Feed and water were
provided ad libitum. Mortality was recorded as it occurred, and birds were inspected daily
for any health-related problems.
The corn-soybean meal based basal diet was formulated to meet or exceed the
nutritional requirements of broilers from hatch to 20 days (Table 5.1). The 6 dietary
treatments were arranged in a 2 x 3 factorial with 2 aflatoxin concentrations (0 and 1.5
mg/kg) and 3 crude protein concentration (18, 22, and 26% for low-, med-, and high CP
diet, respectively, on a calculated basis). The cultured aflatoxin, produced using
Aspergillus parasiticus (NRRL 2999) (Gowda et al., 2008) on ground corn, was obtained
from the University of Missouri with a concentration of 50 mg AFB1/kg. Eight premixes,
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contributing 4.0% of the final diets by weight were prepared with or without 75% of 50 mg
AFB1/kg ground corn, and then blended with the basal diets to create the 6 treatment diets,
respectively. All diets were formulated to be isocaloric, and the amino acid to crude protein
ratios were kept constant for all treatment diets. To estimate endogenous nutrient loss, 72
birds (6 replicate pens per diet and 6 birds per pen) were fed the med-CP diets with or
without 1.5 mg/kg AFB1 from d 0 to 15, and were changed to nitrogen free diets (NFD)
with or without AFB1, respectively, from d 16 to 20.
All diet and ileal samples were analyzed for N (method 990.03; AOAC
International, 2000) using a Leco model FP 2000 N combustion analyzer (Leco Corp., St.
Joseph, MI), gross energy using a Parr adiabatic bomb calorimeter (Parr Instruments Co.,
Moline, IL), dry matter (method 934.01; AOAC International, 2006), and chromium
(method 990.08; AOAC International, 2000). Amino acid profile (method 982.30; AOAC
International, 2006) was determined at the University of Missouri Experiment Station Field
Laboratory (Columbia, MO). The analyzed CP concentrations for the low-, med-, and highCP diets were 16, 21, and 25%, respectively. The aflatoxin concentrations of all diets,
including AFB1, AFB2, AFG1, and AFG2, were analyzed by HPLC at Romer labs (Union,
MO). The analyzed concentrations of AFB1 were ≤ 4.3 μg/kg) for all AF-free diets and
1.84 mg/kg for AF-containing diets. The AFB2 was ≤ 56 μg/kg, and AFG2 was ≤ 22 μg/kg
for all treatments. Dietary AFG1 concentrations were approximately 33% of AFB1
concentrations for the 4 dietary treatments with added aflatoxin, and ≤ 0.8 μg/kg for the
AF-free diets.
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5.3.2

Sample Collection

Body weight and feed intake were measured on d 7, 14, and 20. Average feed intake
(FI), body weight gain (BWG), and gain to feed ratio (G: F) were calculated and were
corrected for mortality. On d 20, all birds were euthanized by CO2 inhalation, and the lower
2/3 ileal digesta were collected by flushing with R.O. (reverse osmosis) water for N, energy,
dry matter, Cr, and amino acid determination. Breast muscle weights were determined from
2 birds per pen, and relative breast muscle weights were calculated as % BW. Serum
samples were collected from 2 birds per pen for serum biochemistry analysis. From 1 bird
per pen, a section of mid-jejunum was collected and stored in 10% neutral buffered
formalin for villi histology analysis. Another piece of mid-jejunum was collected and
preserved in RNAlater (Ambion, Austin, TX) at -80⁰C for quantitative real-time PCR
analysis. In addition, pancreas and small intestine mucosa were collected from 1 bird per
pen for determining digestive enzyme activities.

5.3.3

Dual Sugar Permeability Test

The dual-sugar gut permeability test was performed on d 20 prior to sample collection
as described by Katouzian et al. (2005). Briefly, one bird from each pen was randomly
chosen and given a non-metabolizable sugar solution of 1 mL (0.25 g/mL lactulose and
0.05 g/mL L-rhamnose dissolved in ddH2O) by oral gavage, and blood was collected after
1 h of gavage, centrifuged at 1,400 x g at 4 ⁰C for 15 min for serum separation. Serum
concentration of lactulose and l-rhamnose were then determined by GCxGC/MS after a 2step derivatization (LECO Pegasus 4D GCxGC-TOF, St. Joseph, MI). The L/R ratio was

166
calculated as the concentrations of serum lactulose (in mmol/l) divided by the
concentrations of serum l-rhamnose (in mmol/l).

5.3.4

Sample Biochemistry

Blood was collected from 1 bird per cage via jugular vein after euthanasia for serum
biochemistry analysis. Collected blood was centrifuged at 1,400 x g at 4 ⁰C for 15 min for
serum separation, and the serum was preserved at –20 ⁰C until submitted for biochemical
analysis. All serum samples were analyzed for albumin, globulin, total protein, glucose,
Ca, P, aspartate amino transferase (AST), γ-glutamyl transferase (GGT), and uric acid at
the Veterinary Medical Diagnostic Laboratory of University of Missouri (Columbus, MO)
using an auto-analyzer (Kodak Ektachem Analyzer, Eastman Kodak Co., Rochester, NY).

5.3.5

Digestive Enzyme Activity

Collected pancreas and small intestine mucosa were dissolved in PBS, respectively, to
a concentration of 0.2 g/ml. The mixture was then homogenized, centrifuged at 1,400 x g
at 4⁰C for 15 min, and the clear supernatant was separated for subsequent enzyme activity
analysis. For pancreatic samples, the concentration of total protein (Thermo Scientific kit
23200, Rockford, IL), amylase (Sigma kit MAK009), lipase (Sigma kit MAK046), and
trypsin (BioVision kit K771) were determined according to manufacturer instructions. For
mucosal samples, the activity of sucrase and maltase were determined as described by Sell
et al. (1991). One unit of sucrase activity is defined as the amount of enzyme that cleaves
sucrose to generate 1.0 μmol of glucose per mg of protein at 37 ⁰C. One unit of maltase
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activity is defined as the amount of enzyme that cleaves maltose to generate 1.0 μmol of
glucose per mg of protein at 37 ⁰C.

5.3.6

Jejunal Villi Histology

The jejunal samples were fixed in 10% neutral buffered formalin, processed by
standard paraffin sectioning, and stained with hematoxylin-eosin. The slides were
examined under a light microscope. Measurements of villus height were taken from the top
of villus to the valley between villus, and measurements of crypt depth were taken from
the valley to the basolateral membrane. The villus height: crypt depth ratios (VH:CD) were
calculated. Reported values were means of 10 villi from each bird, 6 birds per treatment.

5.3.7

Jejunal Gene Expression

The jejunal mRNA expression of mTOR pathway (mTOR, 4EBP1, S6K1), intestinal
tight junctions (Claudin 1 and Claudin 2), and small intestinal nutrient transporters (SGLT1,
GLUT2, NaPiIIb, b0,+AT, EAAT3, PepT1, rBAT, yLAT1, and yLAT2) were determined
using quantitative real-time PCR (MyiQ real-time PCR detection system, Bio-Rad,
Hercules, CA, USA) with SYBR mix (Bio-Rad, Hercules, CA, USA). Briefly, total RNA
was extracted using TRIzol® (Invitrogen, Carlsbad, CA, USA) and was quantified at an
absorbance of 260 nm (ND-1000, Nanodrop Technologies Inc., Wilmington, DE). Reverse
transcription was carried out using the M-MLV reverse transcriptase (Promega, Madison,
WI, USA). Water was used as the negative control. All reactions were analyzed in duplicate
and formation of a single PCR product cwas confirmed by melting curves. The mRNA
expression was determined from the threshold cycle (Ct) for respective genes and
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normalized using 18S ribosomal RNA (18SrRNA) within each sample. The primer
sequences used were based on previous reports (Deng et al., 2014; Gilbert et al., 2007)
(Table. 5.2), and descriptions of gene function are shown in Table 5.2.

5.3.8

Statistical Analysis
All data were analyzed as 2-way ANOVA using SAS (SAS 9.4, Cary, NC) for a

completely randomized design. The model included main effects of aflatoxin concentration,
crude protein concentration, and their interaction. Pen was used as the experimental unit
for all data. The means showing significant (P ≤ 0.05) and trending (0.05 < P ≤ 0.10)
treatment differences were then compared using least significant difference procedure. All
data were tested for normality using the UNIVARIATE procedure and common variance
using the GLM procedure. The non-normal gene-expression data were transformed using
the optimal Box-Cox transformation.

5.4
5.4.1

Results

Growth Performance
Mortality was low throughout the study, and was 2 and 4% from low- and med- CP

treatments, respectively, during aflatoxicosis; and 0% from other dietary treatments.
The cumulative performance and breast muscle weight are shown in Table 5.3. A
significant interaction between aflatoxin and dietary protein concentration was observed
for all measures (P ≤ 0.02) except for relative breast muscle weight. Performance reduction
by AFB1 was most profound in birds fed low dietary CP, and was completely eliminated
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when fed high dietary CP (Figure 5.1). The numerical reduction from aflatoxicosis for
BWG was 31, 10, and 1% for birds fed low-, med-, and high-CP diets, respectively. This
indicates that higher crude protein can help attenuate the loss of muscle production and
body weight grain for birds during aflatoxicosis via improved feed efficiency.
The weekly performance followed a similar trend (Table 5.4). Dietary AFB1 started
to depress BWG, FI, and gain:feed ratio in birds fed low-CP diet from wk 2, and continued
to reduce BWG in those fed med-CP diet in wk 3. Birds fed high-CP diet were not affected
by AFB1 at any time (AF by CP interaction; P ≤ 0.03).

5.4.2

Serum Biochemistry

The serum biochemistry results are shown in Table 5.5. Aflatoxin at 1.5 mg/kg
reduced serum albumin, total protein, and globulin in birds fed low- and med-CP diets,
suggesting impaired protein synthesis of the birds, while serum protein concentrations in
birds fed high-CP diet were not affected by AFB1 (AF by CP interaction; P ≤ 0.007). No
interaction was observed for other serum measures, but AFB1 showed a main effect to
reduce serum calcium concentration (P = 0.003) while higher CP concentration increased
serum AST concentration (main effect; P = 0.002). Serum uric acid concentration was also
increased by higher dietary protein (7.41, 9.77, and 10.75 mg/dL for low-, med-, and highCP groups, respectively; P = 0.046), which may be the result of higher protein intake and
subsequent increased protein turnover.
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5.4.3

Jejunal Villi Histology
The jejunum histology results are shown in Table 5.6. No significant interaction

was observed for villus height (VH), crypt depth (CD), or VH:CD ratio. The crypt depth
from birds fed AFB1-contaminated diets were numerically lower compared to control birds
(122 versus 135 μm in birds fed 1.5 and 0 mg/kg AFB1, respectively; P = 0.09). Higher
dietary protein showed a main effect of increasing villus height (P =0.003), indicating a
better absorptive ability of the birds fed high CP regardless of aflatoxin contamination. The
VH:CD ratio was not affected by AFB1 or CP concentration.

5.4.4

Digestive Enzyme Activity
The digestive enzyme activity results are shown in Table 5.7. Significant

interactive effect of AFB1 and CP concentration was observed for mucosal sucrase and
maltase (P ≤ 0.05), with birds fed high dietary protein during aflatoxicosis showing the
highest activity. A similar trend was observed for lipase activity (P = 0.058), while amylase
and trypsin activities were not affected by dietary treatments (P ≥ 0.22).

5.4.5

Gut Permeability
Lactulose (L) and L-Rhamnose (R) are the most common probes to assess intestinal

translocation in humans and animals. Because lactulose is absorbed via the paracellular
pathway when tight junctions are impaired and rhamnose is absorbed transcellularly in the
small intestine, an increase in blood L:R ratio is an indication of increased gut permeability.
No interaction was found for serum L:R ratio, but AFB1 showed a significant main effect
of increasing the L:R ratio (P = 0.0423, Table 5.8), indicating impaired intestinal barrier
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of birds that were fed AFB1-contaminated diets. The L/R ratio was numerically lower when
birds were fed higher dietary CP during aflatoxicosis (L: R ratio was 0.19, 0.13, 0.06 for
low-, med-, high- CP treatment, respectively). Meanwhile, a trending interaction between
CP concentration and AFB1 was observed for serum lactulose (P = 0.10), with birds fed
the low-CP diet showed the highest lactulose concentration during aflatoxicosis.

5.4.6

Nutrient Digestibility
Ileal endogenous N and amino acid loss were estimated using birds fed N-free diets

with or without AFB1, and results showed that dietary AFB1 had a trend of increasing
endogenous N loss (P = 0.09) (Table 5.9). Although there was no significant difference in
endogenous amino acid losses between the 2 treatments, amino acid losses from the AFB1treated birds were all numerically higher than those of control birds by approximately 2030%. Using the endogenous loss values obtained herein, the standardized ileal N and amino
acid digestibility results were calculated (Table 5.10). A significant interactive effect of
AFB1 and CP concentration was observed for standardized N digestibility (P = 0.0001),
where the digestibility reduction by AFB1 was augmented in birds fed low-CP diet, and
was eliminated when fed higher dietary CP. Similar interactions were observed for all
amino acids with few exceptions, where AFB1 reduced the standardized ileal digestibility
in birds fed low-CP diet without affecting those fed higher dietary CP (AF by CP
interaction; P ≤ 0.008). In addition, apparent ileal digestible energy (kcal/kg DM intake)
was significantly reduced by AFB1 in birds fed low-CP diet, but not in the birds fed medor high-CP diets (AF by CP interaction; P < 0.0001).
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5.4.7

Jejunal Gene Expression
The jejunal gene expression results are shown in Table 5.11. The mRNA

expression of mTOR pathway (mTOR, 4EBP1, S6K1), intestinal tight junctions (Claudin
1 and Claudin 2), and small intestinal nutrient transporters (SGLT1, GLUT2, NaPiIIb,
b0,+AT, EAAT3, PepT1, rBAT, yLAT1, and yLAT2) were determined (descriptions of
genes are shown in Table 5.2). No significant interactions were observed for any genes
measured, but diet AFB1 showed a significant main effect of upregulating 4EBP1
expression (P = 0.03). Similarly, AFB1 increased the expression of Claudin 1 (P = 0.04)
and Claudin 2 (P = 0.06). In addition, AFB1 did not have any effect on the sugar
transporters (SGLT1, GLUT2; P ≥ 0.18), but significantly increased the expression of
oligopeptide transporter (PepT1; P = 0.033) and amino acid transporters (EAAT3, rBAT,
yLAT1, and yLAT2; P ≤ 0.04). Expression of the genes measured were not affected by
dietary CP concentration (P ≥ 0.18).

5.5

Discussion

Mycotoxin contamination in animal feeds has been an existing problem for decades,
but due to the great adaptability of these fungi species, it is becoming an increasingly
prevalent and serious risk to the livestock industry worldwide (Grenier and Applegate,
2013). According to a long term worldwide mycotoxin survey, the percentage of aflatoxinpositive samples increased from 16% (2005) to 33% (2009) globally. In Asia, the average
contamination of AF in corn rose from 45 μg/kg (2005) to 183 μg/kg (2009), and
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continuous increase is possible considering the impacts of global climate change which
favors AF production (Streit et al., 2013). Therefore, understanding the effects and
mechanisms of the major agriculture-relevant mycotoxins in livestock animals is necessary
in order to develop effective counteractive strategies. A healthy gastrointestinal tract plays
a vital role in ensuring the health and welfare of an animal, yet there is a dearth of
information on mycotoxin effects on the gut, especially for AF. In the current study, we
have explored the diverse modulation effects of AFB1 on gut functions in broiler chicks,
including gut barrier, endogenous nutrient loss, nutrient digestion, and nutrient absorption.
Intestinal epithelial cells are crucial not only for nutrient uptake, but also for access
restriction of luminal contaminants and antigens to the internal environment. Tight junction
proteins are the major constituent of gut barrier for the latter function, thus any damage to
these protein synthesis and activities may lead to an increase of permeability of the
selective barrier. Previous studies using immunofluorescence or immunoblotting have
shown that deoxynivalenol (DON) and ochratoxin A could reduce the mRNA and protein
expression of various tight junctions in CaCo-2 and IPEC cells (Van de Walle et al., 2010;
Diesing et al., 2011). However, we found herein that AFB1 increased claudin 1 and 2
mRNA expression in vivo. The protein activity of claudin 1 and 2 were not determined in
the current study, thus it is possible that the increase in mRNA expression was a
compensatory effect to restore the impaired claudin proteins. Meanwhile, other tight
junction proteins may have also been affected, as an increased gut permeability in birds
upon AFB1 exposure was observed using the dual sugar test. To our knowledge, this is the
first study where the direct effect of AFB1 on gut barrier was revealed; this could partially
explain the increased susceptibility of animals to enteric infections and other diseases upon
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mycotoxin exposure (Koynarski et al., 2007; Girgis et al., 2008, 2010; Vandenbroucke et
al., 2011; Antonissen et al., 2013). Compared to other poorly absorbed mycotoxins, such
as FB1 and DON (absorption rate 1-20%), AF is highly absorbed in poultry (>80%) mostly
in the upper gut (Grenier and Applegate, 2013). Results herein suggest a high possibility
that either the non-absorbed AF or the AF metabolites that are secreted back into the gut
through the entero-hepatic circulation can have a direct impact the gut epithelium, and thus
are partly responsible for the physiological and metabolic disorders during aflatoxicosis.
In addition, an increased gut permeability may also facilitate the absorption of any
presented mycotoxins through the paracellular route that are normally absorbed at a less
efficient rate, leading to synergistic toxicity effects when the feed is contaminated with
multiple mycotoxins.
In the current study, the endogenous N and amino acid loss during aflatoxicosis
was first determined, and subsequently standardized N and amino acid digestibility were
calculated, which is a more accurate estimation of birds’ digestion capacity compared to
apparent values. The results indicate that diet AFB1 contamination has the potential of
increasing endogenous N loss in broilers, and can significantly reduce energy, N, and
amino acid digestibility. During aflatoxicosis, the increased endogenous N flow may come
largely from sloughed mucus layer. As the major constituent of the mucus layer, mucin
secretion is shown to be increased by anti-nutritional factors through abrasive interactions
with the mucus layer (Montagne et al., 2000). Additionally, increased secretions from the
pancreas and small intestine are likely to contribute to the N flow during AF exposure, as
previous researchers suggested that pancreatic damage during aflatoxicosis may cause an
increased release of proenzymes from pancreatic cells to the intestinal tract (Han et al.,
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2008; Matur et al., 2010). The intestinal epithelium cells have a very high protein turnover
rate (50-75% per day, Cant et al., 1996), thus it is essential that adequate substances are
provided for the protein synthesis. However, a reduced N and amino acid digestibility and
reduced ileal digestible energy was observed in the current study, which may lead to an
insufficient nutrient and energy supply to the intestinal cells, thus affecting normal
activities and functions of these cells. This reduction in energy and amino acid digestibility
are in agreement with others (Applegate et al., 2009; Kermanshahi et al., 2007; Verma et
al., 2007). Pastorelli et al. (2012) suggested an increased maintenance requirement of the
gut upon challenges, which include metabolic costs for repairing damaged tissues and
stimulation of the immune functions. Therefore, the increased maintenance cost along with
the decreased ability of animals to utilize dietary nutrients are indeed factors that lead to
the array of metabolic disturbances during aflatoxicosis. Interestingly, although Thr
supplementation was also provided in the diet, the standardized Thr digestibility was still
decreased during aflatoxicosis. The Thr requirement is the highest among all amino acids
for the intestinal tract as it is required for mucin production. In situations where there is an
increased mucin secretion (i.e. increased endogenous loss as observed herein), goblet cells
will compensate for the mucin losses by increasing mucin synthesis (Horn et al., 2009).
However, when birds are experiencing aflatoxicosis, it is likely that the decreased Thr and
other AA digestibility can lead to insufficient mucin production, resulting in a failure to
compensate sloughed mucin, and consequently lead to an impaired protective function of
the mucus layers to the gut.
Following digestion, subsequent nutrient absorption is another key process to
ensure optimum nutrient uptake and utilization. Girgis et al. (2008) observed an increase
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in jejunum and ileum villus height of birds fed a Fusarium mycotoxins contaminated diet;
the authors suggested that this was possibly a compensation mechanism to counterbalance
the anti-nutritive effects induced by mycotoxins. In disagreement with Girgis et al. (2008),
Applegate et al. (2009) reported no changes in jejunum villus height in laying hens upon
AFB1 challenge, and Wan et al. (2013) noticed decreased villus height and villus/crypt ratio
in ducklings. Herein, AF had no effect on jejunal villi histology (which is consistent with
the unchanged mucosal enzyme activity result); however, a very consistent trend of
increased mRNA expression of jejunal peptide and amino acid transporters were observed,
both on the brush boarder side (b0,+AT, EAAT3, PepT1, rBAT) and the basolateral side
(yLAT1 and 2). This might be a compensatory effect of transporter gene expression on two
levels. First, a higher mRNA production is needed to increase translation process in order
to restore the possible impaired protein activities by AFB1 or AFBO. Second, a higher
absorption rate is necessary to compensate the decreased amino acid digestibility. In
addition, this may also suggest an increased requirement for amino acids absorption and
subsequent protein synthesis during aflatoxicosis. Similarly, Leung et al. (2007) suggested
that the reduced feed intake upon mycotoxin exposure may lead to a lesser amount of bulk
passing through GIT, and thereby increasing nutrient absorption. Utilizing the Ussing
Chamber method in cell culture models, multiple studies have revealed that mycotoxins,
including FB1 and DON, could interfere with glucose absorption (Maresca et al., 2001;
Maresca et al., 2002; Lessard et al., 2009). Maresca et al. (2002) demonstrated that the
inhibition of nutrient uptake by DON is through a specific modulation on intestinal
transporters rather than a non-specific cell damage. However, literature on AF in this regard
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is still scarce, further studies are required to elucidate the mechanisms of how AF
modulates nutrition absorption process in vivo.
Dietary crude protein is a major factor that determines animal performance and
health, especially during aflatoxicosis when protein synthesis and activities are inhibited.
Abdelhamid et al. (1994) evaluated two protein levels in broilers during aflatoxicosis.
However, a very low dosage of AFB1 (0.05 mg/kg) was used, and consequently there was
no statistical difference in growth performance between the positive and negative control
birds. In the current study, we used 1.5 mg/kg AFB1 based on our previous study (Chen et
al., 2014a). As expected, the interaction of dietary protein concentration and AF exposure
were observed on many levels. For growth performance, when a med-CP diet was fed, the
performance response to AF was consistent to our prior observations (Chen et al., 2014a).
The reduced BW gain by 10% compared to control birds was attributed mostly to decreased
G:F ratio (by 9%) and slightly to decreased FI (by 1%). When birds were fed the low-CP
diet, a drastic further decrease by AFB1 in performance was observed, with 21% reduction
in FI and 12% reduction in G:F ratio, resulting in a 31% BW gain decrease compared to
birds fed non-contaminated low-CP diet. Earlier studies suggest a similar response of
augmented aflatoxicosis by low-CP diets (Newbern et al., 1966; Adekunle et al., 1977),
but our results showed that modern broilers also experience such augmentation effect
despite of their much improved feed conversion capacity. Low-CP diets have become a
popular trend given the high ingredient price in recent years, thus caution is needed when
feeding low-CP feeds as the performance of birds may be further impaired upon mycotoxin
contamination, which may result in greater financial loss. On the contrary, the high-CP diet
was able to completely eliminate the effect of AF on performance. While there was still a
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1% reduction of FI compared to control birds, the G:F ratio was completely restored (G:F
= 0.81 and 0.80 for birds fed high-CP diet with and without AFB1, respectively). At the
same time, the serum protein concentrations were completely recovered when birds fed
high-CP diet were exposed to AF, suggesting that excess supply of diet CP can indeed
minimize the effect of AF on protein synthesis. Additionally, we have observed a
significant main effect of increasing villi height with increasing dietary protein, which may
lead to a higher nutrient absorption and consequently contribute to a higher G:F ratio. In
the current study, we have also explored if there is any impact of AF or dietary protein
concentration on the mTOR pathway. The mTOR pathway is a major regulator of protein
synthesis at the point of translation initiation. Briefly, activated mTOR can phosphorylate
4EBP1, which leads to the release of an initiation factor, and subsequently initiation of the
mRNA binding to the ribosome. At the same time, mTOR can also phosphorylate S6K1
(S6 Kinase 1), which activates its downstream protein and promotes translation initiation
(Gingras et al., 2001). In our study, the mRNA expression of mTOR pathway was increased
by AF, but not by CP concentration. A possible explanation is that AFB 1 may have
impaired various protein activities, thus more mRNA production of the mTOR pathway is
required to meet the need of protein synthesis. However, further studies that determines the
phosphorylation of the pathway is needed to verify this speculation, and exploring the
pathways that are responsible for the AFB1 effect on protein synthesis would be of interest.
On the other hand, AFB1 is known to target major organs, primarily the liver, by inducing
oxidative stress and thus impairing normal liver functions (Rawal et al., 2010; Chen et al.,
2014a). Exposure to AFB1 also may lead to immune-suppression and altered renal
functions in broilers (Glahn et al., 1990; Chen et al., 2014a). Although higher dietary
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protein supply may improve hepatic protein synthesis as supported by restored serum
protein concentration herein, some believe that chronic intake of high protein diet may
increase the risk of kidney stone formation and bone loss (Shalini et al., 2002; Amanzadeh
et al., 2003). In the current study, measures of these organ functions or bone health were
not determined; whether higher dietary protein can also eliminate the negative effects of
AFB1 on hepatic and immune functions without compromising renal health and bone
integrity warrant further evaluation. Nevertheless, although higher CP can completely
ameliorate aflatoxicosis in broilers as supported by the measures (performance, serum
biochemistry, and intestinal functions) in the current study, it is not always practical due to
high feed cost. Therefore, individual amino acid or other nutritional supplements that have
a stimulatory effect on protein synthesis may be an alternative as a nutritional approach to
attenuate aflatoxicosis. For instance, branched chain amino acids (Leu, Val, and Ile) have
been shown to be a major stimulator of protein synthesis through the mTOR pathway (Vary
et al., 1999; Anthony et al., 2001), thus potential effects of these amino acids and their
metabolites on protein synthesis during aflatoxicosis warrants further research.

5.6

Summary

Collectively, results from the current study showed that aflatoxin contamination at 1.5
mg/kg diet can significantly impair growth, breast muscle yield, and serum biochemistry
measures in broiler chicks from hatch to 20 d. In addition, AFB1 was able to damage
intestinal barrier functionality, increase endogenous N loss, reduce apparent energy
digestibility, and reduce standardized N and amino acid digestibility while affecting the
gene expression of major nutrient transporters, tight junctions, and protein synthesis
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regulation pathway. Higher dietary protein concentration can significantly improve
performance, major serum measures, and nutrient digestibility of the birds; while lower
dietary protein can augment aflatoxicosis in broilers. The growth performance and health
impairment (including serum measures, gut permeability, and N and amino acid
digestibility) from aflatoxicosis were augmented when birds were fed a lower CP diet, and
were completely eliminated by higher CP diet.
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Table 5.1. Ingredient composition of basal ration (as-fed basis)
Item
Corn
Soybean meal
Corn starch
Dextrose
Salka floc
Vitamin and Trace mineral
Premix1
Monocalcium phosphate
Limestone
Sodium chloride
Soybean oil

NFD
----20.05
64.00
5.0

Composition (%)
Low-CP
Med-CP
66.6
55.0
24.7
35.2
-------------

High-CP
43.3
45.7
-------

0.50

0.35

0.35

0.35

1.9
1.3
---

1.9
1.9
0.47

1.8
1.82
0.47

1.7
1.75
0.47

5.0

2.75

4.03

5.30

L-lysine HCl
--0.34
0.32
0.29
DL-methionine
--0.31
0.40
0.48
L-threonine
--0.12
0.13
0.14
NaHCO3
0.75
------KCl
0.29
------K2CO3
0.26
------MgO
0.20
------Choline chloride
0.25
------Cr2O3
0.5
0.5
0.5
0.5
Calculated analysis
Crude Protein (%)
--18.00
22.03
26.05
Metabolizable Energy (kcal/kg)
3,355
3,153
3,153
3,153
Lysine, %
--1.17
1.44
1.69
Thr, %
--0.77
0.95
1.12
Met, %
--0.59
0.73
0.86
Met+Cys, %
--1.02
1.19
1.35
Ca, %
0.85
1.15
1.15
1.15
Total P, %
0.40
0.75
0.78
0.80
Non-phytate P
0.40
0.51
0.51
0.51
1 Supplied the following per kilogram of diet: vitamin A, 13,233 IU; vitamin D , 6,636 IU;
3
vitamin E, 44.1 IU; vitamin K, 4.5 mg; thiamine, 2.21 mg; riboflavin, 6.6 mg; pantothenic
acid, 24.3 mg; niacin, 88.2 mg; pyridoxine, 3.31 mg; folic acid, 1.10 mg; biotin, 0.33 mg;
vitamin B12, 24.8 µg; choline, 669.8 mg; iron from ferrous sulfate, 50.1 mg; copper from
copper sulfate, 7.7 mg; manganese from manganese oxide, 125.1 mg; zinc from zinc oxide,
125.1 mg; iodine from ethylene diamine dihydroidide, 2.10 mg; selenium from sodium
selenite, 0.30 mg
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Table 5.2. Primer sequences (5’ → 3’) used in quantitative real-time PCR.
Gene

Full name or description

Forward primer

18Sr RNA

18S ribosomal RNA

mTOR

Mechanistic target of rapamycin

4EBP1
S6K1

Eukaryotic translation initiation
factor 4E-binding protein 1
Ribosomal protein S6 kinase 1

CLDN1

Claudin 1

CLDN2

Claudin 2

SGLT1

Na+-independent glucose and
galactose transporter
Na+-independent glucose,
galactose, and fructose transporter
Type IIb sodium-coupled
phosphate co-transporter
Na+-independent cationic and
zwiterionic amino acid transporter
Excitatory amino acid transporter
3, Na+, H+, K+ dependent

F: ATTCCGATAACGAACGAGACT
R: GGACATCTAAGGGCATCACA
F: GGTGATGACCTTGCCAAACT
R: CTCTTGTCATCGCAACCTCA
F: GCGAATGTAGGTGAAGAAGAG
R: AACAGGAAGGCACTCAAGG
F: CAATTTGCCTCCCTACCTCA
R: AAGGAGGTTCCACCTTTCGT
F: AGGTGTACGACTCGCTGCTT
R: AGCAACAAACACACCAACCA
F: CTACAGCTCCCTGCTCAACC
R: ACGGCTATAAGGCAAGCAAG
F: CATCTTCCGAGATGCTGTCA
R: AGGTATCCGCACATCACACA
F: CGTTGGAGTGGTGAACACAG
R: TTAACATGCCCATCAGACCA
F: CTGCAGGACACTGGAGTCAA
R: CCGCAACAGGATTAGAGAGC
F: CAGTAGTGAATTCTCTGAGTGTGAAGCT
R: GCAATGATTGCCACAACTACCA
F: TGCTGCTTTGGATTCCAGTGT
R:
AGCATGACTGTAGTGCAGAAGTAATATAT
F: CCCCTGAGGAGGATCACTGTTGGCAGTT
R: CAAAAGAGCAGCAGCAACGA
F: CCCGCCGTTCAACAAGAG
R: AATTAAATCCATCGACTCCTTTGC
F: CAGAAAACCTCAGAGCTCCCTTT
R: TGAGTACAGAGCCAGCGCAAT
F: GCCCTGTCAGTAAATCAGACAAGA
R: TTCAGTTGCATTGTGTTTTGGTT

GLUT2
NaPiIIb
b0,+AT
EAAT3

PepT1

Oligo-peptide transporter

rBAT
yLAT1

Heavy chain corresponding to the
b0,+ transport system
y+L amino acid transporter 1

yLAT2

y+L amino acid transporter 2
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Table 5.3. Cumulative performance and breast muscle weight of chicks from 0 to 20 d of
age fed varying concentrations of crude protein with or without 1.5 mg/kg AFB1
d 0-20
BWG1
(g/bird)

d 0-20 FI1
(g/bird)

d 0-20
G:F1
(g/bird)

Breast Muscle
Weight2 (g)

Relative Breast
Muscle Weight2
(% BW)

603.0 b

882.1 a

0.68 b

188.2 b

14.8

416.1 c

697.8 b

0.60 c

124.2 c

14.4

660.8 a

849.4 a

0.78 a

232.0 a

16.2

592.2 b

840.9 a

0.71 b

194.0 b

15.8

690.2 a

859.8 a

0.80 a

231.7 a

16.2

682.3 a

847.2 a

0.81 a

235.0 a

16.1

0.02

21.17

0.02

11.60

0.43

0

651.4 a

865.8 a

0.755 a

217.3 a

15.7

1.5

563.5 b

795.3 b

0.703 b

184.4 b

15.4

18

509.6 c

790.0 b

0.641 c

156.2 b

16.11 a

22

626.5 b

845.1 a

0.742 b

213.0 a

15.97 a

26

686.3 a

853.5 a

0.804 a

233.3 a

14.58 b

AFB1

0.0008

0.0004

0.0004

0.0016

0.37

Protein

<0.0001

0.0105

<0.0001

<0.0001

0.002

0.023

0.0005

0.019

0.023

0.92

Dietary treatment
18% CP
18% CP + AFB1
22% CP
22% CP + AFB1
26% CP
26% CP + AFB1
SEM

Main effect means
AFB1

Protein

P-values

Interaction

Means with different superscripts in a column differ significantly (P ≤ 0.05)
Simple effect means represent 6 cages per treatment, 6 birds per pen.
2 Simple effect means represent 6 cages per treatment, 2 birds per pen.
a-c

1
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800

d 0-20 BW gain (g/bird)
690 a

700
600

661 a

682 a

60…
592 b

500
400

416 c
18

22
26
Dietary CP concentration (%)
0 ppm AF

1.5ppm AF

Gain: Feed Ratio
0.9

0.7

0.6

0.81 a
0.80 a

0.78 a

0.8

0.71 b

0.68 b
0.60 c

0.5
18

22
26
Dietary CP concentration (%)
0 ppm AF

1.5ppm AF

Figure 5.1. Interaction plot for body weight gain and G:F ratio of chicks from 0 to 20 d of
age fed varying concentrations of crude protein with or without 1.5 mg/kg AFB1. a-c Means
with different superscripts in a column differ significantly (P ≤ 0.05). Simple effect means
represent 6 cages per treatment, 6 birds per pen.

Table 5.4. Weekly performance of chicks from 0 to 20 d of age fed varying concentrations of crude protein with or without 1.5
mg/kg AFB1 1
BWG (g/bird)

Feed Intake (g/bird)

G:F ratio (g:g)

Dietary treatment
18% CP
18% CP + AFB1
22% CP
22% CP + AFB1
26% CP
26% CP + AFB1
SEM

d 0-7
94
84
99
94
94
95
2.9

d 7-14
238 b
167 c
250 ab
239 b
262 a
269 a
7.3

d 0-14
332 b
251 c
349 ab
334 b
356 ab
364 a
8.9

d 14-20
271 bc
165 d
312 ab
258 c
334 a
318 a
14.0

d 0-7
123
125
114
120
112
106
4.9

d7-14
335 a
268 c
323 ab
321 ab
310 b
312 b
8.0

d 0-14
458 a
393 c
436 ab
437 ab
422 b
418 bc
9.6

d 1420
424 a
305 b
413 a
413 a
438 a
430 a
17.0

Main effect means
AFB1
0
1.5

96
92

250 a
225 b

347 a
316 b

306 a
247 b

116
117

323 a
300 b

439 a
416 b

425 a
383 b

0.83
0.80

0.78 a
0.74 b

0.79 a
0.76 b

0.72 a
0.64 b

18
22
26

89 b
97 a
94 ab

202 c
245 b
266 a

291 c
342 b
360 a

218 c
285 b
326 a

124 a
117 ab
109 b

302 b
322 a
311 ab

426
437
420

365 b
413 b
434 a

0.72 b
0.83 a
0.88 a

0.67 c
0.76 b
0.85 a

0.68 c
0.78 b
0.86 a

0.59 c
0.69 b
0.75 a

AFB1
Protein
Interaction

0.09
0.027
0.16

0.0002
<0.0001
<0.0001

0.0003
<0.0001
<0.0001

<0.0001
<0.0001
0.012

0.88
0.0135
0.44

0.0019
0.0534
0.0002

0.0066
0.22
0.0026

0.0044
0.0010
0.0022

0.32
0.0004
0.06

0.0298
<0.0001
0.021

0.02
<0.0001
0.0028

0.0018
<0.0001
0.20

Protein

d0-7
0.77
0.67
0.87
0.79
0.84
0.90
0.04

d7-14
0.71 c
0.62 d
0.78 b
0.74 bc
0.84 a
0.86 a
0.02

d0-14
0.72 d
0.64 e
0.80 bc
0.77 cd
0.84 ab
0.87 a
0.02

d 14-20
0.64 b
0.54 c
0.75 a
0.63 b
0.76 a
0.74 a
0.03

P-values

Means with different superscripts in a column differ significantly (P ≤ 0.05)
Simple effect means represent 6 cages per treatment, 6 birds per pen.

a-c
1
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Table 5.5. Serum biochemistry of 20 d chicks fed varying concentrations of crude protein with or without 1.5 mg/kg AFB1 1
Total
Glucose
Albumin
Protein
Globulin
Ca
AST 2
GGT 3
Uric acid
Dietary treatment
(mg/dL)
(g/dL)
(g/dL)
(g/dL)
(mg/dL)
(U/L)
(U/L)
(mg/dL)
a
a
a
18% CP
411.8
0.82
2.35
1.53
11.53
157.3
11.17
8.18
18% CP + AFB1
22% CP

309.3
351.0

0.37 b
0.98 a

1.43 b
2.50 a

1.05 b
1.67 a

10.47
11.87

141.8
164.3

13.17
12.50

6.63
8.60

22% CP + AFB1
26% CP

271.2
342.8

0.55 b
0.93 a

1.78 b
2.50 a

1.23 b
1.60 a

11.05
12.07

187.0
194.5

14.00
11.33

10.93
9.80

26% CP + AFB1

356.3

0.92 a

2.50 a

1.57 a

11.60

200.6

11.33

11.70

SEM

48.45

0.07

0.14

0.07

0.30

11.89

1.08

1.31

368.6
312.3

0.91 a
0.62 b

2.45 a
1.91 b

1.60 a
1.28 b

11.82 a
11.04 b

172.1
176.5

11.67
12.83

8.86
9.76

360.6
311.1
349.6

0.60 c
0.77 b
0.93 a

1.89 b
2.14 b
2.50 a

1.29 b
1.45 a
1.58 a

11.00 b
11.46 ab
11.83 a

149.6 b
175.7 a
197.6 a

12.17
13.25
11.33

7.41 b
9.77 ab
10.75 a

0.20
0.22
0.63
represent 6

0.41
0.0463
0.29
cages per

Main effect means
AFB
0
1
1.5
Protein

18
22
26

P-values
AFB1
0.17
<0.0001
<0.0001
<0.0001
0.0031
0.75
Protein
0.57
0.0001
0.0007
0.0021
0.0304
0.0020
Interaction
0.46
0.0029
0.0072
0.0097
0.60
0.29
a-c
Means with different superscripts in a column differ significantly (P ≤ 0.05). 1 Simple effect means
treatment, 2 birds per pen.2 AST= Aspartate transaminase.3 GGT= Gamma glutamyl transpeptidase

191

192
Table 5.6. Jejunum villus histology of 20-d old chicks fed varying concentrations of crude
protein with or without 1.5 mg/kg AFB11
Villus height
Dietary treatment
(μm)
Crypt Depth (μm)
VH:CD ratio
18% CP
708.2
119.8
6.0
18% CP + AFB1
676.8
118.7
5.8
22% CP
807.2
129.0
6.4
22% CP + AFB1
755.8
123.2
6.2
26% CP
887.0
155.8
5.7
26% CP + AFB1
844.0
122.6
7.1
SEM

43.98

8.31

0.46

800.8
759.0

134.9
121.5

6.0
6.4

18
22
26

692.5 b
781.5 ab
865.7 a

119.3
126.1
129.2

5.9
6.3
6.4

AFB1
Protein
Interaction

0.27
0.0032
0.97

0.091
0.087
0.17

0.49
0.55
0.22

Main effect means
0
AFB1
1.5
Protein

P-values

Means with different superscripts in a column differ significantly (P ≤ 0.05)
Simple effect means represent 6 birds per treatment; 10 villi per intestinal segment were
measured per bird
a-b
1
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Table 5.7. Digestive enzyme activity of 20-d old chicks fed varying concentrations of
crude protein with or without 1.5 mg/kg AFB1 6
Sucrase1
Maltase2 Amylase3
Lipase4
Trypsin5
Dietary treatment
18% CP
280 a
1703 ab
879
1.17
13.87
a
ab
18% CP + AFB1
299
1621
1251
1.11
14.24
a
a
22% CP
288
1712
1156
0.86
11.51
ab
22% CP + AFB1
194
1278 ab
1184
0.65
14.94
b
b
26% CP
155
1016
1185
0.88
10.55
a
a
26% CP + AFB1
299
1816
1067
1.81
16.02
Main effect means
0
AFB1
1.5
Protein

241
264

1477
1571

1114
1116

0.90
1.21

12.16
15.34

18
22
26

289
241
227

1662
1495
1416

1065
1019
1261

1.41
0.78
1.23

14.05
13.64
13.57

AFB1
Protein
Interaction

0.47
0.33
0.03
41.2

0.59
0.58
0.05
238.4

0.96
0.54
0.41
230.1

0.22
0.32
0.058
0.28

0.22
0.98
0.73
3.07

P-values

SEM

Means with different superscripts in a column differ significantly (P ≤ 0.05)
Determined in mid-jejunum mucosal sample. One unit is the amount of enzyme that
cleaves sucrose to generate 1.0 μmol of glucose per mg of protein at 37 ⁰C.
2 Determined in mid-jejunum mucosal sample. One unit is the amount of enzyme that
cleaves maltose to generate 1.0 μmol of glucose per mg of protein at 37 ⁰C.
3 Determined in pancreatic sample using Sigma assay kit (MAK009). One unit is the
amount of amylase that cleaves ethylidene-pNP-g7 to generate 1.0 μmol of p-nitrophenol
per mg of protein per minute at 25 ⁰C.
4 Determined in pancreatic sample using Sigma assay kit (MAK046). One unit is the
amount of enzyme that generates 1.0 μmol of glycerol from tryglycerides per mg of protein
per minute at 25 ⁰C.
5 Determined in pancreatic sample using BioVision assay kit (K771). One unit is the
amount of trypsin that cleaves the substrate yielding 1.0 μmol of p-NA per mg of protein
per minute at 25 ⁰C.
6 Simple effect means represent 6 birds per treatment
a-b
1
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Table 5.8. Dual-sugar gut permeability of 20-d old chicks fed varying concentrations of
crude protein with or without 1.5 mg/kg AFB11
Lactulose/Rhamnose
Lactulose
Rhamnose
Dietary treatment
ratio
(mol/L)
(mol/L)
18% CP
0.050
3.86
73.04
18% CP + AFB1
0.190
42.78
166.96
22% CP
0.062
3.66
67.91
22% CP + AFB1
0.128
8.72
78.32
26% CP
0.043
1.80
44.88
26% CP + AFB1
0.057
2.79
50.44
SEM
0.04
8.71
22.10
Main effect means
AF
0
1.5
Protein

0.051 b
0.125 a

3.10
18.09

61.94
98.57

18
22
26

0.120
0.095
0.040

23.32
6.19
2.29

120.00 a
73.11 ab
47.66 b

AFB1
Protein
Interaction

0.042
0.19
0.30

0.077
0.076
0.10

0.11
0.017
0.13

Pvalues

Means with different superscripts in a column differ significantly (P ≤ 0.05)
Simple effect means represent 6 birds per treatment

a-b
1
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Table 5.9. Endogenous N and amino acid losses of 20-d old chicks fed N-free diet
with or without 1.5 mg/kg AFB11
NFD+1.5 ppm
NFD2
P value
SEM
AFB1
（mg/kg DM intake)
Crude protein

2051

2619

0.09

192.7

Aspartic Acid

616

746

0.40

96.8

Threonine

414

496

0.34

52.8

Serine

400

487

0.29

51.1

Glutamic Acid

779

966

0.41

142.4

Proline

408

463

0.32

34.2

Glycine

356

423

0.38

48.7

Alanine

336

412

0.41

57.7

Cysteine

215

257

0.18

19.3

Valine

411

497

0.36

58.4

Methionine

102

132

0.40

22.0

Isoleucine

318

388

0.39

51.6

Leucine

513

643

0.37

91.1

Tyrosine

199

252

0.35

35.4

Phenylalanine

287

370

0.33

53.7

Lysine

371

488

0.44

96.3

Histidine

165

204

0.39

28.6

Arginine

315

391

0.48

67.7

1
2

Simple effect means represent 6 replicate cages per treatment
NFD= Nitrogen free diet

Table 5.10. Apparent ileal digestible energy (ADE, kcal/kg DM intake) and standardized N and amino acid digestibility (%) of 20d old chicks fed varying concentrations of crude protein with or without 1.5 mg/kg AFB11
Dietary
treatment
18% CP
18% CP + AFB1

a

3731
2903 c

b

86.4
74.4 c

c

87.6
74.9 c

ab

87.6
72.1 c

ab

88.8
75.7 b

ab

92.4
84.4 c

ab

90.6
77.8 c

ab

86.9
67.7 c

a

90.5
77.5 b

a

86.9
64.9 b

ab

88.0
72.1 c

a

96.8
93.9 b

ab

88.7
74.9 c

a

90.9
79.9 b

ab

88.2
75.3 c

ab

90.1
78.8 c

a

91.6
81.9 b

a

91.3
80.0 b

93.3 a
84.4 b

22% CP
22% CP + AFB1

3470 b
3583

85.0 b
88.6 ab

85.0 ab
89.1 ab

84.4 b
89.0 ab

85.2 b
91.0 a

90.0 b
93.0 ab

87.2 b
90.0 ab

83.4 b
88.1 ab

87.3 a
90.7 a

82.4 a
87.0 a

85.0 b
89.5 ab

96.3 a
98.0 a

86.8 b
90.1 ab

88.2 a
91.1 a

86.3 b
90.1 ab

87.8 b
90.8 ab

89.2 a
92.9 a

89.5 a
92.1 a

91.3 a
94.2 a

89.7 a
87.2 ab

90.6 a
87.8 ab

90.0 a
87.0 ab

91.8 a
89.2 ab

93.9 a
91.9 ab

91.7 a
88.4 ab

90.1 a
86.5 ab

91.8 a
89.0 a

87.4 a
84.8 a

91.2 a
88.3 ab

97.5 a
97.1 a

91.6 a
89.3 ab

92.0 a
89.7 a

91.4 a
89.4 ab

92.1 a
90.1 ab

93.7 a
91.9 a

93.1 a
91.0 a

94.8 a
93.4 a

1.44

1.44

1.57

1.80

1.76

1.25

1.34

2.29

1.72

2.17

1.85

0.63

1.56

1.42

1.46

1.42

1.73

1.35

Main effect means
AF 0
3643 a
3342 b
1.5

87.0 a
83.4 b

87.8 a
83.9 b

87.3 a
82.7 b

88.6
85.3

92.1
89.8

89.8 a
85.4 b

86.8 a
80.8 b

89.9 a
85.7 b

85.6 a
78.9 b

88.1 a
83.3 b

96.9
96.3

89.0 a
84.7 b

90.4 a
86.9 b

88.6 a
84.9 b

90.0 a
86.5 b

91.5
88.9

91.3 a
87.7 b

93.1
90.7

3317 b
3527 a
3634 a

80.4 b
86.8 a
88.5 a

81.3 b
87.0 a
89.2 a

79.8 b
86.6 a
88.5 a

82.3 b
88.1 a
90.5 a

88.4 b
91.5 a
92.9 a

84.2 b
88.6 a
90.0 a

77.3 b
85.7 a
88.2 a

84.0 b
89.0 a
90.4 a

75.9 b
84.7 a
86.1 a

80.0 b
87.2 a
89.7 a

95.3 b
97.2 a
97.3 a

81.8 b
88.5 a
90.4 a

85.4 b
89.7 a
90.9 a

81.8 b
88.2 a
90.4 a

84.5 b
89.3 a
91.1 a

86.7 b
91.1 a
92.8 a

85.6 b
90.8 a
92.1 a

88.9 b
92.7 a
94.1 a

<.0001
0.0045
<.0001

0.0172
0.0002
0.0001

0.0259
0.0008
0.0002

0.0186
0.0016
<.0001

0.10
0.0019
0.0002

0.08
0.0197
0.0014

0.0022
0.0050
<.0001

0.0158
0.0014
0.0002

0.0209
0.0166
0.0006

0.0045
0.0020
<.0001

0.0199
0.0005
<.0001

0.47
0.0313
0.0081

0.0137
0.0002
<.0001

0.0205
0.0120
0.0004

0.0252
0.0001
<.0001

0.0261
0.0020
0.0003

0.18
0.0206
0.0049

0.0137
0.0014
0.0002

0.14
0.0230
0.0046

ADE

N

Asp

Thr

Ser

Glu

Pro

Gly

Ala

Cys

Val

Met

Ile

Leu

Tyr

Phe

Lys

His

Arg

ab

26% CP
26% CP + AFB1

3727 a
3541

SEM

68.11

ab

CP

18
22
26
P-values
AFB1
Protein
Interaction

Means with different superscripts in a column differ significantly (P ≤ 0.05)
Simple effect means represent 6 birds per treatment
P-values and SEM are based on Box-Cox transformation

a-b
1
2
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Table 11. Jejunal gene expression of 20-d old chicks fed varying concentrations of crude protein with or without 1.5 mg/kg AFB1 1,
2

CLDN
2
1.19 b
2.86 a
0.85 b
1.03 ab
1.73 ab
2.01 ab

SGLT
1
0.78 b
2.89 a
1.24 ab
0.80 b
1.12 ab
1.69 ab

GLUT
2
1.34
3.50
0.69
0.72
1.12
2.02

NaPiII
b
1.04 ab
2.45 a
1.55 ab
0.45 b
1.08 ab
1.84 ab

b0,+AT

0.90
1.83
1.06
0.87
1.10
1.85

CLDN
1
0.80
1.74
0.77
1.29
1.34
1.84

0.93
1.86
0.92
1.42
2.04
1.59

EAAT
3
1.35
3.20
1.48
1.69
0.52
1.49

0.03

0.06

0.12

0.07

0.04

0.04

0.04

0.07

1.06
1.71

0.93 b
1.51 a

1.02
1.51

0.97 b
1.63 a

1.26
1.97

1.05
1.94

1.05
2.08

1.22
1.58

1.71
0.89
1.56

1.35
0.97
1.34

1.36
0.96
1.47

1.27
1.03
1.59

2.03
0.94
1.87

1.84
1.02
1.41

2.42
0.71
1.57

0.13
0.41
0.28

0.0335
0.28
0.44

0.17
0.61
0.23

0.0361
0.42
0.58

0.06
0.54
0.09

0.18
0.89
0.07

0.22
0.18
0.16

mTOR

4EBP1

S6K1

26% CP + AFB1

1.12
2.31
0.77
1.01
1.30
1.81

0.92
1.78
0.63
1.32
1.24
1.45

SEM

0.03

Dietary treatment
18% CP
18% CP + AFB1
22% CP
22% CP + AFB1
26% CP

Main effect means
AF
0
1.5
CP

18
22
26
P-values
AFB1
Protein
Interaction

PepT1

rBAT

yLAT1

yLAT2

1.00
3.24
0.93
3.09
0.75
1.39

0.97
3.10
0.91
2.93
0.76
1.37

0.94
2.42
1.04
1.13
0.96
1.57

0.85
2.46
0.91
1.65
0.97
1.53

0.04

0.04

0.04

0.03

0.06

1.30
1.62

1.12 b
2.13 a

0.89 b
2.57 a

0.88 b
2.47 a

0.98 b
1.71 a

0.91 b
1.88 a

1.75
1.00
1.46

1.39
1.17
1.82

2.27
1.59
1.01

2.12
2.01
1.07

2.03
1.92
1.07

1.68
1.09
1.26

1.66
1.28
1.25

0.94
0.62
0.09

0.07
0.54
0.56

0.02
0.66
0.32

0.0334
0.68
0.24

0.0284
0.68
0.24

0.0398
0.81
0.46

0.0031
0.85
0.27

Means with different superscripts in a column differ significantly (P ≤ 0.05)
Simple effect means represent 6 birds per treatment
P-values and SEM are based on Box-Cox transformation

a-b
1
2
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CHAPTER 6. IMPACT OF DIETARY PROTEIN CONCENTRATION ON
PERFORMANCE AND NUTRIENT DIGESTIBILITY IN PEKIN DUCKS
DURING AFLATOXICOSIS

6.1

Abstract

A 14-d study was conducted to determine the impact of dietary crude protein
concentration on performance, serum biochemistry, and nutrient digestive functions in
Pekin ducklings during aflatoxicosis. A total of 144 male Pekin ducklings were randomly
allotted to 4 dietary treatments arranged in a 2 x 2 factorial with 2 crude protein (20 and
24% on an analyzed basis) with or without 0.2 mg/kg AFB1 (0.21 mg/kg analyzed). The
AFB1 reduced BW gain, feed intake, and breast muscle weight by 33 to 43 % (P < 0.0001).
Serum concentration of protein, glucose, and Ca were also decreased by AFB1 (P ≤ 0.0015),
while pancreatic activities of amylase and lipase were increased by AFB 1 (P < 0.005).
Apparent N digestibility was not affected by dietary treatment, whereas apparent ileal
digestible energy was reduced 7.6% by AFB1 (P < 0.001). Higher dietary CP improved
BW gain, G:F ratio, and breast muscle weight (P < 0.05), and tended to improve feed intake
(P = 0.094), but did not improve serum measures, digestive enzyme activity, or nutrient
digestibility. No statistical interaction of AFB1 by CP was observed for any measures.
Results from the current study suggest that AFB 1 at low concentration can significantly
impair performance of Pekin ducklings primarily through inhibited feed intake, as well as
influence nutrient digestion processes (jejunum morphology, digestive
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enzyme activity, and apparent energy digestibility). Higher dietary CP can improve growth
performance of ducklings regardless of AF exposure, but did not interact with dietary AFB1
on performance, serum biochemistry, or nutrient digestion in Pekin ducklings from hatch
to 14 d.

6.2

Introduction

As a fungal secondary metabolite of the Aspergillus species, aflatoxin B1 (AFB1) is
known to be the most toxigenic mycotoxin (Yunus et al., 2011). Feed contamination with
AFB1 has been a major feed safety concern due to its negative effects on growth
performance, production, hepatic functions, and immune system in many livestock species
(Ledoux et al., 1999; Yarru et al., 2009; Andretta et al., 2011; Grenier and Applegate, 2013).
Compared with broilers, limited research is available in ducks on AFB1 toxicity. In fact,
among all poultry species, ducks are the most susceptible specie to AFB1 (Muller et al.,
1970). Prior study from our lab in Pekin ducklings showed that for every 0.10 mg/kg
increase in feed AFB1 contamination, cumulative BW gain will decrease by 169 g per bird
from 0-14 d; and that AFB1 at very low concentrations (≤ 0.3 mg/kg) can significantly
impair the duck’s liver function and innate immune characteristics (Chen et al., 2014a).
Besides AFB1’s effects on performance and hepatic and immune functions, studies
focusing on its impact on the gastro-intestinal tract has been extremely rare in poultry.
Because there is a close association between performance and gut functions, any
disturbances of nutrient digestion and absorption in the small intestine may result in growth
disorders of an animal. Indeed, in 20-d broiler chicks, AFB1 exposure can significantly
increase endogenous N loss and reduce standardized N and amino acid digestibility, thus
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resulting in reduced G:F ratio and growth depression (Chen et al., 2015); yet such
information is extremely scarce for ducks. Therefore, there is a need to explore how AFB1
affects nutrient digestion and absorption in Pekin ducks and the mechanisms behind it.
Because AFB1 is known to be a potent inhibitor of protein synthesis (Sporn et al., 1966;
Garvican et al., 1973), it is very likely that dietary protein concentration has an impact on
the degree of aflatoxicosis by altering the supply of protein synthesis substrates. Low
protein diets have become an increasingly popular trend in poultry production in order to
reduce feed cost and minimize environmental load. However, feeding low CP diet (18%
compared to 22%) was shown to significantly exacerbate aflatoxicosis when broiler chicks
were exposed to 1.5 mg/kg AFB1, while raising CP concentration attenuated the harm from
inhibited protein synthesis during aflatoxicosis (Chen et al., 2015). The threshold
concentration of AFB1 to compromise growth and health in ducks is at least 10-fold lower
than that in broilers (Chen et al., 2014a), and it is within the realistic concentration range
in field situations (Streit et al., 2013). Hence it is important to determine whether such
interactive effects also exist for ducks. Therefore, the objectives of the current study were
to explore the interactive effects of dietary crude protein concentration and AFB1 exposure
on performance, serum biochemistry, and nutrient digestive functions in Pekin ducklings.

6.3
6.3.1

Materials and Methods

Experimental Birds and Diets
The animal care and use protocol was reviewed and approved by the Purdue

University Animal Care and Use Committee. A total of 144 male Pekin ducklings were
obtained from a commercial hatchery (Maple Leaf Farms, Leesburg, IN), weighed, tagged,
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and randomly allotted to 24 cages. All ducklings were housed on raised wire floors in an
environmentally controlled room and were fed from 0 to 14 d of age. Feed and water were
provided ad libitum. Birds were inspected daily for health problems, and mortality was
recorded as it occurred.
The corn-soybean meal based basal diets were formulated to meet or exceed the
nutritional requirements of ducks from hatch to 14 days (Table 6.1). Four dietary
treatments were arranged in a 2 x 2 factorial with 2 aflatoxin concentration (0 and 0.2
mg/kg) and 2 crude protein concentrations (20% and 24%). The cultured aflatoxin material
(50 mg/kg) was produced on ground corn using Aspergillus parasiticus (NRRL 2999) as
described by Gowda et al. (2008). Four premixes, contributing 0.5% of the final diets by
weight, were prepared with or without 80.3% 50 mg AFB1/kg ground corn, and then
blended with the basal diet (20% CP or 24% CP) to create the 4 treatment diets, respectively.
All diets were formulated to be isocaloric, and the amino acid to crude protein ratios were
kept constant for all treatment diets.
Dietary AF concentrations, including AFB1, AFB2, AFG1, and AFG2, were analyzed
by High Performance Liquid Chromatography (HPLC) at Romer labs (Union, MO). The
analyzed concentrations of AFB1 were below the limit of detection (< 0.7 μg/kg) for diets
without added AF, and were 0.221 and 0.215 mg/kg for 20% CP+AF and 24% CP+AF
diets, respectively. Analyzed AFB2 was ≤ 7.5 μg/kg, and AFG2 was ≤ 2.6 μg/kg for all
treatment diets. Dietary AFG1 concentrations were approximately 30% of AFB1
concentrations for the 2 dietary treatments with added AF, and < 0.7 μg/kg for the 2 dietary
treatments without added AF.
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6.3.2

Sample Collection

Feed intake (FI) and individual BW were measured weekly. Average feed intake and
BW gain were calculated and were corrected for mortality. All ducklings were euthanized
by intraventricular injection of isopropyl alcohol, and two ducklings from each cage (12
ducklings per treatments) were randomly selected for blood collection. From all birds, the
lower 2/3 ileal digesta were collected for dry matter, N, chromium, and energy
determination. Breast muscle weight was determined from 3 birds per pen, and relative
breast muscle weight was calculated as % of BW. A section of mid-jejunum was collected
from 1 bird per pen and stored in 10% neutral buffered formalin for villi histology analysis.
In addition, pancreas and small intestine mucosa were collected from 1 bird per pen for
subsequent determination of digestive enzyme activities.

6.3.3

Serum Biochemistry Analysis

Blood samples were centrifuged at 1,400 x g at 4 ⁰C for 15 min for serum separation.
Collected serum was preserved at –20 ⁰C until submitted for biochemical analysis. Six
replicate serum samples per treatment were analyzed at the Veterinary Medical Diagnostic
Laboratory of University of Missouri (Columbus, MO) for glucose, albumin, globulin, total
protein, Ca, P, aspartate amino transferase (AST), γ-glutamyl transferase (GGT), and uric
acid using an auto-analyzer (Kodak Ektachem Analyzer, Eastman Kodak Co., Rochester,
NY).
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6.3.4

Digestive Enzyme Activity

The pancreas and small intestine mucosa samples were dissolved in PBS, respectively,
to a final concentration of 0.2 g/ml. Subsequently, the mixture was homogenized,
centrifuged at 1,400 x g at 4⁰C for 15 min, and the clear supernatant was separated for
enzyme activity analysis. Pancreatic enzymes activities were determined using respective
commercial kit. Specifically, total protein (Thermo Scientific kit 23200, Rockford, IL),
amylase activity (Sigma kit MAK009), lipase activity (Sigma kit MAK046), and trypsin
activity (BioVision kit K771) were determined according to manufacturer instructions.
Mucosal activities of sucrase and maltase were determined as described by Sell et al. (1991).
One unit of sucrase activity is defined as the amount of enzyme that cleaves sucrose to
generate 1.0 μmol of glucose per mg of protein at 37 ⁰C. One unit of maltase activity is
defined as the amount of enzyme that cleaves maltose to generate 1.0 μmol of glucose per
mg of protein at 37 ⁰C.

6.3.5

Jejunal Villi Histology

Collected jejunum samples were fixed in 10% neutral buffered formalin, processed by
standard paraffin sectioning, and stained with hematoxylin-eosin. The slides were then
examined under a light microscope. Measurements of villus height were taken from the top
of villus to the valley between villus, and measurements of crypt depth were taken from
the valley to the basolateral membrane. The villus height: crypt depth ratios (VH:CD ratio)
were calculated. Reported values were means of 10 villi from each bird, 6 birds per
treatment.
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6.3.6

Nutrient Digestibility
All diet and ileal samples were analyzed for dry matter (method 934.01; AOAC

International, 2006), chromium (method 990.08; AOAC International, 2000), N (method
990.03; AOAC International, 2000) using a Leco model FP 2000 N combustion analyzer
(Leco Corp., St. Joseph, MI), and energy using a Parr adiabatic bomb calorimeter (Parr
Instruments Co., Moline, IL). The analyzed CP concentrations for the 20% CP- and 24%
CP-diets were 20.31 and 24.07 %, respectively.

6.3.7

Statistical Analysis

All data were analyzed by 2-way ANOVA using SAS (SAS 9.4, Cary, NC) for a
completely randomized design. Pen was used as the experimental unit. Model included
main effects of aflatoxin concentration, crude protein concentration, and their interaction.
Treatment means were compared using the least significant difference procedure when
significant (P ≤ 0.05) and trending (0.05 < P ≤ 0.10) treatment effects were observed. All
data were tested for normality using the UNIVARIATE procedure and common variance
using the GLM procedure.

6.4
6.4.1

Results

Growth Performance

Growth performance and breast muscle weight results are shown in Table 6.2. Based
on the factorial analysis, 0.2 mg/kg AFB1 showed a significant main effect of reducing
cumulative BWG, FI, and breast muscle weight by 33, 35, and 43%, respectively (P <
0.0001). Cumulative G:F ratio was not affected by dietary AFB1 (P = 0.33). Compared to
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birds fed 20% CP diet, dietary crude protein concentration at 24% significantly improved
BWG, G:F, breast muscle weight, and relative breast muscle weight (P ≤ 0.03), with a trend
to increase FI (P = 0.094). The improvement in BWG, FI, G:F, and breast muscle weight
were 18, 8, 9, and 40%, respectively. There was no statistical interaction between AFB1
and dietary CP concentration for any measures (P ≥ 0.18). However, the numerical
reduction of BWG from aflatoxicosis was 39% for birds fed 20% CP, but was only 27%
for birds fed 24% CP. Similarly, the reduction of relative breast muscle weight from
aflatoxicosis was 34% for the 20% CP group, but was only 5% for the 24% CP group.
The weekly performance followed a similar trend (Table 6.2). As expected, 0.2 ppm
AFB1 started to depress BWG (by 14%) from 0 to 7 d (P = 0.0013), but the negative effect
became more substantial during 7 to14 d (reduction was 48%; P < 0.0001). A similar trend
was seen for FI (P = 0.064 and < 0.001 for 0-7 d and 7-14 d, respectively), while G:F ratio
was not affect by AFB1 at any time (P ≥ 0.18). Crude protein concentration at 24%
significantly increased BWG from 0 to 7 d (P = 0.0013) and 7 to 14 d (P < 0.0001), and
improved FI by 14% from 7 to 14 d (P < 0.0001). Gain: feed ratio was significantly
increased by the higher CP diet during 0 to 7 d (by 11%; P = 0.002).

6.4.2

Serum Biochemistry

The serum biochemistry results are shown in Table 6.3. Aflatoxin at 0.2 ppm reduced
serum concentrations of glucose, albumin, total protein, globulin, and calcium (P < 0.002),
suggesting reduced feed intake and impaired protein synthesis of the ducklings. Higher
crude protein concentration did not improve serum content of these 5 measures (P ≥ 0.22).
Serum uric acid concentration was significantly increased by higher dietary protein (11.34
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vs 7.37 mg/dL for 24% and 20% CP, respectively; P = 0.006), which may be resulted from
higher protein intake and thus excess amino acid intake and oxidation.

6.4.3

Digestive Enzyme Activity and Nutrient Digestibility
Results for digestive enzyme activity are shown in Table 6.4. Activity of mucosal

enzymes (sucrase and maltase) were not affected by treatment diets (P ≥ 0.33). On the
contrary, a significant effect of AFB1 was observed for pancreatic amylase and lipase (P <
0.005), with birds fed AF-contaminated diets showing higher enzyme activity. In addition,
birds fed 20% CP during aflatoxicosis showed the highest lipase activity (AFB1 by CP
interaction; P = 0.069). Pancreatic protease activity was not affected by treatments (P ≥
0.22).
Consistent with the unaffected protease activity, the apparent N digestibility was not
affected by dietary treatments (P ≥ 0.45) (Table 6.5). No changes for apparent DM
digestibility were found between treatments (P ≥ 0.26). On the contrary, 0.2 mg/kg AFB1
showed a significant main effect of decreasing the apparent digestible energy (ADE) (P =
0.0003), which was also reduced by higher dietary CP concentration (P = 0.0003). No
AFB1 by CP interaction was detected for any digestibility measures.

6.4.4

Jejunal Villi Histology
The jejunal villi histology results are shown in Table 6.6. The crypt depth (CD)

from birds fed AFB1-contaminated diets were significantly increased compared to control
birds (P = 0.0122). While villi height and crypt depth were not statistically affected (P ≥
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0.22) by dietary protein concentration statistically (P ≥ 0.22), birds fed higher dietary CP
showed a significantly increased VH:CD ratio (main effect P =0.023).

6.5

Discussion

With the high prevalence and continuously increasing risk of AF contamination in
feedstuffs worldwide (Streit et al., 2013), better understanding and elucidation of
aflatoxicosis is in particular need for ducks, the most susceptible poultry species to AF.
Considering the popularity of low-protein diets in the poultry industry in the past few years,
and the fact that AFB1 potently inhibit protein synthesis, the question arises as to whether
interactive effects between AFB1 and dietary CP exist, where lowering dietary protein
supply may augment aflatoxicosis and thus lead to further production loss. In the current
study, we have explored the impact of dietary protein concentration on the degree of
aflatoxicosis in Pekin ducklings by evaluating growth performance, serum biochemistry
panel, as well as nutrient digestion and absorption.
Using graded cultured AFB1 from 0.1 to 0.3 mg/kg, our prior study revealed that the14d BWG of Pekin ducklings can be reduced by 15% with every 0.1 mg/kg AFB1 increase in
the diet. Consistently, in the current study, BWG reduction by 0.2 mg/kg AFB1 was
approximately 33% compared to control birds (main effect of AF < 0.0001). This reduction
can be attributed primarily to decreased FI (by 35%, main effect < 0.0001), while G:F ratio
was not affected by AFB1. However, others have documented decreased G:F ratio by 17%
in ducks at 42 d when 0.04 mg/kg AFB1 contaminated diet was fed (Han et al., 2008).
Shifting from FI inhibition to FCR suppression by AFB1 is possible as the ducks mature.
Nevertheless, the observation herein is in agreement with our previous conclusion that
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inhibited FI is the most profound harm of AFB1 exposure in young ducklings (Chen et al.,
2014a). On the other hand, higher CP improved the G:F ratio from 0.72 to 0.80, which may
be partially attributed to the increased villi height: crypt depth ratio (P = 0.021); yet unlike
the experimental hypothesis, it was not able to completely restore the dramatically inhibited
FI in ducks (FI reduction by AFB1 was 38 and 33% for birds fed 20 and 24% CP diet,
respectively; main effect of CP concentration = 0.094). On the contrary, because reduced
feed efficiency is a major contributor to growth depression in broiler chicks when exposed
to AFB1, the high-CP diet (26%) was able to completely eliminate the BWG reduction by
AF by restoring G:F ratio in broilers at 20 d (Chen et al., 2015). This discrepancy in how
AF affects performance between broilers and ducks suggest that different counteractive
strategies that are species-specific may warrant future consideration, although it is possible
that interactive effects may become significant if ducks were fed to market age or more
dietary CP concentrations were included.
The serum biochemistry panel results are in agreement with performance. As expected,
serum proteins (albumin, globulin, and total protein) were all reduced significantly by
AFB1. This is a consistent response that is often observed in AF-related studies in poultry
(Chen et al., 2014a, b; Chen et al., 2015; Zhao et al., 2010), indicating that AFB1 impaired
liver function and strongly inhibited protein synthesis. However, in contrast to our
observation in broilers where serum protein concentrations were completely restored in
birds fed higher CP diets (AFB by CP interaction; P < 0.001) (Chen et al., 2015), such
amelioration effect by 24% CP diet compared to 20% CP diet on serum protein
concentration in ducklings was not observed in the current study. Similarly, serum glucose
concentration was decreased by AFB1 by approximately 41%, possibly from reduced FI.
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However, this reduction was not attenuated by feeding higher dietary CP. Clearly, excess
supply of diet CP can minimize the effect of AF on performance by improving nutrient
utilization only when feed efficiency, rather than feed intake, is the primary factor for
impaired growth.
Digestion and absorption in the small intestine are key processes to ensure optimal
nutrient utilization and consequently growth performance; these processes are very likely
to be affected upon AFB1 exposure. However, there is limited literature addressing this
issue as of today, especially in ducks. Han et al., (2008) reported increased digestive
enzyme activities upon AFB1 exposure in 42 d Cherry Valley ducks. The authors suggest
that increased proenzymes released from the injured pancreas during aflatoxicosis is a
plausible reason. Similarly, in the current study, AFB1 significantly increased pancreatic
amylase and lipase activity in Pekin ducklings. Another possible explanation is a
compensatory effect of the birds in response to lowered FI to meet their nutrient need, but
this increase in enzyme activities was not able to restore the growth impairment from AFB1.
Pancreatic protease was not affected by dietary treatments, which is consistent with the
unaffected apparent ileal N digestibility that was observed. Conversely, others have
showed decreased N digestibility during aflatoxicosis both in broilers (Verma et al., 2002;
Chen et al., 2015) and in ducks (Han et al., 2008). In the latter study, a very low
concentration of AFB1 (0.04 mg/kg) was fed, thus it is likely that the AFB1 contamination
was not high enough to drastically suppress FI, but instead, exerted its effects on the
nutrient digestion process. Consistent with the reduced AME in broilers fed 1 to 2 mg/kg
AFB1 reported by Verma et al. (2002), a main effect of AFB1 on reducing the apparent ileal
digestible energy was observed herein, which did not agree with the unaffected DM
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digestibility result. In the meantime, higher CP also reduced ileal digestible energy. It is
uncertain what caused this reduction, but there might be a higher endogenous loss with
increased FI when birds were fed higher dietary protein. However, apparent digestible
energy was increased with increasing dietary CP concentration (from 16% to 26%) in
broiler chicks (Chen et al., 2015). Further studies determining the endogenous loss and
metabolizable energy in ducks during aflatoxicosis are needed for verification.
Collectively, based on our results, it is clear that AFB1 as low as 0.2 mg/kg can
dramatically reduce FI and thus BWG of Pekin ducklings from hatch to 14 d of age. Serum
biochemistry and digestible energy were also negatively affected. There were no statistical
interactive effects between aflatoxin and dietary CP concentration, but higher dietary CP
had main effects of increasing G:F ratio and thus partially restored the BWG of the birds.
Nevertheless, reduced FI cannot be restored by higher dietary CP supply, and therefore,
feeding higher dietary CP may be a nutritional approach to attenuate aflatoxicosis in
broilers, but may be less successful in Pekin ducks. Regardless, feeding high-CP diets is
not always economically practical in production; rather, attention should be paid to the
different mechanisms of AF’s actions in these two species so that specific counteractive
strategies can be developed. In ducks, future focus should be on exploring the mechanisms
of how aflatoxin inhibit feed intake. In the meantime, strategies are needed to minimize
AF exposure before the stage of absorption by the birds, which include regular feed
sampling and analysis and use of aflatoxin adsorbents. Future directions regarding broiler
chicks may include evaluating the effects of certain amino acids or other nutrient
supplements that have a stimulatory effect on protein synthesis, in order to determine if
they can become effective and economical approaches for ameliorating aflatoxicosis. On
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the other hand, in both broilers and ducks, feeding low protein diets was found to
exacerbate the negative effects of AF, either significantly or numerically (which is still
considerable in practice). Therefore extra caution is needed when feeding low CP diets,
especially at times when the weather or storage conditions favor AF production in feed
ingredients.
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Table 6.1. Ingredient composition and calculated analysis of basal ration (as-fed basis)
Item

20% CP Diet

24% CP Diet

62.67

50.77

29.70

40.15

0.35

0.35

Monocalcium phosphate

1.70

1.70

Limestone

1.90

1.90

Sodium chloride

0.47

0.47

Soybean oil

1.49

2.85

L-lysine HCl

0.30

0.30

DL-methionine

0.30

0.39

L-threonine

0.12

0.12

Cr2O3

0.50

0.50

Aflatoxin-Corn premix

0.50

0.50

Crude Protein (%)

20.00

24.00

Metabolizable Energy (kcal/kg)

3100

3100

Lys, %

1.28

1.56

Thr, %

0.86

1.02

Met, %

0.61

0.75

Met+Cys, %

1.06

1.23

Ca, %

1.14

1.19

Corn
Soybean meal
Vitamin and Trace mineral

Premix1

Calculated analysis

Non-phytate P
0.48
0.50
Supplied the following per kilogram of diet: vitamin A, 13,233 IU; vitamin D3, 6,636 IU;
vitamin E, 44.1 IU; vitamin K, 4.5 mg; thiamine, 2.21 mg; riboflavin, 6.6 mg; pantothenic
acid, 24.3 mg; niacin, 88.2 mg; pyridoxine, 3.31 mg; folic acid, 1.10 mg; biotin, 0.33 mg;
vitamin B12, 24.8 µg; choline, 669.8 mg; iron from ferrous sulfate, 50.1 mg; copper from
copper sulfate, 7.7 mg; manganese from manganese oxide, 125.1 mg; zinc from zinc oxide,
125.1 mg; iodine from ethylene diamine dihydroidide, 2.10 mg; selenium from sodium
selenite, 0.30 mg.
2 Four premixes, contributing 0.5% of the final diets by weight were prepared with or
without 80.3% 50 mg AFB1/kg ground corn, and then blended with the basal diet (20% CP
or 24% CP) to create the 4 treatment diets, respectively.
1

Table 6.2. Cumulative and periodic performance and breast muscle weight of ducklings from 0 to 14 d of age.
Treatments

Feed
Intake1
(g/duck)

BW gain1
(g/duck)

Gain:Feed
ratio1 (g/g)

Breast
Muscle
Wt2 (g)

Breast
Muscle
Wt2
(% BW)

0-7 d
BWG1
(g/duck)

0-7 d
FI1
(g/duck)

0-7 d
G:F
ratio1
(g/g)

7-14 d
BWG 1
(g/duck)

7-14 d
FI1
(g/duck)

7-14 d
G:F
ratio1
(g/g)

20% CP

788

570

0.73

12.15

1.85

157

209

0.75

409

579

0.71

20% CP+ AFB1

489

347

0.71

5.25

1.22

135

174

0.77

213

316

0.68

24% CP

826

622

0.76

14.40

2.03

173

187

0.82

446

639

0.70

24% CP+ AFB1
SEM

554
29.2

456
18.1

0.83
0.030

9.89
1.033

1.92
0.183

150
6.0

175
12.9

0.86
0.025

303
16.9

381
24.5

0.81
0.043

806.7
521.6

595.9
401.5

0.74
0.77

13.28
7.57

1.94
1.57

165.0
142.4

197.8
172.5

0.82
0.79

427.4
257.9

608.9
348.6

0.71
0.74

638.4
689.9

458.2
539.2

0.72
0.79

8.70
12.14

1.54
1.97

145.6
161.9

191.6
178.7

0.76
0.84

311.2
374.1

447.3
510.2

0.70
0.76

<0.0001
0.0002
0.13

0.33
0.021
0.16

<0.0001
0.004
0.27

0.062
0.030
0.18

0.001
0.013
0.94

0.064
0.33
0.48

0.13
0.002
0.49

<0.0001
0.0014
0.14

<0.0001
0.019
0.91

0.38
0.18
0.14

Main effect means
AFB1 (mg/kg)
0
0.2
Crude Protein (%)
20
24

Source of variation, P-value
AFB1
<0.0001
Crude Protein
0.094
Interaction
0.65
1
2

Simple effect means represent 6 cages per treatment, 6 birds per cage.
Simple effect means represent 6 cages per treatment, 3 birds per cage.
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Table 6.3. Serum profile of ducklings fed 20 or 24% dietary protein with or without 0.2 mg/kg aflatoxin B1
(AFB1) from 0 to 14 d of age 1, 2
Total
Glucose
Albumin
Protein
Globulin
Ca
AST
GGT
Uric acid
Dietary treatment
(mg/dL)
(g/dL)
(g/dL)
(g/dL)
(mg/dL)
(U/L)
(U/L)
(mg/dL)
20% CP
362
1.15
2.85
1.70
14.13
157
1.20
8.08
20% CP + AFB1
202
0.20
0.77
0.57
9.75
218
1.00
6.67
24% CP
362
1.13
2.93
1.80
13.53
78
0.83
12.50
24% CP + AFB1
225
0.23
1.02
0.78
11.07
119
0.50
9.78
SEM
29.7
0.045
0.131
0.109
0.932
37.4
0.313
1.227
Main effect means
AFB1 (mg/kg)
0
361.8
1.14
2.89
1.75
13.83
168
1.02
10.29
0.2
213.3
0.22
0.89
0.68
10.41
117
0.75
8.23
Crude Protein (%)
20
281.9
0.68
1.81
1.13
11.94
188
1.10
7.37
24
293.3
0.68
1.98
1.29
12.30
98
0.67
11.14
Source of variation, P-value
AFB1
<0.0001
Crude Protein
0.71
Interaction
0.70
1
2

<0.0001
0.85
0.58

<0.0001
0.22
0.53

<0.0001
0.16
0.60

0.0015
0.70
0.32

0.19
0.027
0.79

0.44
0.19
0.84

0.11
0.006
0.60

Simple effect means represent 6 cages per treatment, 2 birds per pen
AST= Aspartate transaminase, GGT= Gamma glutamyl transpeptidase
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Table 6.4. Digestive enzyme activity of ducklings fed 20 or 24% dietary protein with or
without 0.2 mg/kg aflatoxin B1 (AFB1) from 0 to 14 d of age 1, 2
Mucosa
Dietary treatment
20% CP
20% CP + AFB1
24% CP
24% CP + AFB1
SEM
Main effect means
AFB1 (mg/kg)
0
0.2
Crude Protein (%)
20
24
Source of variation, P-value
AFB1
Crude Protein
Interaction

Pancreas

Sucrase2
154
120
129
131
14.9

Maltase3
1497
1538
1711
1853
153.3

Amylase
540
996
708
854
84.8

Lipase
19.37 b
39.83 a
20.54 b
26.98 b
3.68

Protease
345
494
354
400
76.6

142
125

1604
1696

623
925

19.8
33.4

350
447

137
130

1518
1783

768
781

29.5
23.75

419
377

0.33
0.70
0.25

0.61
0.10
0.75

0.0048
0.80
0.11

0.0015
0.13
0.069

0.22
0.58
0.51

a-b Means

with different superscripts in a column differ significantly (P < 0.05).
effect means represent 6 cages per treatment, 1 birds per pen
2 One unit is the amount of enzyme that cleaves sucrose to generate 1.0 μmol of glucose
per mg of protein at 37 ⁰C.
3 One unit is the amount of enzyme that cleaves maltose to generate 1.0 μmol of glucose
per mg of protein at 37 ⁰C.
4 One unit is the amount of amylase that cleaves ethylidene-pNP-g7 to generate 1.0 μmol
1 Simple

of p-nitrophenol per mg of protein per minute at 25 ⁰C.
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Table 6.5. Apparent ileal digestible energy (ADE) and apparent ileal digestibility of dry
matter (DM) and N of ducklings fed 20 or 24% dietary protein with or without 0.2 mg/kg
aflatoxin B1 (AFB1) from 0 to 14 d of age 1, 2

ADE
(kcal/kg)
3681

DM
digestibility
(%)
73.13

N
digestibility
(%)
86.81

20% CP + AFB1

3452

72.92

87.24

24% CP

3456

69.44

85.09

24% CP + AFB1

3119

71.39

86.70

SEM

49.05

1.59

1.39

0

3555

74.17

85.83

0.2

3286

73.96

86.97

20

3553

75.58

86.91

24

3288

72.55

85.90

0.0003

0.46

0.45

0.0003

0.26

0.55

0.25

0.75

0.77

Dietary treatment
20% CP

Main effect means
AFB1 (mg/kg)

Crude Protein (%)

Source of variation, P-value
AFB1
Crude Protein
Interaction
1 Simple

effect means represent 6 cages per treatment, 6 birds per pen
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Table 6.6. Jejunal villi histology of ducklings fed 20 or 24% dietary protein with or
without 0.2 mg/kg aflatoxin B1 (AFB1) from 0 to 14 d of age 1, 2
Villi Height
(μm)
616.2

Crypt Depth
(μm)
103.2

VH:CD
ratio
5.98

20% CP + AFB1

668.7

121.7

5.57

24% CP

665.0

95.6

6.92

24% CP + AFB1

705.2

112.8

6.28

SEM

44.67

6.16

0.32

0

64.06

9.94 b

6.45

0.2

68.69

11.72 a

5.92

20

64.24

11.24

5.77 b

24

68.51

10.42

6.60 a

AFB1

0.33

0.012

0.14

Crude Protein

0.37

0.22

0.023

Interaction

0.90

0.92

0.72

Dietary treatment
20% CP

Main effect means
AFB1 (mg/kg)

Crude Protein (%)

Source of variation, P-value

a-b Means

with different superscripts in a column differ significantly (P < 0.05).
effect means represent 6 cages per treatment, 1 bird per cage, 10 villi per bird

1 Simple
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CHAPTER 7. IMPACT OF DIETARY BRANCHED CHAIN AMINO ACIDS
CONCENTRATION ON BROILER CHICKS DURING AFLATOXICOSIS

7.1

Abstract

A 20-d trial was conducted to determine the effects of dietary branched-chain
amino acids (BCAA) on performance, nutrient digestibility, and gene expression of the
mTOR pathway in broiler chicks when exposed to aflatoxin B1 (AFB1). The 6 dietary
treatments were arranged in a 2 x 3 factorial with 3 BCAA concentrations (1.16, 1.94, and
2.73%) with or without 1.5 mg/kg AFB1 (1.77 mg/kg analyzed). Each diet was fed to 8
replicate cages (6 chicks per cage) from 6 to 20 d of age. Exposure to AFB1 significantly
reduced gain:feed ratio and breast muscle weight (P < 0.05), and tended to decrease
cumulative BW gain (P = 0.087), while increasing dietary BCAA improved all
performance measures (P ≤ 0.0002), except relative breast muscle weight. Apparent ileal
digestibility of N and 9 amino acids were increased by AFB1 (P ≤ 0.05), but were reduced
by higher dietary BCAA (P ≤ 0.023). Jejunum histology was not affected by AFB1, while
higher dietary BCAA tended to increase villus height (P = 0.08). Additionally, the gene
expression of mTOR pathway (mTOR, 4EBP1, and S6K1) from liver and jejunum were
not affected by dietary treatments, while muscle expression of S6K1 tended to be increased
by AFB1 (P = 0.07). No significant interaction between AFB1 and dietary BCAA were
observed for any measures in the current study. Results from this study suggested that feed
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AFB1 contamination can significantly reduce growth performance and breast muscle
growth in broiler chicks at 20 d. Higher BCAA supply may have beneficial impact on bird
performance, but this effect is independent of AFB1 exposure.

7.2

Introduction

Aflatoxins (AF), secondary metabolites of Aspergillus species, are prevalent
mycotoxins in feedstuffs worldwide and one of the most potent hepatocarcinogens. Among
the many subgroups of AF, AFB1 is considered the most toxigenic (Yunus et al., 2011)
and feed contamination of AFB1 is known to lead to various negative effects on
performance and health in poultry species (Yarru et al., 2009; Grenier and Applegate, 2013;
Chen et al., 2014ab, 2015). A well-known major mechanism of AFB1 toxicity is its
inhibitory effect on protein synthesis (Sporn et al., 1966; Garvican et al., 1973). Sporn et
al (1966) first revealed that AFB1 is capable of binding DNA and inhibits incorporation of
cytidine-H3 into rat liver nuclear RNA. Subsequent studies showed that AFB1 has a direct
inhibitory action on protein synthesis associated with polysome disaggregation (Garvican
et al., 1973). Because participation of various proteins is vital in all the structural units and
biological processes of an animal, uncertainty remains whether altering nutrient supply
may influence protein synthesis and subsequent performance and health of an animal
during aflatoxicosis.
Protein synthesis is a highly regulated process by various cellular signaling pathways,
with the mTOR (mammalian target of rapamycin) pathway being a major player. Briefly,
activated mTOR can phosphorylate the eukaryotic translation initiation factor 4E-binding
protein 1 (4EBP1), which leads to the release of translation initiation factor 4E (eIF4E).
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The availability of eIF4E is the limiting factor for translation initiation, as it forms a
complex with other initiation factors (eIF4F, eIF4G, and eIF4A) and regulates mRNA
binding to the ribosome. In the meantime, mTOR can also phosphorylate ribosomal protein
S6 kinase 1 (S6K1), which activates S6, a protein that promotes translation initiation.
Branched chain amino acids (BCAA), especially leucine, have been reported to be a major
activator of mTOR, thus are stimulators of protein synthesis through the activation of
translation initiation. In laboratory animals, several researchers consistently found that
BCAA supplementation could increase 4EBP1 phosphorylation and reduce 4EBP1- eIF4E
association, while activating S6 phosphorylation (Vary et al. 1999; Anthony et al. 2001).
Within the limited literature on this aspect for poultry, a recent study by Deng et al. (2014)
showed that 1.73 and 2.03% dietary Leu could indeed stimulate the mTOR pathway in
neonatal chicks compared to those fed 1.43% Leu.
To date, the impact of dietary nutrients on aflatoxicosis has been less explored. Prior
research from our lab revealed that dietary protein concentration had interactive effects
with AF exposure in broilers on many levels. Birds fed higher dietary crude protein can be
completely protected from multiple adverse effects by AF through improved protein
synthesis and subsequently higher feed efficiency (Chen et al., 2015). Because of the
stimulatory effect of BCAA on protein synthesis via the mTOR pathway, it is likely that
they may thus attenuate the negative effects of AFB1 in birds upon exposure. Therefore,
the objective of this study was to explore the impact of dietary BCAA concentration on
performance, serum biochemistry, nutrient digestibility, and gene expression of the mTOR
pathway in broilers during aflatoxicosis.
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7.3
7.3.1

Material and Methods

Experimental Birds and Diets
A total of 288 male broiler chicks (Ross 708) were obtained from a commercial

hatchery and fed a common starter diet from hatch to 6 d. On d 6, birds were individually
weighed and randomly allotted to 6 treatments, 8 replicate cages per treatment, and 6 chicks
per cage. All chicks were housed in battery cages in an environmentally controlled room.
Feed and water were provided ad libitum. Birds were inspected daily for any health
problems, and mortality was recorded as it occurred. The animal care and use protocol was
reviewed and approved by the Purdue University Animal Care and Use Committee.
The corn-soybean meal based basal diets were formulated to meet or exceed the
nutritional requirements of broilers from 6 to 20 d (Table 1). The 6 dietary treatments were
arranged in a 2 x 3 factorial with 2 aflatoxin concentrations (0 and 1.5 mg/kg) and 3 BCAA
concentrations. Dietary Leu concentrations were formulated to be 1.16, 1.94, and 2.73%
for low-, med-, and high-BCAA diets, respectively. Concentrations of diet Ile and Val were
maintained at 59 and 69% of Leu concentration, respectively. The cultured aflatoxin (50
mg AFB1/kg) was produced using Aspergillus parasiticus (NRRL 2999) on ground corn at
University of Missouri as described by Gowda et al. (2008). Six premixes, contributing
4.0% of the final diets by weight were prepared with or without 75% 50 mg AFB1/kg
ground corn, and then blended with the basal diets to create the 6 treatment diets. All
treatment diets were formulated to be isocaloric and isonitrogenous.
All diet and ileal samples were analyzed for dry matter (method 934.01; AOAC
International, 2006), N (method 990.03; AOAC International, 2000; Leco model FP 2000
N, Leco Corp., St. Joseph, MI), and chromium (method 990.08; AOAC International,
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2000). Amino acid profile (method 982.30; AOAC International, 2006) was determined at
the University of Missouri Experiment Station Field Laboratory (Columbia, MO). The
analyzed Leu concentrations for the low-, med-, and high-BCAA diets were 1.09, 1.86, and
2.76%, respectively. The aflatoxin concentrations of all diets, including AFB1, AFB2,
AFG1, and AFG2, were analyzed by HPLC at Romer labs (Union, MO). The analyzed
concentrations of AFB1 were ≤ 0.8 μg/kg for all AF-free diets and 1.77 mg/kg for AFcontaining diets. The AFB2 was ≤ 70 μg/kg, and AFG2 was ≤ 29 μg/kg for all treatments.
Dietary AFG1 concentrations were approximately 31% of AFB1 concentrations for the 4
dietary treatments with added aflatoxin, and were below limit of detection for the AF-free
diets.

7.3.2

Sample Collection
Feed intake and body weight per pen were measured on d 6, 13, and 20. Average

feed intake (FI), body weight gain (BWG), and gain to feed ratio (G: F) were calculated
and were corrected for mortality. On d 20, all birds were euthanized by CO2 inhalation,
and the distal two-thirds ileal digesta (lower 2/3 of of the ileal section from Meckel’s
diverticulum to the ileal-cecal junction) were collected for dry matter, N, Cr, and amino
acid determination. Breast muscle weights were recorded from 2 birds per pen, and relative
breast muscle weights were calculated as % BW. Serum samples were collected via jugular
vein from 2 birds per pen immediately following euthanasia for serum biochemistry
analysis. From 1 bird per pen, a section of mid-jejunum was collected and stored in 10%
neutral buffered formalin for villi histo-morphometry. Additionally, a piece of mid-
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jejunum, liver, and breast muscle was collected from 1 bird per pen and preserved in
RNAlater® (Ambion, Austin, TX) at -80⁰C for quantitative real-time PCR analysis.

7.3.3

Serum Biochemistry

Collected blood was centrifuged at 1,400 x g at 4 ⁰C for 15 min. The separated serum
was preserved at –20 ⁰C until submission for biochemical analysis. All samples were
analyzed for albumin, globulin, total protein, glucose, Ca, P, aspartate amino transferase
(AST), γ-glutamyl transferase (GGT), and uric acid at the Veterinary Medical Diagnostic
Laboratory of University of Missouri (Columbus, MO) using an auto-analyzer (Kodak
Ektachem Analyzer, Eastman Kodak Co., Rochester, NY).

7.3.4

Jejunal Villi Histology

The collected jejunal samples were fixed in 10% neutral buffered formalin, processed
by standard paraffin sectioning, and stained with hematoxylin-eosin. Slides were examined
using a light microscope. Measurements of villus height were taken from the top of villus
to the valley between villus, and measurements of crypt depth were taken from the valley
to the basolateral membrane. The villus height: crypt depth ratios (VH:CD) were calculated.
Reported values were means of 10 villi from each bird, 8 birds per treatment.

7.3.5

Gene expression

The mRNA expression of the mTOR pathway (mTOR, 4EBP1, S6K1) of jejunum,
liver, and muscle samples were determined using quantitative real-time PCR (MyiQ realtime PCR detection system, Bio-Rad, Hercules, CA, USA) with SYBR mix (Bio-Rad,
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Hercules, CA, USA). Briefly, total RNA was extracted using TRIzol® (Invitrogen,
Carlsbad, CA, USA) and was quantified at an absorbance of 260 nm (ND-1000,
Nanodrop Technologies Inc., Wilmington, DE). Reverse transcription was carried out
using the M-MLV reverse transcriptase (Promega, Madison, WI, USA). Water was used
as the negative control. All reactions were run in duplicate and formation of a single PCR
product was confirmed by melting curves. The mRNA expression was determined from
the threshold cycle (Ct) for respective genes and normalized using 18S ribosomal RNA
(18SrRNA) within each sample. The primer sequences used were based on previous
reports (Deng et al., 2014): mTOR (F) 5’-GGTGATGACCTTGCCAAACT-3’; (R) 5’CTCTTGTCATCGCAACCTCA-3’. 4EBP1 (F) 5’-GCGAATGTAGGTGAAGAAGAG3’; (R) 5’-AACAGGAAGGCACTCAAGG-3’. S6k1 (F) 5’-CAATTTGCCTCCCTAC
CTCA-3’; (R) 5’-AAGGAGGTTCCACCTTTCGT-3’. 18sRNA (F) 5’-ATTCCGATA
ACGAACGAGACT-3’; (R) 5’-GGACATCTAAGGGCATCACA-3’.

7.3.6

Statistical Analysis
All data were analyzed as 2-way ANOVA using SAS (SAS 9.4, Cary, NC) for a

completely randomized design. The model included main effects of aflatoxin concentration,
BCAA concentration, and their interaction. Pen was used as the experimental unit, and
treatment means showing significant (P ≤ 0.05) and trending (0.05 < P ≤ 0.10) differences
were compared using the least significant difference procedure. All data were tested for
normality using the UNIVARIATE procedure and common variance using the GLM
procedure. Non-normal data were transformed using Box-Cox transformation.
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The relationship between Δ feed intake (FI) and ΔBW gain (BWG) for low-, medand high-BCAA groups during AFB1 exposure was analyzed using linear regression:
ΔBWG = α + β x ΔFI as described by Pastrorelli et al. (2012). The analysis was carried
out using the REG procedure in SAS. The intercept (α) represents reduction in BWG
related to changes in maintenance (i.e. not associated with changed in feed intake). The
slope (β) represents the extent of BWG change associated with the reduction in feed
efficiency in challenged birds.

7.4

Results

Mortality was low throughout the study, and was approximately 2% across
treatments. The cumulative performance and breast muscle weight are shown in Table 7.2.
Based on the factorial analysis, 1.5 mg/kg AFB1 reduced cumulative gain: feed ratio and
breast muscle weight (P < 0.05), and tended to decrease cumulative BW gain (P = 0.087).
Increasing dietary BCAA concentration incrementally improved all performance measures
(BW gain, feed intake, gain:feed ratio, and breast muscle weight) (P < 0.001) No significant
interaction between aflatoxin and dietary BCAA concentration was observed for any
measure.
The weekly performance results are shown in Table 7.3. Dietary AFB1 significantly
depressed BWG and gain:feed ratio by approximately 10% during d 6-13 (P = 0.03), but
these effects were not significant during d 13-20. Higher BCAA protein concentration
significantly increased BWG, feed intake, and gain:feed ratio at all times (P < 0.001).
The relationship between change in BW gain (ΔBWG) and feed intake (ΔFI) are
shown in Figure 7.1. For all dietary BCAA concentration groups, the relationship between
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ΔFI and ΔBWG upon AFB1 exposure was linear (R2 > 0.99). The intercepts were negative
for low and med- BCAA groups, indicating that when FI is not affected (when x = 0), there
would be an increase in maintenance cost and thus a lowered BW gain. The maintenance
cost upon AFB1 exposure was highest in birds fed low-BCAA, and was incrementally
decreased as dietary BCAA concentration increased (-0.68, -0.07, and +0.04% for low-,
med- and high-BCAA groups, respectively). However, changes in maintenance only
accounted for a small fraction of the overall BW gain response (Figure 7.2), while the
primary contributor was reduction associated with feed efficiency in challenged birds. The
latter was highest in med-BCAA group (- 8.36%) and lowest in high-BCAA group (0.14%).
The serum biochemistry results are shown in Table 7.4. Aflatoxin at 1.5 ppm tended
to reduce serum albumin concentration (P = 0.095), while significantly increased serum
AST concentration (P = 0.034). Unlike hypothesized, higher dietary BCAA reduced serum
concentrations of albumin, total protein, globulin, and GGT (P < 0.01), while it increased
serum AST and uric acid (P < 0.0001).
The jejunum histology results are shown in Table 7.5. The villus height: crypt depth
ratio from birds fed AFB1-contaminated diets were lower compared to control birds (6.90
versus 6.13 μm) for control and AFB1-fed birds, respectively; P = 0.05). Higher dietary
BCAA tended to increase villus height (P = 0.08), indicating a better absorptive ability of
the birds. Crypt depth was not affected by dietary treatments, and no interaction between
AFB1 and dietary BCAA were detected for villi histology.
The apparent ileal N and amino acid digestibility results are shown in Table 7.6.
Interestingly, digestibility of N and 9 amino acids (Thr, Gly, Cys, Val, Met, Ile, Leu, Lys,
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Arg) were all increased by AFB1 (P ≤ 0.05), while higher dietary BCAA reduced the
digestibility of N and all amino acids except Leu, Ile, and Val (P ≤ 0.023). No significant
interactive effects of AFB1 and BCAA concentration were observed (P ≥ 0.17).
The gene expression results are shown in Table 7.7. The muscle expression of S6K1
tended to be increased by AFB1 (P = 0.07), while expression of all other genes, whether
from muscle, liver, or jejunum, were not affected by dietary treatments (P ≥ 0.13).

7.5

Discussion

Consumption of aflatoxin-contaminated feed has been known to lead to a collection
of negative effects in poultry, including reduced performance and production and
compromised organ functions, resulting in huge economic loss for the producers. Because
AF contamination is becoming an increasingly prevalent risk worldwide (Grenier and
Applegate, 2013), it is important to fully understand the mechanisms of AF in livestock
animals and how dietary modulation may influence the extent of aflatoxicosis.
Unfortunately, as of today, information about the impact of dietary nutrients on
aflatoxicosis is yet limited. Dietary amino acids are key components of poultry feed to
ensure a balanced and sufficient supply as protein synthesis precursors, but they also play
vital roles in regulating nutrient utilization as signaling molecules (Li et al., 2011). Because
AFB1 is a potent inhibitor of protein synthesis, and that BCAA are known to stimulate
translation initiation of protein synthesis, it is of interest to explore the interaction between
dietary BCAA concentration and AFB1 exposure. In the current study, the hypothesis that
higher dietary supply of BCAA may mitigate aflatoxicosis by stimulating the mTOR
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pathway was tested in 6-20 d broiler chicks fed graded concentrations of BCAA with or
without 1.5 mg/kg AFB1.
The concentration of AFB1 at 1.5 mg/kg was chosen based on our prior experience
to induce aflatoxicosis, with the expectation of a significant BW gain reduction by
approximately 10 % in 20 d broilers (Chen et al., 2014a, 2015). Herein, although BW
reduction by AFB1 during d 6-13 was significant (by 10%, P = 0.03), the main effect of
AFB1 on cumulative BW gain was only a trending effect (P = 0.087) with an approximately
7% reduction. Intriguingly, in the current study, birds were generally smaller than expected.
It is noteworthy that the same experiment was repeated twice with similar outcomes.
Analyzed AFB1 concentration was on target (1.77 mg/kg), and the possibilities of vitamin
deficiency, contamination by other mycotoxins, or heavy metal contamination were
excluded. One plausible cause might be the high content of cornstarch in the treatment
diets, which may have an inhibited effect on feed intake compared to a complete cornsoybean meal diet. Nevertheless, AFB1 exposure still led to a significant reduction of G:F
ratio but not feed intake, which is consistent with previous observations (Chen et al., 2015).
The former might be partially attributed to the reduced villi height: crypt depth ratio as
observed in jejunal histology samples. In the meantime, the effects of 3 dietary BCAA
concentrations with or without AF exposure were also investigated. According to NRC
(1994) recommendation, the leucine requirement for broilers is 1.2%; while a common
corn-soybean diet (22% crude protein) fed today normally contains approximately 1.9%
leucine. In the current study, the graded concentrations of 1.16, 1.94, and 2.73% were
chosen to represent low- (basal-), medium-, and high- dietary leucine. To avoid BCAA
antagonism, the valine: leucine and isoleucine: leucine ratios were kept constant for all
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treatments according to the suggested optimal BCAA ratios by Pastor et al. (2013). As
hypothesized, higher dietary BCAA improved all performance measures, yet there was no
statistical interaction observed; thus the effects of BCAA were independent of AFB1
exposure. Based on the main effect means, reduction of BW gain by 54% in birds fed lowBCAA diets compared to those fed med-BCAA diets can be attributed primarily to reduced
feed intake (by 43%) and to a lesser extent to reduced gain: feed ratio (19%); the latter
might be partially the result of the increased villi height (508 versus 582 μm in low- and
med-BCAA groups, respectively). On the other hand, the improvement of BW gain (by
47%) in birds fed high-BCAA diets was entirely due to increased feed intake (51%). This
may suggest that the stimulatory effect of BCAA supplementation on gain: feed ratio is
more considerable if dietary BCAA is deficient, but may be attenuated once dietary supply
reaches sufficient concentrations. On the other hand, although there was no statistical
interaction between AFB1 and dietary BCAA concentration on performance measures,
fraction analysis (Figure 2) revealed that the majority of the BWG reduction can be
attributed to changes in feed efficiency (changes related to reduction in feed intake). This
observation is in agreement with Pastrorelli et al. (2012), who reported similar partitioning
pattern of the growth response in pigs during mycotoxicoses. Interestingly, increasing
dietary BCAA concentration decreased the maintenance cost and increased feed efficiency
reduction upon AFB1 exposure, suggesting that dietary BCAA concentration can alter the
partitioning of factors affecting BW gain in birds during aflatoxicosis.
Significantly reduced serum protein concentration by AF, an indication of impaired
hepatic protein synthesis, is a consistent observation in all of our previous studies (Chen et
al., 2014 a,b; 2015). However, the same effect was not observed in the current study, except
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that AF tended to decrease serum albumin (P = 0.095). This agrees with the performance
results, indicating a milder aflatoxicosis than expected, which is possibly due to the low
feed intake and thus low intake of AFB1, or the fact that birds were fed AFB1-contaminated
diets starting from d 6 instead of d 1. In the meantime, for unknown reasons, the serum
protein concentrations were significantly reduced by higher dietary BCAA in the current
study. The rate of skeletal muscle protein synthesis and accretion are highest in the neonatal
phase, but decreases significantly with aging (Denne and Kalhan, 1987; Davis et al., 1989).
According to Deng et al. (2014), the stimulatory effect of high leucine diet on protein
synthesis was attenuated after d 7. Therefore, this discrepancy in serum protein
concentrations might be a result of attenuated BCAA effects by aging as blood was
collected in 20 d birds herein, although the increased serum uric acid concentration in birds
fed high-BCAA diets indicated an excess of amino acid intake and thus higher amino acid
oxidation.
Intestinal modulation by AFB1 has been less explored in poultry species. Our recent
study showed that 1.5 mg/kg AFB1 significantly increased endogenous N loss and
decreased standardized N and amino acid digestibility in 20 d chicks (Chen et al., 2015).
In the current study, even without correction for endogenous loss, the apparent ileal
digestibility of N and 9 amino acids (Asp, Thr, Gly, Ala, Cys, Val, Met, Ile, Leu, Lys, His,
Arg) were all increased by AFB1. Although this observation was in contrast to our own
experience, increased nutrient digestibility upon mycotoxin exposure has been found in
similar studies by others (Feng et al., 2011; Danicke et al., 2005; Leung et al., 2007), which
were explained either as a compensatory effect of the animals in response to reduced feed
intake, or a result of reduced viscosity of certain feeds due to the capability of growing
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fungi to degrade cell walls. The latter explanation may better fit in the scenario of the
current study, as feed intake was not affected by AF exposure at any time. In contrast to a
prior report where higher dietary crude protein increased ileal digestibility of N and amino
acids (Chen et al., 2015), another intriguing finding in the current study was the reduced
apparent ileal digestibility of N and most amino acids by increasing dietary BCAA; with
the exception of the 3 BCAAs, whose digestibility were increased by higher dietary BCAA,
as was expected due to crystalline BCAA in those diets. Nonetheless, this reduction in
nutrient digestibility did not result in decreased feed efficiency, but instead, birds fed higher
BCAA showed higher gain: feed ratio. Therefore, it is possible that higher BCAA may
have beneficial effects on nutrient absorption and subsequent utilization, resulting in
improved feed efficiency and better BWG. On the other hand, digestibility of other dietary
nutrients, including carbohydrates and lipids, which were not evaluated in the current study,
may have been influenced by dietary BCAA concentrations and thus lead to different
gain:feed ratio and performance results. There is unfortunately a dearth of information
within the literature in this regard to compare the current results to, thus further exploration
of how dietary BCAA supply affects nutrient digestion, absorption, and utilization warrants
attention.
The mTOR pathway is extensively involved in the regulation of protein synthesis
at the point of translation initiation. AFB1 is a potent inhibitor of protein synthesis, yet little
is known on the relation between AFB1 and the mTOR pathway. To our knowledge, this is
the first study to explore AF effects on the mTOR pathway in vivo. The mRNA expression
of mTOR, 4EBP1, and S6K1 were determined in jejunum, liver, and breast muscle.
However, no significant changes of the mTOR pathway were observed upon AF exposure,
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with only a trending effect of increased muscle S6K1 expression by AFB 1. As mentioned
earlier, the extent of aflatoxicosis was not as significant as expected, which may result in a
lesser response within the organism. On the other hand, stimulated phosphorylation of
4EBP1 and S6K1 by leucine have been observed in muscles cells in several mammal
species (Kimball et al., 1999; Vary et al. 1999; Anthony et al. 2001; Dreyer et al., 2008).
Recent evidence revealed that similar effects by leucine also exists in poultry (Deng et al.,
2014). By feeding broilers chicks 3 dietary leucine concentrations (1.43, 1.73, and 2.03 %),
the authors found that dietary leucine ≥ 1.73% increased mTOR phosphorylation and S6K1
phosphorylation at d 3 and 7, but not at d 14. However, in the current study, no significant
changes on the mTOR pathway gene expression were detected by graded dietary BCAA
concentration in 20 d birds. It is possible that differences may have been present if the same
analysis were carried out for younger birds (≤ 7 d). On the other hand, the expression of
the corresponding proteins in the mTOR pathway was not determined in the current study.
Because gene expression cannot be equated with protein expression and subsequent
functions, further experiments measuring the protein activity of regulatory pathways as
well as fractional protein synthesis rate upon dietary BCAA modification are necessary to
better elucidate the effects of BCAA on protein synthesis. Nevertheless, the breast muscle
weight, a major outcome of protein synthesis, was significantly decreased by AFB 1 while
increased by higher BCAA. Our observations herein emphasize the complexity of the
dynamic relationship between aflatoxicosis and dietary nutrients. Under the current
experimental conditions, it can be concluded that higher BCAA is able to improve growth
performance of broiler chicks regardless of AFB1 exposure, but may influence other
functions of the animal (e.g. nutrient digestibility, serum measures). While higher dietary
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crude protein was able to completely ameliorate aflatoxicosis through higher supply of
protein synthesis substrates in prior work (Chen et al., 2015), the beneficial effects of
higher BCAAs in the current study may have come from stimulated feed intake together
with enhanced feed efficiency. Clearly, the exact roles that BCAA and their metabolites
play in poultry with or without AFB1 exposure and the respective mechanisms await further
research to better understand the perplexing AF-diet interactions.
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Table 7.1. Ingredient composition of basal ration (as-fed basis)
Item
Corn
Soybean meal
Corn starch
Vitamin and Trace mineral
Premix1
Monocalcium phosphate
Limestone
Sodium chloride
Soybean oil
L-lysine HCl
DL-methionine
L-threonine
L-tryptophan
Arginine
L-valine
Glycine
L-isoleucine
Cr2O3
Calculated analysis
Crude Protein (%)
Metabolizable Energy
(kcal/kg)
Lysine, %
Thr, %
Met, %
Met+Cys, %
Leu, %
Ile, %
Val,%
Ca, %
Total P, %
Non-phytate P
1

Starter diet
55.2
35.4
---

Composition (%)
Low-BCAA Med-BCAA
41.9
44.4
19.9
19.0
20.4
19.2

High-BCAA
44.8
19.0
19.2

0.35

0.35

0.35

0.35

1.8
1.8
0.47
4.23
0.30
0.32
0.12
-------------

2.0
1.9
0.47
3.95
0.97
0.49
0.49
0.09
0.37
0.20
5.87
0.14
0.5

2.0
1.9
0.47
2.68
1.00
0.50
0.50
0.10
0.40
0.77
4.90
0.62
0.5

2.0
1.9
0.47
1.53
1.00
0.50
0.50
0.10
0.40
1.33
3.9
1.09
0.5

22.07

22.55

22.55

22.55

3,184

3,184

3,184

3,184

1.43
0.94
0.65
1.12
1.88
0.91
1.01
1.15
0.78
0.51

1.47
0.98
0.70
1.00
1.16
0.68
0.80
1.15
0.67
0.50

1.47
0.98
0.70
1.01
1.94
1.13
1.34
1.15
0.67
0.50

1.47
0.98
0.70
1.01
2.73
1.60
1.88
1.15
0.67
0.50

Supplied the following per kilogram of diet: vitamin A, 13,233 IU; vitamin D 3, 6,636 IU; vitamin E,
44.1 IU; vitamin K, 4.5 mg; thiamine, 2.21 mg; riboflavin, 6.6 mg; pantothenic acid, 24.3 mg; niacin,
88.2 mg; pyridoxine, 3.31 mg; folic acid, 1.10 mg; biotin, 0.33 mg; vitamin B 12, 24.8 µg; choline,
669.8 mg; iron from ferrous sulfate, 50.1 mg; copper from copper sulfate, 7.7 mg; manganese from
manganese oxide, 125.1 mg; zinc from zinc oxide, 125.1 mg; iodine from ethylene diamine
dihydroidide, 2.10 mg; selenium from sodium selenite, 0.30 mg.
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Table 7.2. Cumulative performance and breast muscle weight of chicks from 6 to 20 d of
age fed varying concentrations of branched chain amino acids (BCAA) with or without
1.5 mg/kg AFB1

Dietary treatment

d 6-20
BWG1
(g/bird)

d 6-20 FI1
(g/bird)

d 6-20 G:F1
(g/bird)

Breast
Muscle
Weight2 (g)

Relative
Breast
Muscle
Weight2
(% BW)

Low-BCAA

116

209

0.56

22.24

9.1

Low-BCAA + AFB1

101

211

0.48

22.09

9.6

Med-BCAA

251

379

0.66

41.44

11.0

Med-BCAA + AFB1

219

362

0.61

29.54

8.6

High-BCAA

346

553

0.63

49.00

9.6

High-BCAA + AFB1

345

567

0.62

42.58

9.1

SEM

11.0

12.9

0.03

3.27

0.78

0
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380

0.62

37.56

9.9

1.5

222

380

0.57

31.40

9.1

Low

109 c

210 c

0.52 b

22.16 c

9.4

Medium

235 b

370 b

0.64 a

35.49 b

9.8

High

346 a

560 a

0.62 a

45.79 a

9.4

AFB1

0.087

0.44

0.035

0.049

0.23

BCAA

<0.0001

<0.0001

0.0002

<0.0001

0.81

0.37

0.51

0.45

0.21

0.25

Main effect means
AFB1

BCAA

P-values

Interaction

in a column with no common superscripts are significantly different (P ≤ 0.05)
Simple effect means represent 8 cages per treatment, 6 birds per pen.
2 Simple effect means represent 8 cages per treatment, 2 birds per pen.

a-c Means
1

Table 7.3. Weekly performance of chicks from 6 to 20 d fed varying concentrations of branched chain amino acids (BCAA) with
or without 1.5 mg/kg AFB1 1
Dietary treatment
Low-BCAA
Low-BCAA + AFB1
Med-BCAA
Med-BCAA + AFB1
High-BCAA
High-BCAA + AFB1

BWG (g/bird)
d 6-13
d 13-20
39.0
77.0
34.8
66.6
88.7
161.9
72.4
146.2
115.7
230.3
111.5
233.8

Feed Intake (g/bird)
d 6-13
d 13-20
79.8
129.9
79.1
131.4
129.1
250.1
123.4
240.0
176.8
376.5
174.6
397.0

G:F ratio (g:g)
d 6-13
d 13-20
0.49
0.60
0.44
0.51
0.69
0.65
0.59
0.61
0.65
0.62
0.64
0.61

SEM

4.43

8.01

3.99

10.43

0.031

0.036

Main effect means
AFB1
0
1.5

81.1 a
72.9 b

156.4
148.9

128.5
125.7

252.1
256.1

0.61 a
0.55 b

0.62 a
0.58 b

36.9 c
80.5 b
113.6 a

71.8 c
154.1 b
232.1 a

79.4 c
126.2 b
175.7 a

130.7 c
245.1 b
386.7 a

0.46 b
0.64 a
0.64 a

0.56 b
0.63 a
0.61 ab

0.04
<0.0001
0.42

0.10
0.10
0.49

BCAA

Low
Medium
High

P-values
AFB1
0.03
0.26
0.39
0.80
BCAA
<0.0001
<0.0001
<0.0001
<0.0001
Interaction
0.30
0.47
0.8172
0.36
a-c
Means in a column with no common superscripts are significantly different (P ≤ 0.05)
1
Simple effect means represent 8 cages per treatment, 6 birds per pen.
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(a) Y=-0.68 + 0.45X, R2 = 0.99, P < 0.0001

(b) Y = - 0.07 + 0.66X, R2 > 0.99, P < 0.0001

10

-5
-10

-30

Δ FI

15

-45

-25

-5
-10

Δ FI

-30

15

-45

-25

-5

Δ BWG

-25

10

10

Δ BWG

Δ BWG

-45

(c) Y = 0.041 + 0.71 X, R 2 > 0.99, P < 0.0001
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Figure 7.1. Relationship between the change in BW gain (ΔBWG) and feed intake (ΔFI) of 20-d broiler chicks challenged with
1.5 mg/kg AFB1 when fed a low-BCAA (a), medium-BCAA (b), or high-BCAA (c) diet. Each dot represents the percentage
difference between challenged birds (n = 8 replicates per BCAA group) and the average of unchallenged birds fed the same diet.
R2: coefficient of correlation. P-value: level of significance.
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Mean growth response (% of
unchanllenged)

Low-BCAA
0.0

Med-BCAA

High-BCAA

-0.07

0.04
-0.14

-0.68

-2.0

-4.0

-5.58
-8.36

-6.0
-8.0
-10.0

Maintenance

Feed efficiency

Figure 7.2. Partitioning of the reduction in average BW gain in 20-d broiler chicks following a 1.5 mg/kg AFB1 challenge between
the fraction due to change in maintenance requirement or due to the change in feed efficiency. Fraction due to change in
maintenance = the intercept of respective linear regression equation (Figure 1). Fraction due to change in feed efficiency = total
response – fraction due to change in maintenance.
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Table 7.4. Serum biochemistry of 20-d chicks fed varying concentrations of branched chain amino acids (BCAA) with or without
1.5 mg/kg AFB1 1
Glucose
(mg/dL)
351
367
362
355
351
347
21.8

Albumin
(g/dL)
1.18
1.21
1.15
1.06
1.08
1.00
0.03

Total
Protein
(g/dL)
2.91 ab
3.03 a
2.89 ab
2.69 bc
2.71 b
2.59 c
0.07

355
356

1.14
1.09

2.84
2.77

1.70
1.68

12.15
12.01

99.90
108.30

9.50
10.13

9.20
9.87

Low
Medium
High

359
359
349

1.20 a
1.11 b
1.04 c

2.97 a
2.79 b
2.65 c

1.78 a
1.68 b
1.61 b

12.16
11.90
12.19

102.1 b
94.6 b
115.7 a

10.94 a
9.25 b
9.25 b

7.28 b
8.61 b
12.73 a

AFB1
BCAA
Interaction

0.91
0.89
0.85

0.095
<0.0001
0.13

0.28
0.0003
0.077

0.58
0.0043
0.11

0.57
0.53
0.17

0.034
<0.0001
0.32

0.19
0.0063
0.39

0.40
<0.0001
0.88

Dietary treatment
Low-BCAA
Low-BCAA + AFB1
Med-BCAA
Med-BCAA + AFB1
High-BCAA
High-BCAA + AFB1
SEM
Main effect means
AFB1
0
1.5
BCAA

Globulin
(g/dL)
1.74
1.83
1.74
1.63
1.64
1.59
0.05

Ca
(mg/dL)
11.91
12.41
12.11
11.69
12.44
11.94
0.29

AST 2
(U/L)
100.00
104.13
92.13
97.13
107.63
123.71
4.27

GGT 3
(U/L)
11.00
10.88
9.00
9.50
8.50
10.00
0.58

Uric acid
(mg/dL)
6.76
7.79
8.48
8.75
12.38
13.09
0.75

P-values

Means in a column with no common superscripts are significantly different (P ≤ 0.05). 1 Simple effect means represent 8 cages
per treatment, 2 birds per pen.2 AST= Aspartate transaminase.3 GGT= Gamma glutamyl transpeptidase
a-c
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Table 7.5. Jejunum villus histology of 20-d old chicks fed varying concentrations of
branched chain amino acids (BCAA) with or without 1.5 mg/kg AFB11

Dietary treatment
Low-BCAA
Low-BCAA + AFB1
Med-BCAA
Med-BCAA + AFB1
High-BCAA
High-BCAA + AFB1
SEM

Villus height
(μm)
535
490
604
553
592
581

Crypt Depth
(μm)
84
81
88
86
79
97

VH:CD ratio
6.46
6.17
7.06
6.57
7.63
6.01

35.1

5.7

0.48

574
539

85
89

6.90
6.13

Main effect means
AFB1

0
1.5

BCAA

Low
Medium
High

508 b
582 a
579 ab

82
91
89

6.27
6.62
6.65

AFB1
BCAA
Interaction

0.21
0.078
0.86

0.36
0.30
0.27

0.053
0.70
0.49

P-values

Means in a column with no common superscripts are significantly different (P ≤ 0.05)
Simple effect means represent 8 birds per treatment; 10 villi per intestinal segment were
measured per bird
a-b
1

Table 7.6. Apparent N and amino acid digestibility (%) of 20-d old chicks fed varying concentrations of branched chain amino
acids (BCAA) with or without 1.5 mg/kg AFB11
Dietary treatment

N

Asp

Thr

Ser

Glu

Pro

Gly

Ala

Cys

Val

Met

Ile

Leu

Tyr

Phe

Lys

His

Arg

Low-BCAA

90.7

87.1

89.3

83.6

92.6

86.9

98.4

88.1

77.8

89.5

97.5

89.4

89.5

87.3

89.1

95.0

88.1

94.4

Low-BCAA + AFB1

92.3

91.3

91.3

88.9

94.9

90.7

98.6

91.5

83.2

92.0

98.3

92.4

92.4

91.2

92.3

95.9

91.8

95.9

Med-BCAA

88.9

85.8

86.5

83.4

91.8

85.9

97.6

86.2

72.5

92.0

96.5

92.7

92.7

86.3

88.1

94.3

87.7

94.1

Med-BCAA + AFB1

90.8

86.6

89.9

84.6

92.3

86.5

98.2

87.6

74.7

93.9

97.2

93.5

93.6

86.9

88.6

94.7

88.5

94.6

High-BCAA
High-BCAA +
AFB1

87.1

79.9

86.2

79.2

88.4

81.6

96.4

82.5

65.6

93.9

95.0

92.6

93.2

82.1

83.6

92.4

83.6

92.0

88.1

81.6

88.5

79.5

89.0

82.5

97.2

83.1

69.2

95.1

95.7

93.7

94.1

82.7

83.8

93.4

84.7

92.9

SEM

0.57

1.08

0.61

1.08

0.66

0.92

0.15

0.88

1.61

0.41

0.25

0.46

0.46

0.90

0.98

0.38

0.87

0.44

0

88.9 b

84.3 b

87.3 b

82.1 b

90.9

84.8

97.4 b

85.6 b

72.0 b

91.8 b

96.3 b

91.6 b

91.8 b

85.2

86.9

93.9 b

86.5 b

93.5 b

1.5

90.4 a

86.5 a

89.9 a

84.3 a

92.1

86.6

98.0 a

87.4 a

75.7 a

93.7 a

97.1 a

93.2 a

93.4 a

86.9

88.3

94.7 a

88.3 a

94.5 a

Low

91.5 a

89.2 a

90.3 a

86.2 a

93.8 a

88.3 a

98.5 a

89.8 a

80.5 a

90.7 c

97.9 a

90.9 b

90.9 b

89.2 a

90.7 a

95.4 a

90.0 a

95.1 a

Med

89.9 b

86.2 b

88.2 b

84.0 a

92.1 b

86.2 b

97.9 b

86.9 b

73.6 b

93.0 b

96.9 b

93.1 a

93.2 a

86.6 b

88.3 a

94.5 a

88.1 a

94.4 a

High

87.6 c

80.7 c

87.4 b

79.4 b

88.7 c

82.1 c

96.8 c

82.8 c

67.4 c

94.5 a

95.4 c

93.2 a

93.6 a

82.4 c

83.7 b

92.9 b

84.1 b

92.5 b

Main effect means
AFB1

BCAA

P-values
AFB1

0.0139

0.09

0.0001

0.12

0.18

0.13

0.0002

0.1001

0.0380

<.0001

0.0064

0.0020

0.0026

0.16

0.33

0.0418

0.08

0.0500

BCAA

<.0001

<.0001

0.0023

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

0.0010

0.0002

<.0001

<.0001

<.0001

<.0001

<.0001

0.69

0.45

0.57

0.17

0.51

0.35

0.28

0.46

0.74

0.43

0.99

0.18

0.20

0.28

0.43

0.66

0.41

0.69

Interaction

Means in a column with no common superscripts are significantly different (P ≤ 0.05)
Simple effect means represent 8 cages per treatment, 6 birds per pen.

a-c
1
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Table 7.7. Jejunum, muscle, and liver gene expression of 20-d old chicks fed varying concentrations of branched chain amino
acids (BCAA) with or without 1.5 mg/kg AFB1 1, 2

Dietary treatment
Low-BCAA
Low-BCAA + AFB1
Med-BCAA
Med-BCAA + AFB1
High-BCAA
High-BCAA + AFB1
SEM

S6K1

Muscle
mTOR
4EBP1

S6K1

mTOR

Liver
4EBP1

S6K1

1.39
1.13
1.39
1.68
0.83
1.16
0.05

2.13
0.79
1.29
2.09
0.86
1.04
0.08

1.27
0.85
1.45
1.41
1.02
1.50
0.02

1.15
1.35
1.01
2.05
1.61
1.81
0.03

1.12
1.44
0.93
1.89
1.11
1.89
0.08

1.14
1.25
1.06
2.32
1.26
2.14
0.05

1.75
2.63
2.54
2.28
1.63
2.57
0.06

2.36
2.64
3.31
3.13
1.64
1.43
0.64

1.44
2.83
2.75
2.89
1.54
2.10
0.05

1.20
1.32

1.43
1.31

1.25
1.26

1.26
1.74

1.05
1.74

1.15
1.90

1.97
2.49

2.44
2.40

1.91
2.61

Low
Medium
High

1.26
1.54
0.99

1.46
1.69
0.95

1.06
1.43
1.26

1.25
1.53
1.71

1.28
1.41
1.50

1.20
1.69
1.70

2.19
2.41
2.10

2.50
3.22
1.54

2.13
2.82
1.82

AFB1
BCAA
Interaction

0.23
0.93
0.95

0.87
0.69
0.14

0.39
0.55
0.30

0.19
0.42
0.77

0.13
0.84
0.98

0.071
0.55
0.41

0.90
0.36
0.95

0.49
0.23
0.92

0.82
0.31
0.93

Main effect means
AFB1
0
1.5
BCAA

mTOR

Jejunum
4EBP1

P-values

Means in a column with no common superscripts are significantly different (P ≤ 0.05)
Simple effect means represent 8 birds per treatment
P-values and SEM are based on Box-Cox transformation

a-b
1
2
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CHAPTER 8. CYTOTOXICITY OF VARIOUS CHEMICALS AND MYCOTOXINS
IN FRESH PRIMARY DUCK EMBRYONIC FIBROBLASTS: A COMPARISON
TO HEPG2 CELLS

8.1

Abstract

To cost-effectively screen the overall toxicity of a sample, especially in the case of
food and feed ingredient quality control, a sensitive bioassay is necessary. With the wide
variety of cytotoxicity assays, performance comparison between assays using different
cells has become of interest. Fresh primary duck embryonic fibroblasts (DEF) were
hypothesized to be a sensitive tool for in vitro cytotoxicity screening; cell viability of DEF
in response to various cytotoxins was determined and compared with response of HepG2
cells. The IC50 values obtained by alamar blue assay in DEF cells had high correlation (r2
= 0.96) with those obtained in HepG2 cells. Within the same toxin, primary DEF yielded
significantly lower IC50 values than that obtained from HepG2 cells using the MTT and
Alamar blue assay. Additionally, primary DEF responded to all mycotoxins tested using
the alamar blue assay, while HepG2 was less sensitive, especially at short exposure times.
The estimated IC50 for aflatoxin B1, fumonisins B1, and deoxynivalenol in DEF after 72h
incubation were 3.69, 4.19, and 1.26 μg/ml, respectively. Results from the current study
suggest that primary DEF are more sensitive to cytotoxins and mycotoxins compared to
HepG2, and thus may have great potential as an effective tool for cytotoxicity assessment.
The question remains whether in vitro IC50 values can accurately predict in vivo toxicity,
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however, the current study accentuates the need for further attention to identify sensitive
cell models for in vitro cytotoxicity screening and subsequent exploration of speciesspecific prediction models for in vivo toxicity.

8.2

Introduction

Constituents in food or feed ingredients are often at the risk of contamination with
various toxic or hazardous compounds, which may result in harmful effects to the health
of consumers and animals. To ensure the health of both humans and animals, rapid and
economic bioassays that evaluate the potential toxicity of various compounds without the
use of whole animal testing are desired (Gutleb et al., 2002; Jondeau et al., 2006; Cheli et
al., 2014). Modern analytical methods such as liquid or gas chromatography-mass
spectrometry are able to identify and quantify different compounds with excellent
sensitivity and accuracy. However, these methods can be less powerful when the sample
contains unknown toxins (where no standards are available) or contains multiple toxins
that have interactive effects (e.g. additive or synergistic effects of two mycotoxins).
Therefore, a rapid and sensitive bioassay that cost-effectively screens the overall toxicity
of a sample regardless of the chemical characteristics or the underlying mechanism is
necessary.
The use of cell culture models to assess cytotoxicity of xenobiotics has gained its
popularity as it is capable of high-throughput screening when combined with microplate
assays (Crespi, 1995). Because of their unlimited life-span and stable phenotype, various
established cell lines are convenient in vitro models for such purpose; among them, the
human hepatoma cell line HepG2 is one of the most extensively used cell models. The
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HepG2 cells retain many features of normal liver cells, and display liver-specific metabolic
responses to different chemicals (Knowles eta l., 1980). In addition, these cells also are
shown to be slightly more sensitive to cytotoxic compounds compared to other commonly
used cell lines, such as HeLa or ECC-1 cells (Schoonen et al., 2005). However, established
cell lines that have gone through numerous passages may have lost a significant portion of
the in vivo characteristics. For instance, HepG2 cells have been shown to express low
cytochrome P450 activities and thus low biotransformation activity in comparison with the
human liver (Rodriguez-Antona et al., 2002). Thus the information obtained from cell lines
about cytotoxicity is limited to the intrinsic toxicity of the parent compound (RodriguezAntona et al., 2002). Compared with established cell lines, fresh primary cells that are
isolated directly from an animal (with no passages) are considered to be the closest
representation of in vivo organismal characteristics. The use of primary hepatocytes can
provide valuable information on the metabolic activities of activation or detoxification of
various compounds (Henstler et al., 2000), but they are often technically difficult to obtain.
On the other hand, derived from mesoderm, fibroblasts are relatively undifferentiated cells
that have high abundance in connective tissue (Garfield, 2010). The extraction of primary
embryonic fibroblasts, whether from mouse or other animals, has been well documented
and is relatively easy to perform (Couchman et al., 1982; Xu, 2005; Garfield, 2010); these
cells are often used as a tool to investigate gene functions and assess drug activities (Lowe
et al., 1993; Hoki et al., 2003; Yang et al., 2009). Compared to mammal embryos, fertilized
eggs from poultry species are of high availability and their embryos are easier to obtain for
further cell extraction. Because ducks are known to be extremely sensitive to various toxic
compounds, such as aflatoxin (Bintvihok, 2011; Chen et al., 2014), primary duck
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embryonic fibroblasts (DEF) may also retain high sensitivity to various cytotoxins in vitro
and thus be a potential versatile tool in many branches of toxicity research.
Numerous in vitro cytotoxicity assays with different endpoints are available for cell
culture. The most commonly used endpoint is primarily based on cell viability. The 3-[4,5dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay, first developed by
Mosmann (Mosmann, 1983), uses colorimetric measurement to quantify viable cells after
being treated with toxic compounds. It is based on the reduction of a yellow soluble
tetrazolium salt to a blue insoluble MTT formazan product by mitochondria enzymes. The
alamar blue assay is based on the ability of living cells to convert a redox dye (resazurin)
into a fluorescent end product (resorufin) (O’Brien et al, 2000), which soon gained its
popularity as a simple and rapid test without any washing steps. Also, alamar blue is not
toxic to cells and the assay does not require killing of the cells to obtain measurements, as
with the MTT assay, which permits monitoring of the cell kinetics without compromising
the cultures (O’Brien et al., 2000). Alamar blue has been shown to be useful in measuring
cytotoxicity and proliferation of cells in adherent and non-adherent human and animal cell
lines (Fields, 1993; Shahan et al., 1994). In addition, several researchers have suggested a
higher sensitivity of alamar blue assay compared to others, including the MTT assay (Pagé
et al., 1993; Hamid et al., 2003). Therefore, for the current study, our objective was to
determine the responses of primary DEF to various chemicals and mycotoxins using the
alamar blue and/or MTT cell viability assays, and compare with responses of HepG2 cells.
The hypothesis was that fresh primary DEF may exhibit higher sensitivity in response to
various toxins compared to HepG2 cells.
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8.3
8.3.1

Materials and Methods

Chemicals and Reagents
Eagle’s minimum essential medium (EMEM), fetal bovine serum (FBS), penicillin

(10,000 IU/mL) and streptomycin (10,000 μg/mL) solution, and 0.25% trypsin/0.53 mM
EDTA solution were purchased from ATCC (Manassas, VA ). Phosphate buffered saline
without Ca2+ and Mg2+ (PBS), dimethylsulfoxyde (DMSO), Medium 199, HEPES, Lglutamine, sodium bicarbonate, 0.4% trypan blue solution, sodium lauryl sulfate (SLS,
purity > 98.5%), acrylamide (purity > 99%), allyl alcohol (purity > 99%), copper sulfate
(purity > 99%), phenol (purity > 99%), nitrobenzene (purity > 99%), tetrachloroethylene
(purity > 99%), thiazolyl blue tetrazolium bromide (MTT), aflatoxin B1 (from Aspergillus
flavus), fumonisins B1 (from Fusarium moniliforme), and deoxynivalenol (DON) were
purchased from Sigma-Aldrich (St. Louis, MO). The alamar blue assay kit (CellQuantiBlue kit, CQBL004) was purchased from BioAssay systems (Hayward, CA)

8.3.2

Cell and Culture Media
Pekin duck embryos at E14 were obtained from a commercial hatchery (Maple Leaf

Farms, Leesburg, IN). Primary duck embryonic fibroblasts (DEF) were then extracted by
trypsinization after the embryo was decapitated, eviscerated, and homogenized. Fresh
primary DEF were plated in 96-well culture plates (Corning, Tewksbury MA) at a density
of 2.5 x 106 viable cells/ml using medium 199 (Gibco) containing 3% FBS, 10 mM HEPES,
1% penicillin- streptomycin mixture, 2 mM L-glutamine, and 1.9 g/L sodium bicarbonate.
Only fresh primary DEF (without passage) were used in subsequent cytotoxicity assays.
The HepG2 human hepatoma cell line was obtained from American Tissue Culture
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Collection (ATCC HB-8065, Manassas, VA). Cells were seeded in 75-cm2 tissue culture
flasks in EMEM supplemented with 10% FBS, and 1% penicillin-streptomycin mixture.
Cells were harvested by trypsinization and their viability was assessed by Trypan Blue
Exclusion test. The cells were then plated in 96-well culture plates at a density of 2.5 x 105
viable cells/ml. Both primary DEF and HepG2 cells were incubated overnight and
maintained in a humidified atmosphere at 37°C and 5% CO2.

8.3.3

Concentration-response Curve

After an overnight incubation in 96-well plates, the medium was removed and cells
were exposed to test chemicals for 24 h in 100 μL of respective fresh cell culture media
with reduced serum content. Seven chemicals that cover a range of toxicity potential were
tested in each assay in a dose response manner by direct addition in medium: sodium lauryl
sulfate (SLS) (0.01 to 1.73 mM), acrylamide (1.1 to 141 mM), allyl alcohol (1.72 to 221
mM), copper sulfate (0.001 to 3.13 mM), phenol (0.53 to 67.8 mM) or after dissolution in
DMSO at a final concentration of 0.1% (v/v): nitrobenzene (0.13 to 291 mM), and
tetrachloroethylene (2.29 to 294 mM). All chemicals were tested by MTT and alamar blue
assays in both DEF and HepG2 cells. For toxicity evaluation of mycotoxins, the AFB1, FB1,
and DON were dissolved in ethanol to a stock concentration of 1 mg/ml and diluted using
respective media upon use. Both DEF and HepG2 cells were treated by the 3 mycotoxins,
respectively, from 0.08 to 10 μg/ml for 24, 48, or 72 h, and were tested by alamar blue
cytotoxicity assay. For all assays, control cells were exposed to media only or medium
containing vehicle. Each concentration was tested in replicates of 3 wells, and the reported
results are the mean of at least three independent experiments.
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8.3.4

Cytotoxicity Assays

The alamar blue assay was performed using the CellQuanti-Blue assay kit (BioAssay
systems, CQBL004). Two hours before the end of the treatment incubation, 10 μl reagent
was added to each well. Plates were returned to the incubator and the fluorescence intensity
was read after 2 hours (excitation wavelength = 540 nm, emission wavelength = 600 nm).
The percent viability is expressed as blank-corrected fluorescence emitted by treated cells
compared to control.
For MTT assay, the MTT was dissolved in sterile PBS at 5 mg/ml, and a volume of 10
μL was added to each well. After 4 h incubation, the medium was discarded from all wells,
and 100 μL of DMSO was added to dissolve the end product, formazan. The absorbance
was then read at 570 nm and background absorbance was read at 690 nm. Cell viability
was calculated by [(A570 – A690)test/(A570 – A690)control] x 100.

8.3.5

IC50 Value Calculation and Statistics

GraphPad Prism 6 software (GraphPad Prism Software Inc., San Diego, CA) was used
to calculate the concentration associated with 50% inhibition of cell viability (IC50 values)
using a Hill function, non-linear regression analysis. The IC50 values were analyzed by 2way ANOVA using SAS system (SAS 9.4, Cary, NC) for a completely randomized design
to determine the sensitivity of each assay. The model included main effects of cell (primary
DEF or HepG2), assay (MTT or alamar blue), and their interaction. For assay comparisons,
the IC50 values were transformed in log values and analyzed by linear regression using
GraphPad Prism 6 software.
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8.4
8.4.1

Results

In vitro Toxicity of Testing Chemicals

The concentration-response curves of the 7 testing chemical in primary DEF and
HepG2 cells are shown in Figure 8.1 and Figure 8.2, respectively. All curves have an r2 ≥
0.80, with the exception of nitrobenzene in DEF (r2 = 0.67) and tetracholoethylene in
HepG2 (r2 = 0.72) using the MTT assay. The toxicological potential of the testing
compounds in both DEF and HepG2 cells, expressed by their IC50 values, is summarized
in Table 1. Regardless of the assay used, tetracholoethylene showed the highest IC50 value
(≥ 25.91 mM) in both DEF and HepG2 cells, suggesting the lowest toxicity. Copper sulfate
and sodium lauryl sulfate (SLS) showed the highest toxicity with IC50 values lower than
0.65 mM. The cytotoxic effects of acrylamide, allyl alcohol, phenol, and nitrobenzene were
intermediate for both cell types.
Compared to MTT assay, alamar blue assay in both DEF and HepG2 generated better
goodness of fit, with all testing compounds having an r2 ≥ 0.90 (Figure 8.1 and 8.2). Within
the same testing compound, primary DEF generally yielded significantly lower IC50 values
than that obtained from HepG2 cells (cell main effect; P ≤ 0.0003 for 6 out of 7 chemicals).
When the alamar blue assay was used, primary DEF showed the lowest IC 50 value in
response to all treatments except for copper sulfate (cell by assay interaction; P < 0.0003),
indicating that primary DEF were more sensitive to the toxicity of xenobiotics compared
to HepG2 cell line.
Using the respective IC50 values obtained, a comparison of methods was performed by
linear regression analysis (Figure 8.3). The relationship between methods were expressed
by their equations of regression. All cell-assay combinations showed high correlation (r2 >
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0.80) of the IC50 values. The best correlations were obtained between DEF-alamar blue
method and HepG2-MTT method (r2 = 0.962) with a slope close to 1.0 (Y=0.96X + 0.52),
indicating that these two methods are interchangeable for assessing in vitro cytotoxicity
when ranking of toxicity potential is desired.

8.4.2

In vitro Toxicity of AFB1, FB1, and DON

The concentration-response curves of AFB1, FB1, and DON tested in primary DEF and
HepG2 cells are shown in Figure 8.4. A difference in cell sensitivity was observed for all
mycotoxins. In HepG2 cells, cell viability was not affect by treatments until cells were
incubated for 72h. On the contrary, primary DEF were more responsive to the mycotoxin
treatments, and the reduction in cell viability increased as exposure time increased. All
curves from primary DEF had an r2 ≥ 0.70, whereas multiple curves from HepG2 cells
failed to fit the Hill function, non-linear regression model due to a lack of cell response,
and thus no IC50 values were calculated from those curves. Based on the obtained IC50
(Table 2), with increasing exposure time, the IC50 values (μg/ml) decreased and the
goodness of fit was improved. In primary DEF, IC50 for AFB1, FB1, and DON upon 72h
incubation were 3.69, 4.19, and 1.26 μg/ml, respectively, suggesting an in vitro toxicity
ranking of DON > AFB1 > FB1 in primary DEF. In HepG2 cells, the IC50 values were 12.55
μg/ml for AF and 51.46 μg/ml for DON (72h exposure), which were higher than those
obtained from DEF cells.
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Discussion

With a wide variety of in vitro cytotoxicity assays that rely on different mechanisms
or endpoints, performance comparison between assays using different cells (primary or
established cell lines) has become of interest (Gutlet et al., 2002; Jondeau et al., 2006; Cheli
et al., 2014). In this current study, we investigated the potential of fresh primary DEF as
an in vitro cytotoxicity screening tool, and compared its response with that of HepG2 cells
using MTT and/or alamar blue assays.
Although the relevance of in vitro cytotoxicity results to in vivo responses remains an
important issue, the IC50 value, concentration of a compound that inhibits 50% of the cell
viability in vitro, may help predict in vivo toxicity (Clemedson and Ekwall, 1999; Ekwall
et al., 2000; Halle, 2002). The 7 test chemicals herein represent a variety of cytotoxins that
are potential feed and food contaminants. For instance, acrylamide exists in many cooked
or heated foods and is of concern as a possible carcinogen; allyl alcohol is well-known
hepatotoxicant that is often used as a raw material for glycerol and oil production; whereas
phenol is largely used for plastic synthesis and thus food packaging, it is corrosive to the
eyes, skin, and respiratory tract, and is toxic to intestinal organs and the central nervous
system. These compounds were chosen to cover a range of toxic potentials, with reported
IC50 values varying from 0.05 to 145 mM (Halle, 2002). Sodium lauryl sulfate (SLS) is a
commonly used anionic surfactant in cleaning and hygiene products, pharmaceutical
vehicles, and foods. Prolonged exposure of SLS is shown to cause skin irritation and
aphthous ulcers, along with the ability to induce cytolytic process and cellular damage
(Effendy and Maibach, 1995). Indeed, among all testing chemicals, SLS showed the lowest
IC50 values regardless of cell type or assay used, with the DEF-alamar blue assay
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generated the lowest IC50 (0.065 mM). Copper sulfate is an inorganic metal salt that
commonly exists in drinking water; it is known to cause nausea, diarrhea, and other severe
symptoms including liver or kidney injury upon exposure. In rabbits, the lowest possible
toxic concentration of copper sulfate was reported to be 3.7 μg/mL (0.024 mM)
(Roychoudhury et al., 2010). Consistently, in the current study, its IC50 was also at the
lower end in all assays (≤ 0.633 mM), indicating strong cytotoxicity potential. Likewise,
the toxicity potential of other chemicals tested in the current study was consistent with
previous reports (Halle, 2002; Jondeau et al., 2006), but their respective IC50 values were
generally lower in DEF cells compared to that in HepG2 cells regardless of the cytotoxicity
assay used, suggesting higher sensitivity of the fresh primary DEF cells. Compared to
established cell lines, fresh primary cells can be more difficult to obtain without access to
the animal, and can require specialized handling techniques to ensure harvest of
consistently homogeneous cell populations. Nevertheless, higher sensitivity of fresh
primary DEF to cytotoxins herein compared to HepG2 cells highlights their potential
application in future in vitro cytotoxicity screening, but much attention should be given
when transitioning a research model to a test model to the optimization and standardization
of the protocols (Cheli et al., 2014).
Both cytotoxicity assays used in this study, the MTT and the alamar blue assay, rely
on enzymatic transformation of the assay reagent. While MTT is based on the activity of
mitochondrial succinic dehydrogenases, both cytosolic and mitochondria enzymes are
suggested to be involved in alamar blue reaction (O’Brien et al., 2000; Gonzalez et al.,
2001). From our results, lower variations (standard error of IC50) have been observed for
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alamar blue assay in comparison to MTT assay regardless of the cell type used, which is in
agreement with previous report (Nociari et al., 1998). Interestingly, a significant interaction
of IC50 of the 7 testing chemicals between cell type and the assay was observed in the
current study. In primary DEF cells, the alamar blue assay generally yielded similar or
lower IC50 values as expected compared to that from MTT assay. Conversely, in HepG2
cells, IC50 values from the MTT assay were significantly lower than that from the alamar
blue assay with the exception of SLS. Possible altered mitochondria enzyme activity in
HepG2 cells compared to primary cells might be an explanation (Rodriguez-Antona et al.,
2002), which may lead to a reduced transformation of MTT, resulting in overestimation of
sample toxicity. On the other hand, different responses may be observed if alternative
cytotoxicity assays based on other cell functions were employed. For instance, the LDH
assay, which measures the leakage of intracellular lactate dehydrogenase (LDH) into the
culture medium upon cell membrane damage, may detect the toxicity response at a later
stage than MTT assay if exposed to a mitochondrial toxin (Fotakis and Timbrell, 2008).
Thus, cell responses to the same compound can vary depending on multiple factors,
including the nature of the assay, the choice of cells, exposure time and concentrations, etc.
Indeed, standardization and interpretation of in vitro cytotoxicity screening can be a
complex process; thus it is important to employ multiple primary cells and cell lines from
different origins when developing and validating a cytotoxicity bioassay. In the current
study, consistently better responses of primary DEF cells to the alamar blue assay could be
an initial indication that this cell-assay combination in particular could be a more reliable
and sensitive tool for cytotoxicity screening, but future comparative studies including other
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cell types besides HepG2 as well as other cytotoxicity assays are needed to verify the
sensitivity of DEF for in vitro toxicity screening.
Because alamar blue permits a simpler and more reproducible method for screening
overall toxicity compared to MTT assay, we chose to evaluate the in vitro toxicity of 3
mycotoxins using the alamar blue assay. As secondary metabolites of Aspergillus and
Fusarium species, AFB¬1, FB1, and DON are known to be highly prevalent contaminants
in a variety of food and feedstuffs. When consumed by humans or animals, these
mycotoxins

can

cause

diverse

toxic

effects

including

growth

depression,

immunosuppression, liver damage, and carcinogenic effects (Mirocha and Christensen,
1974; Rotter, 1996; Henry et al., 1999; Chen et al., 2014). Similar to our results with testing
chemicals, a difference in cell sensitivity has been observed for the three mycotoxins tested.
Primary DEF cells were able to detect all mycotoxins under current experimental
conditions, while HepG2 cells were less sensitive, especially at shorter exposure times. The
IC50 values obtained herein suggested that DON had the strongest toxicity in primary DEF
cells (1.26 μg/ml or 4.25 μM). In Caco-2 cells, the IC50 for DON was shown to be 21.5
μM (Kouadio et al., 2005), which is more than 4 fold higher than our result. For FB1, our
estimated IC50 based on 48 and 72 h incubation was 14.27 μg/ml (19.8 μM) and 4.19 μg/ml
(5.8 μM), respectively, while Creppy et al. (2004) reported that IC50 values of FB1 were
45, 31, and 64 uM in C6 glioma cells, Caco-2 cells, and Vero cells after 48 h incubation.
With an IC50 of 3.69 μg/ml (11.8 μM) in primary DEF, toxicity potential of AFB1 was
intermediate of the 3 mycotoxins tested herein, ¬yet in livestock, AFB1 tend to be the most
potent mycotoxin in impairing performance and health (Chen et al., 2014; Andretta e tal.,
2011; Yunus et al., 2011). This inconsistency might be due to limited activity of hepatic
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enzymes in the fibroblasts, as AFB1 needs to undergo an extensive transformation by the
hepatic cytochrome P450 family into the metabolically active metabolite, exo-AFB1-8, 9epoxyde, to exert its toxicity (Yunus et al., 2011). However, the hepatic cells (HepG2)
herein were less sensitive at detecting AFB¬1 below 72h exposure, indicating that the DEF
still retain reasonable activity of the transformation enzymes to activate AFB1.
Whether in vitro IC50 values can be used to predict in vivo toxicity with sufficient
accuracy has received much interest yet is still a challenging question. Creppy et al. (2004)
used IC50 obtained from 3 cell lines to estimate starting doses for in vivo acute toxicity of
FB1 using the following prediction model: log (LD50 [mmol/kg])=(0.435 log
IC50[mmol/l])+0.625, and their estimated in vivo LD50 for FB1 were 671 to 923 mg/kg.
Using the same model, estimated in vivo LD50 for AFB1, DON, and FB1 based on our
results were 252, 208, and 510 mg/kg. These concentrations of FB1 might be relevant for
broilers, but can be significant overestimations in the case of AFB1 and DON for both
poultry and pigs. While broilers are more tolerant to FB1 toxicity, a contamination ≥ 20
mg/kg in final feed can significantly reduce growth of pigs (Dersjant-Li et al., 2003). For
poultry, the FDA regulation limits concentrations of AFB1, DON, and FB1 in final feeds
to be 0.1, 50, and 5 mg/kg; but different susceptibility still exists even among poultry
species. In the case of AF, the concentration of AFB1 that reduces 50% body weight for
ducklings (approximately 0.45 mg/kg) is much lower compared to that for broilers (> 4
mg/kg) (Chen et al., 2014). Nevertheless, instead of acute clinical mycotoxicosis induced
by high dose of mycotoxin contamination, the bigger concern in practice is subclinical
effects resulting from chronic low intake of mycotoxins. The latter often include depressed

263
feed intake, reduced feed efficiency, and impaired growth performance and production
along with compromised health of the animals, which ultimately result in economic loss to
the producer. This reiterates the complexity of validating and appropriately interpreting
results from a cell based bioassay. Based on the review by Gutleb et al. (2002) which
summarized 149 cytotoxicity studies for Fusarium mycotoxins, remarkable discrepancies
of the IC50 values exist between cell lines even for the same mycotoxin. Thus, future
research should focus on the identification of sensitive cell models for a particular mode of
action and subsequent exploration of species-specific prediction models for in vivo toxicity.
For such purpose, several critical points of a bioassay must be strictly defined in order to
allow more consistency in the results and better comparability between laboratories (Gutleb
et al., 2002; Cheli et al., 2014). Additionally, further attention should be given to the
understanding of additive, synergistic, and antagonistic effects of multiple mycotoxins in
in vitro systems and implications for animal responses as well as feed and food safety
regulations.
Together, the observations herein demonstrated a higher sensitivity of primary DEF to
mycotoxins compared to HepG2. Primary DEF has been used largely in virology studies,
particularly in studies of hepatitis virus and avian influenza (Witter et al., 1969; Volmer et
al., 2010; Su et al., 2011), yet by far has not been applied in cytotoxicity research. Our
results showed that when ranking of toxicity potentials is desired, both MTT and alamar
blue assays in primary DEF can generate comparable results as in HepG2 cells. Because
of the higher sensitivity of primary cells over cell lines, along with the advantages of
fluorescent assay over colorimetric assay, application of alamar blue assay in primary DEF
could be a more powerful tool for cytotoxicity screening in vitro. Indeed, the DEF-alamar
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blue assay showed the highest sensitivity (lowest IC50) in detecting toxicity of compounds
of interest based on our results. In conclusion, our results suggest that fresh primary DEF
has high sensitivity to various cytotoxins and mycotoxins, and thus may have great
potential in serving as a cytotoxicity screening model in vitro.
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Table 8.1. IC50 values (mM) of 7 chemicals obtained by MTT and alamar blue assays in HepG2 cells and primary duck embryo
fibroblasts (DEF) 1
Alamar blue assay

a-d

1

MTT assay

P-value

DEF

HepG2

DEF

HepG2

SEM

Cell

Assay

Interaction

Sodium lauryl sulfate

0.065 c

0.171 bc

0.449 a

0.200 b

0.042

0.6006

0.0004

0.0022

Acrylamide

11.19 b

36.46 a

7.84 b

14.25 b

2.473

0.0003

0.0003

0.0024

Allyl alcohol

14.09 c

147.86 a

15.96 c

58.26 b

7.259

<0.0001

<0.0001

<0.0001

Copper sulfate

0.169

0.620

0.050

0.441

0.033

<0.0001

0.0008

0.40

Phenol

8.85 c

36.23 a

9.57 c

18.60 b

1.227

<0.0001

0.0001

<0.0001

Nitrobenzene

6.97 b

96.98 a

8.08 b

15.42 b

2.657

<0.0001

<0.0001

<0.0001

Tetracholoethylene

25.80 d

194.77 a

104.41 c

147.70 b

8.689

<0.0001

0.0482

<0.0001

Means with no common superscripts within a row are significantly different (P <0.05).

Reported values represent means of at least 3 independent experiments.
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Table 8.2. IC50 values (μg/ml) of aflatoxin B1, fumonisin B1, and deoxynivalenol (DON)
following 24-, 48-, and 72-h exposure in primary duck embryo fibroblasts (DEF) and
HepG2 cells measured by the Alamar blue bioassay 1
Mycotoxins

Time (h)

Aflatoxin B1

24

Fumonisin B1

DON

HepG2

DEF
IC50

r2

---2

52.02

0.75

48
72

--12.55

33.86
3.69

0.82
0.94

24

---

---

48
72
24
48

------540.8

14.27
4.19
3.61
1.64

IC50

r2

0.83

0.66

0.70
0.94
0.80
0.86

72
51.46
0.34
1.26
0.89
represent average of at least 3 three experiments.
2 IC value was not calculated because data didn’t fit the Hill function non-linear
50
regression model (no reduction of cell viability).
1 Means
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Figure 8.1. Concentration-response curves of 7 chemicals tested in MTT and Alamar blue
assays in primary duck embryo fibroblast (DEF). Data are means of at least three
experiments ±SEM.
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Figure 8.2. Concentration-response curves of 7 chemicals tested in MTT and Alamar blue
assays in Human HepG2 cells. Data are means of at least three experiments ±SEM.
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Figure 8.3. Linear regression analysis comparing cytotoxicity responses from MTT and
alamar blue assays in HepG2 cells and primary duck embryo fibroblasts (DEF). X= log
IC50 (first assay) and Y= log IC50 (second assay). Y=aX+ b, equation of regression. r2=
coefficient of correlation. P-value: level of significance. Black dots represent the 7
chemical treatments: (1) sodium lauryl sulfate (2) acrylamide (3) allyl alcohol (4) copper
sulfate (5) phenol (6) nitrobenzene (7) tetracholoethylene, respectively.

Figure 8.4. Concentration-response curves of aflatoxin B1, fumonisin B1, and deoxynivalenol (DON) tested by Alamar blue assay
in primary duck embryo fibroblast (DEF) and Human HepG2 cells. Data are means of at least three experiments ±SE

0
-0 .5

0 .0

0 .5

1 .0

50

0
-1 .5

1 .5

0 .0

0 .5

1 .0

50

0
-1 .5

1 .5

-1 .0

-0 .5

0 .0

0 .5

1 .0

4 8 h A f la t o x in B 1

4 8 h F u m o n is in B 1

48h DON

H epG 2

50

0
-1 .0

-0 .5

0 .0

0 .5

1 .0

1 .5

H epG 2

50

0
-1 .5

H epG 2

50

0 .0

0 .5

1 .0

H epG 2

50

0
-1 .5

1 .5

-1 .0

1 .0

L o g c o n c e n t r a t i o n (  g /m l)

1 .5

DEF
H epG 2

50

0
-0 .5

0 .0

0 .5

1 .0

L o g c o n c e n t r a t i o n (  g /m l)

0 .0

0 .5

1 .0

1 .5

72H D O N

100

-1 .0

-0 .5

L o g c o n c e n t r a t i o n (  g /m l)

1 .5

DEF

100

H epG 2

50

275

0

C e ll v ia b ility (% o f c o n tr o l)

DEF

0 .5

-0 .5

DEF

7 2 h F u m o n is in B 1

100

0 .0

-1 .0

1 .5

100

L o g c o n c e n t r a t i o n (  g /m l)

7 2 h A f la t o x in B 1

-0 .5

DEF

100

C e ll v ia b ility (% o f c o n tr o l)

L o g c o n c e n t r a t i o n (  g /m l)

L o g c o n c e n t r a t i o n (  g /m l)

C e ll v ia b ility (% o f c o n tr o l)

-0 .5

H epG 2

L o g c o n c e n t r a t i o n (  g /m l)

DEF

-1 .0

-1 .0

DEF

100

L o g c o n c e n t r a t i o n (  g /m l)

100

-1 .5

H epG 2

C e ll v ia b ility (% o f c o n tr o l)

C e ll v ia b ility (% o f c o n tr o l)

-1 .0

DEF

100

C e ll v ia b ility (% o f c o n tr o l)

50

C e ll v ia b ility (% o f c o n tr o l)

H epG 2

C e ll v ia b ility (% o f c o n tr o l)

C e ll v ia b ility (% o f c o n tr o l)

DEF

100

-1 .5

24h DON

2 4 h F u m o n is in B 1

2 4 h A f la t o x in B 1

0
-1 .0

-0 .5

0 .0

0 .5

1 .0

L o g c o n c e n t r a t i o n (  g /m l)

1 .5

276

CHAPTER 9. SUMMARY

Aflatoxins (AF), especially AFB1, are major agriculture-relevant mycotoxins with
high prevalence in feeds and feed ingredients, posing serious risks to the livestock industry
globally. Extensive research reports are available on the adverse effects of AF on
performance, liver functions, and immune functions in broilers, but information about AF
effects on the gastrointestinal tract is rare and inconclusive. Among poultry species, ducks
are the most susceptible to AF toxicity, yet compared with broilers, limited research is
available on AF toxicity in ducks. In order to minimize the adverse effects of AFB1,
Hydrated sodium calcium aluminosilicate (HSCAS), a non-nutritive mycotoxin adsorbent,
has been used to reduce AFB1 absorption in poultry. However, because of the diverse types
of aluminosilicates and different processing methods, the HSCAS products may not
possess the same physical properties, and thus must be evaluated individually to determine
their efficacy in animals. Also, the efficacy of HSCAS has been less evaluated in ducks. In
addition to the non-nutritive AF adsorbents, dietary nutrients may also interact with
aflatoxin before and after intestinal absorption. Studies investigating this issue are
relatively limited, and most literature sources are dated, therefore, evaluation of such
interactive effects of nutrients and AF is needed for modern poultry species, which are
fundamentally very different from birds prior to the 1990s. On the other hand, a key step
in understanding mycotoxin effects and intervening effective counteractive strategies is the
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accurate analysis of mycotoxins or good estimation of the toxicity potential of a mycotoxincontaining sample. In recent years, cell culture models have been used extensively in
assessing in vitro toxicity of various toxins. However, cytotoxicity of AFB1 is less studied
in cells from poultry species. In order to fill in these gaps, a set of experiments were
designed to 1) determine the comprehensive effects, including that on gut health, of AFB1
in today’s broiler chicks and ducks, 2) evaluate the efficacy of a HSCAS to ameliorate
aflatoxicosis in broilers and ducks, 3) explore the interactive effects of dietary protein and
amino acids with aflatoxicosis in broilers and ducks, and 4) explore the potential of fresh
primary duck embryonic fibroblasts to screen cytotoxicity of various toxins in vitro.
Results from the first set of studies demonstrated that broiler chicks at 21 d of age
were not affected by 0.5 or 1 mg/kg AFB1, but 2 mg/kg AFB1 can significantly reduce feed
intake, BW gain, and gain to feed ratio, increase relative liver weight, negatively affect
serum measures (particularly serum proteins, Ca, P, and serum concentration of hepatic
enzymes) and complement activity, and alter hepatic gene expression associated with liver
anti-oxidant function, AFB1 metabolism, and immune functions. Compared with broilers,
ducks are indeed much more susceptibility to AFB1 toxicity; for every 0.10 mg/kg increase
in dietary AFB1, cumulative feed intake and BW gain decreased approximately 230 and
169 g per duckling from hatch to 14 d. Additionally, AFB1 at very low concentrations can
significantly impair liver function and gene expression, and innate immune measures in
Pekin ducklings. Ducks older than 14 d may become more resistant to AFB1 toxicity, but
the exact effect of age on aflatoxicosis in ducks remains to be elucidated. Regarding
intestinal functions, we have first revealed that AFB1 can directly affect intestinal barrier
function by increasing gut permeability in broiler chicks, which suggests a high possibility

278
that either the non-absorbed AF or the AF metabolites that are secreted back into the gut
through entero-hepatic circulation can have direct impact on the gut epithelium, and thus
are partly responsible for the physiological and metabolic disorders during aflatoxicosis.
Also, the endogenous N and amino acid loss during aflatoxicosis was first determined in
broilers; results indicate that diet AFB1 contamination has the potential to increase
endogenous N loss in broilers, and can significantly reduce energy, N, and amino acid
digestibility. Meanwhile, exposure to AFB1 also affects gene expression of major nutrient
transporters, tight junctions, and protein synthesis regulation pathway in broilers.
Conversely, effects of AFB1 on the gastrointestinal tract are less noticeable in ducks.
Jejunum morphology, digestive enzyme activity, and apparent energy digestibility of 14 d
Pekin ducklings were altered by 0.2 mg/kg AFB1, but the negative effects of AFB1 resulted
primarily from inhibition of feed intake for ducks.
In broilers, supplementing HSCAS at 0.05% effectively improved BW gain from
14 to 21 d, and partially ameliorated aflatoxicosis by reducing relative liver weight, and
partially restoring the negatively affected serum biochemistry measures. Whilst in Pekin
ducks, inclusion of 0.05% HSCAS improved BW gain and feed intake of 14-d old ducks
fed 0.2 mg/kg AFB1 to control levels, but did not improve 20-d growth performance. The
latter may indicate that while older birds became more resistant to AFB1, reducing AFB1
absorption by HSCAS may be less influential on the birds’ performance. Supplementation
of HSCAS also improved a few serum measures (Ca, ALT and GGT) and serum
complement activity (Rb L100 and L50 values), suggesting that HSCAS can partially
prevent hepatocyte damage in ducks when exposed to AF. However, there was a lack of
effectiveness of HSCAS in improving the majority of serum measures and liver lesions.
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Interestingly, in both broilers and ducks, HSCAS improved the liver antioxidant functions
by upregulating the mRNA expression and protein activity of major anti-oxidant enzymes,
suggesting this particular HSCAS may stimulate anti-oxidant function and improve the
ability of the birds to cope with oxidative stress during aflatoxicosis. Whether this is a
direct effect on the liver and/or indirect result from reduced AFB1 absorption remains to
be determined.
The impact of dietary crude protein concentration was evaluated in broilers and ducks
during aflatoxicosis. In 20-d broiler chicks, compared with those fed control diet (22% CP),
higher dietary protein concentration (26%) significantly improved performance, major
serum measures, and nutrient digestibility of the birds; while lower dietary protein (18%)
dramatically exacerbated aflatoxicosis in broilers. The growth performance and health
impairment (including serum measures, gut permeability, and N and amino acid
digestibility) from aflatoxicosis were augmented when birds were fed a lower CP diet, and
were completely eliminated by higher CP diet. Conversely, there were no statistical
interactive effects between aflatoxin and dietary CP concentration in 14-d Pekin ducks, but
higher dietary CP had main effects of increasing G:F ratio and thus partially restored the
BW gain of the birds. Nevertheless, reduced FI cannot be restored by higher dietary CP
supply, and therefore, feeding higher dietary CP may be a nutritional approach to attenuate
aflatoxicosis in broilers, but may be less successful in Pekin ducks. On the other hand, in
both broilers and ducks, feeding low protein diets exacerbated the negative effects of AF,
either significantly or numerically. Therefore extra caution is needed when feeding low CP
diets, especially at times when the weather or storage conditions favor AF production in
feed ingredients.
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Branched chain amino acids are key regulators in the initiation of protein synthesis.
While higher dietary crude protein was able to completely ameliorate symptoms associated
with aflatoxicosis, higher dietary BCAA improved all performance measures in broilers
exposed to AFB1, yet there was no statistical interaction observed. Thus, the effects of
BCAA were independent of AFB1 exposure, and that the beneficial effects of higher BCAA
in the current study may have come from stimulated feed intake together with enhanced
utilization of amino acids (thus improved feed efficiency), but BCAA may also influence
other functions of the animal based on altered nutrient digestibility and serum biochemistry
measures. These observations emphasize the complexity of the dynamic relationship
between aflatoxicosis and dietary nutrients. The exact roles that BCAA and their
metabolites play in poultry with or without AFB1 exposure and the respective mechanisms
await further research to better understand AF-diet interactions.
By exploring the response of fresh primary duck embryonic fibroblasts to various
cytotoxins and mycotoxins, it was demonstrated that primary DEF had a higher sensitivity
to toxins compared to HepG2 cells. Because of the higher sensitivity of primary cells over
cell lines, along with the advantages of fluorescent assay over colorimetric assay,
application of alamar blue assay in primary DEF has great potential in serving as a more
powerful tool for cytotoxicity screening in vitro. Although the questions remains whether
in vitro IC50 values can be used to predict in vivo toxicity with sufficient accuracy is still
unknown, good in vitro estimation of the toxicity potential of samples may be useful in
initial screening of feed and feed ingredients. Future research should focus on the
identification of sensitive cell models for a particular mode of action and subsequent
exploration of species-specific prediction models for in vivo toxicity. Additionally, further
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attention should be given to the understanding of additive, synergistic, and antagonistic
effects of multiple mycotoxins in in vitro systems and implications for animal responses as
well as feed and food safety regulations.
Collectively, the experiments presented, along with further research, will begin to
unravel an ever clearer picture of the comprehensive impact of AFB 1 in poultry species
upon different dietary modification conditions. With better understanding of the
interrelationships between AFB1, nutrients, and animal health, a revolution of aflatoxicosis
prevention and optimal poultry production will expectantly follow.
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